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ABSTRACT 
The aim of this study was to investigate the effects of various polysaccharides and their 
breakdown products on the proliferation and migration of cells involved in wound 
healing, both in vitro and in vivo, with the ultimate aim of developing a commercially 
viable collagen dressing containing an active polysaccharide fragment which would 
stimulate the wound healing response to such a degree that good quality and 
significantly faster healing would take place. 
Hyaluronic acid (HA), chondroitin sulphate (CS), heparin, Oxidised Regenerated 
Cellulose (ORC) and pectin were tested in this study. Some HA fragments and CS 
fragments significantly stimulated (p<O.05) the proliferation of Bovine Aortic 
Endothelial (BAEC) cells, although other HA or CS fragments were without effect. All 
HA and CS fragments tested also had no effect on the migration of L929 cells in the 
Boyden Chamber assay. Pectin stimulated the proliferation and migration of L929 cells, 
whereas, ORC 1 and heparin both suppressed proliferation (25% - 45% inhibition) of 
these cells but stimulated their migration. When injected subcutaneously into Polyvinyl 
alcohol sponges in the rat wound model at concentrations of 10 and 50J.1g/ml, heparin 
brought about an increased presence of granulation tissue in the wound after 10 days 
and 7 days respectively. 
These results indicate that structurally similar polysaccharides can have profoundly 
different effects on cell proliferation and migration, and thus have potential therapeutic 
use in guiding cell movement in wound healing. 
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AIMS OF THE STUDY 
Chronic wounds are defined as those which do not follow the expected sequence of 
repair in terms of healing time, appearance and response to appropriate treatment. They 
can be divided into 2 distinct categories by their etiology : (i) pressure, ischaemic, 
venous, neuropathic and diabetic ulcers and (ii) infected, traumatic, and dehisced post-
surgical wounds. Their degree of severity can range from epidermal injury to full-
thickness skin loss with subsequent tissue necrosis which can affect underlying 
structures such as muscle, tendon and bone. Treatment of chronic wounds has changed 
in recent years due to the discovery of specific mechanisms which regulate repair. To 
date however, there are no products on the market that have proven clinically to reduce 
the healing time of chronic wounds although many investigators are studying this area. 
Some of these treatments are discussed below. 
The addition of growth factors to chronic wounds (Robson et ai, in press; Marks et ai, 
1991; Robson et ai, 1992) has had encouraging results, however, the cost to 
manufacture these on a large scale may result in a costly product and may not be 
commercially viable for hospitals who have to treat hundreds of thousands of patients 
each year. Other treatments have included the addition of extracellular matrix 
molecules, such as collagen with added glycosaminoglycans (GAGs) which are known 
to influence the adhesion, proliferation and differentiation of cells (Yannas & Burke, 
1980; Hook et ai, 1982; McPherson et ai, 1988; Doillon et ai, 1988; Srivastava et ai, 
1990). 
XXlV 
It has previously been reported that Hyaluronic acid (HA) oligosaccharides have the 
ability to stimulate angiogenesis in the chick chorioallantoic membrane in vivo and 
endothelial cell proliferation in vitro (West & Kumar, 1989; Rooney et ai, 1993). These 
findings suggest there may be a role for the degradation products of HA and other 
GAGs in the wound healing process. 
Currently, Johnson & Johnson have a number of collagen dressings on the market 
including Instat (haemostat) and Fibracol (collagen-alginate topical dressing), are keen 
to expand the product range by incorporating a bioactive polysaccharide(s) in into these 
dressings in order to stimulate chronic wound healing. 
The aims of this project therefore were: 
• To investigate the role of certain naturally occurring plant and animal 
polysaccharides and their oligosaccharides, in addition to one synthetically derived 
polysaccharide, on their ability to inhibit or stimulate cell types associated with 
wound healing in order to ascertain their potential to stimulate the wound healing 
process. 
• To ascertain whether these polysaccharides and oligosaccharides stimulate wound 
healing processes in certain animal models both in combination with collagen and on 
their own. 
• To develop a wound healing dressing prototype that would reduce healing time of 
chronic wounds significantly. 
xxv 
GENERAL INTRODUCTION 
1.1 INTRODUCTION 
The first written records documenting wound healing come from Ancient Egypt. They 
describe the use of fresh meat, fat, honey and castor oil as dressings or adhesive plaster 
to bring wound edges together. In later years, the Romans irrigated wounds with wine, 
sea water and oil and laid figs on ulcerating wounds (Cohen et ai, 1992). By 1346, 
English soldiers were carrying boxes of spiderwebs to lay across their bleeding wounds 
and circa 1600, Shakespeare described the use of flax and egg-white for bleeding face 
wounds in several of his plays. The materials used for dressings were most commonly 
linen and flax, but, wool, cotton and flannel were also used (Cohen et ai, 1992). 
During the past 25 years the wound dressing market has developed quickly primarily 
due to the work of George Winter (1962) on the effects of occlusive dressings in pigs. 
He developed the criteria for the ideal wound dressing and this resulted in the 
production of many new wound products. He advocated that the ideal dressing should 
(a) maintain a moist environment, (b) remove excess exudate, (c) permit gaseous 
exchange, (d) demonstrate impermeability to microorganisms, (e) demonstrate a low 
level of adherence to the wound and (t) be free from particulate and toxic contaminants. 
Even today, wound management products have incorporated some of these principles: 
some devices are intended as a mechanical barrier for compression or absorption of 
exudates, whereas others are intended to manage the micro-environment of wounds 
(Collyer, 1994). 
1.2 WOUND HEALING 
There are several excellent texts on wound healing (Fowler, D. 1989; Morgan & 
Pledger, 1992; Asmussen & Sollner, 1993). The following section will only attempt to 
summarise these works and introduce new findings where appropriate. 
The healing response can be conveniently separated into 4 major biological 
components: (1) the vascular response, (2) blood coagulation, (3) inflammation and (4) 
formation of new tissue. The four components of wound healing do not occur one after 
the other but overlap to varying degrees and are described in the following sections. 
1.2.1 Vascular Response 
A cutaneous or deep wound is usually accompanied by bleeding and this has the effect 
of cleaning the wound by washing out any foreign bodies which may be present. A few 
seconds later, the blood vessels begin to constrict which prevents further blood loss and 
a clot is formed (Weksler, 1988). Following vasoconstriction, mast cells release 
histamine and serotonin that promote vasodilation to allow the recirculation of blood 
and this results in a local rise in temperature around the wound after about 10 minutes 
(Westaby, 1985). The mast cell components also cause the endothelial cells in the 
vessels to move apart, thereby increasing the permeability of the capillary walls to allow 
erythrocytes, leukocytes, platelets and plasma to move from the blood into the wound 
(Wahl & Wahl, 1992). Finally, the wound becomes oxygen deficient due to vascular 
stasis and the high concentration of CO2 causes the accumulation of fluid in the tissue. 
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1.2.2 Blood Coagulation 
The body creates its own "bandage" by forming a scab. Scab formation is regulated by 
the blood vessel walls, platelets, damaged connective tissue cells and the coagulation 
system and begins when damaged cells release suitable mediators to initiate the 
coagulation cascade (Wahl & Wahl, 1992). When damage occurs to a vessel wall, 
mediators like von Willebrand factor immediately adhere to the collagen exposed on the 
vessel wall and this stimulates platelets to change their shape from flat discs to spherical 
structures with long pseudopods (Sixma & Wester, 1977). With these processes, they 
make contact with each other and accumulate to form a plug. This is mediated by the 
release of Thromboxane A2 which stimulates platelet aggregation (Fowler, 1989). The 
blood clot itself consists of a fibrin and fibronectin mesh in which other blood cells such 
as erythrocytes are caught (Adzick & Longaker, 1992). The clot rapidly dries in air 
thereby protecting the wound from the external environment and preventing further 
blood loss. The deposition of this fibrin matrix is thought to provide a scaffold on which 
inflammatory cells can enter the wound site (Weigel et ai, 1986). 
1.2.3 Inflammation 
The first cells to appear at the wound site are the neutrophils which have the ability to 
phagocytose and release enzymes which break down degenerating connective tissue. 
Their primary role is to create a bacteria free wound and rapidly decrease in number 
when no infection is present (Fowler, 1989). Soon after, monocytes are attracted into 
the wound by chemotactic factors such as Platelet Derived Growth Factor (PDGF), 
Transforming Growth Factor P (TGFB) and C5a (Ross et al., 1986; Wahl et al., 1987; 
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Marder et al., 1985). Once in the wound, the monocytes transfonn into macrophages 
and reach maximum numbers after 24 hours (Fowler, 1989). The function of the 
macrophage is as a phagocyte-destroying bacteria and cellular debris, however it also 
produces or releases many growth factors needed for the fonnation of granulation tissue 
(Knighton & Fiegel, 1989). 
In addition to the non-specific defence system, the body also has a specific immune 
response in which antibodies are effective against a specific antigen (Barbul, 1992). 
Antibodies are produced by B-Iymphocytes and are assigned to different 
immunoglobulin classes: IgG, 19A, IgM, IgE and IgD (Roitt, 1980). The 
immunoglobulins circulate in the serum and on recognising an antigen, either bind to it 
or mark it for destruction by phagocytes. In conjunction with B-Iymphocytes which 
produce antibodies, T -lymphocytes are also involved in specific defence. They do not 
produce antibodies but instead act as "killer cells", identifying and destroying foreign 
cells, thereby fighting infection and encouraging new tissue fonnation. The immune 
response will not be described further. 
1.2.4 Formation of New Tissue 
To ensure good wound healing, new blood vessels begin to bud from intact vessels and 
grow into the wound, activated by growth factors and other mediators already present in 
the wound (Whalen, 1992). Parallel to this vascularisation, fibroblasts migrate along the 
fibrin matrix, rapidly dividing and producing proteoglycans and collagen fibres 
essential for the stability of the tissue (Morgan & Pledger, 1992). The new vascularised 
4 
tissue forms small, rounded nodes of tissue on the wound bed known as granulation 
tissue, and appears granular, dark red and shiny. 
Following granulation tissue formation, the fibrin matrix is broken down by the enzyme 
plasmin and fibroblasts transform into fibrocytes or myofibroblasts, the latter being able 
to draw the wound edges together by contraction (Fowler, 1989). At the end of the 
wound healing process, the wound is closed by epithelialisation. This is initiated by an 
increased rate of cell division in the basal layer of the epidermis and migration of the 
resulting epithelial cells towards each other from the wound margins, resulting in the 
defect being covered by a fine layer of skin (Chernoff & Robertson, 1990). Repair is not 
complete until some time after coverage by the epithelium and an increase in the tensile 
strength has been achieved. Remodelling of the new tissue takes months with the 
deposition of type 1 collagen fibrils, resulting in the formation of a scar, which lacks 
some components of normal tissue and it is therefore less functional (Adzick & 
Longaker, 1992). 
1. 3 EXTRACELLULAR MATRIX COMPONENTS IN WOUND 
HEALING 
The extracellular matrix (ECM) has an important role in wound healing. In the past, it 
was thought to be an inert support material, providing a scaffold that stabilised the 
physical structure of tissues (Alberts et aI, 1983) The ECM is now known to influence 
adhesion, migration, proliferation and differentiation of cells (Hook et aI, 1982). The 
ECM is composed of two main classes of extracellular macromolecules: collagen and 
glycosaminoglycans. The collagen fibres strengthen and help to organise the matrix, 
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while the gel-like glycosaminoglycans permit the diffusion of nutrients, metabolites and 
hormones between the blood and the tissue cells. Elastin, proteoglycans, fibronectin and 
laminin are also part of the ECM (Alberts et ai, 1983). The relative amounts of the 
different types of matrix macromolecules and the way they are organised within the 
ECM vary with the type of matrix. 
1.3.1 
1.3.1.1 
Collagen 
Introduction 
The collagens are a family of highly characteristic fibrous proteins found in all 
multicellular animals. They constitute 25% of the total protein in mammals and are 
therefore extremely abundant. The polypeptide chains have the repeating structure of 
Gly-X-Y, where X is usually proline and Y hydroxyproline. This sequence does not 
apply to the non-helical domains at each of the collagen molecule. The triple helix 
consists of 3 alpha chains wrapped around each other with each chain containing about 
1000 amino acids, right-handed and rod-shaped (Bailey, 1985). Collagen is responsible 
for many of the essential characteristics of connective tissue, particularly their 
mechanical and biological properties (Bailey & Light, 1989; Gorham S.D., 1991). To 
date, 16 different genetic forms have been isolated and identified. Some of these types 
and their structures are listed in Table 1.1 (Bailey & Light, 1989 ; Martin et ai, 1985 ; 
Summers et ai, 1988). Type I is the major component of most collagen based prosthetic 
materials. 
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Type Molecular Configuration Tissue Location 
I [al(l)h a2(1) Bone, cornea, skin, 
tendon 
II [a 1 (I) h trimer Tumours, skin 
III [a 1(111)]3 Cartilage, vitreous 
IV [al(IV)h a2(IV), plus a.3(IV), a.4(IV), Basement membranes 
a.5(IV) chains 
V [al (V) h a2(V)] Placental tissue, bone, 
[al(V)]2 a2(V) a.3(V)] skin 
[a I (V)h 
VI [a.l(VI) a.2(VI) a.3(VI)] Uterus, skin, cornea, 
cartilage 
VII [a I (VII)h Amniotic membrane, 
skin, oesphagus 
VIII [a I (VIIlh a2(VIII)] Endothelial cells 
IX [a 1 (IX) a.2(IX) a.3(IX)] Cartilage, vitreous 
X [a I (X)h Calcifying cartilage 
XI [a I (XI) a.2(XI) a.3(XI)] Cartilage, invertebral disc 
XII [a I (XII)h Skin, tendon, cartilage 
XIII a. 1 (XIII) Endothelial cells, 
epidermis 
XIV [a. 1 (XIV)]3 Skin, tendon, cartilage 
Table 1.1 The Collagen Family 
1.3.1.2 Synthesis of Collagen 
Synthesis of collagen has been described in many reviews (Duance & Bailey, 1981 ; 
Last & Reiser, 1984; Burgeson & Nimni, 1992), and therefore only a brief account will 
be given here. 
The precursor chains of the collagen molecule are synthesised on ribosomes, transferred 
into the endoplasmic reticulum where the signal sequences are removed, then secreted 
in secretory granules from the Golgi apparatus in its triple helical form (Duance & 
Bailey, 1981; Weinstock & Leblond, 1974). The individual collagen molecules then 
spontaneously aggregate to form a "quarter-stagger" arrangement to form fibrils. The 
heads of the collagen molecules are staggered along the length of the fibril resulting in 
the characteristic 64 nm spacing of cross-striations (Duance & Bailey, 1981). Following 
formation of the fibrils, intermolecular cross-linking takes place which stabilises the 
collagen (Eyre, 1985). 
1.3.1.3 Degradation of Collagen 
Collagen degradation is important in the repair or replacement of damaged tissue in 
wound healing. There are three groups of enzymes which are responsible for collagen 
degradation: the metalloproteinases, neutral proteinases and lysosomal cathepsins 
(Duance & Bailey, 1981 ; Sellers & Murphy, 1981). During degradation, collagen 
fragments are generated from the fibre which are then capable of being phagocytosed 
and degraded in lysosomes by acid-proteinases (Bailey & Etherington, 1985) 
Collagen and collagen-derived peptides have been found to serve as chemoattractants 
for fibroblasts and neutrophils in vitro and therefore may function as chemotactic 
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stimuli to effect cell migration to sites of inflammation in vivo (Laskin et ai, 1986; 
Postlethwaite et al., 1978; Albini & Adelmann-Grill, 1985). Such a role for collagen 
peptides may be important in the development of biological dressings. 
1.3.2 Glycosaminoglycans 
Glycosaminoglycans (GAGs) are high molecular weight carbohydrate polymers and are 
important structural elements of the extracellular matrix of animal connective tissue. 
They consist of polymers of repeating disaccharide units that contain a hexosamine and 
either a carboxylate or sulphate ester, or both, which provide the chains with linear 
arrays of anionic groups. The following GAGs are found in mammalian tissues : 
hyaluronic acid, chondroitin 6-sulphate, chondroitin-4-sulphate, dermatan sulphate, 
heparin, heparan sulphate and keratan sulphate and the principal repeating units of the 
individual GAGs are shown in Fig 1.1 
GAGs normally exist covalently bound to core proteins in the form of proteoglycans. 
Table 1.2 shows the five different classes of proteoglycan each differing in GAG 
composition, core protein size or source (Templeton, 1992). Family a proteoglycans 
consist of multiple glycosaminoglycan chains. This family of proteoglycans associate 
with hyaluronic acid to form large aggregates, and reside in the extracellular 
compartment. Aggrecan belongs to this family and has a 220kDa core protein with over 
100 chondroitin sulphate chains and a keratan sulphate-rich region also (Doege et ai, 
1987). Family b proteoglycans are small molecules containing only 1 or 2 GAG chains 
and are found in the connective tissue (Templeton, 1992). Decorin belongs to this 
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NAM:E SOURCE CORE GAG CHAINS 
PROTEIN SIZE 
(kDa) 
Family a Large extracellular 
proteoglycans 
Aggrecan Cartilage 220 > l000CS, > 10KS 
Versican Fibroblasts 265 12-15 CS 
Family b Small connective 
tissue 
proteoglycans 
Decorin Many cells 36 IDS 
Biglycan Many cells 38 2DS 
Fibromodulin Many cells 41 lKS 
Family c Basement 
membrane heparan 
sulphates 
EHS tumour 400 2-3 HS 
Glomerular 30-400 2-6HS 
basement membrane 
Family d Cell surface 
proteoglycans 
Syndecan Mammary 31 1-2 CS, 1-2 HS 
epithelium 
Betaglycan Fibroblasts 110 CS,HS 
Hepatocytes 35-77 HS 
Thrombomodulin Endothelial cells 60 1 CS 
Familye Intracellular 
proteoglycans 
Serglycin Many cells 17-19 Heparin, CS, DS, 
HS 
Table 1.2 Classification of Proteoglycans 
family and has a core protein of only 40kDa (Krusius & Ruoslahti, 1986). Family c 
proteoglycans are the basement membrane heparan sulphate proteoglycans which have 
large core proteins (400kDa), but only have 2 to 4 heparan sulphate chains (Templeton, 
1992). Family d are the cell surface proteoglycans such as the mouse mammary 
epithelial proteoglycan, syndecan. Syndecan consists of a 30kDa core protein with a 
hydrophobic transmembrane domain and has chondroitin and heparan sulphate chains in 
the extracellular region (Saunders et ai, 1989). The last family, Family e, are the 
intracellular proteoglycans which include serglycin, a 15-20kDa proteoglycan. 
Serglycin contains either chondroitin, dermatan or heparan sulphates and can be shed 
from the surface of the cell during development (Templeton, 1992). 
Each GAG chain is attached by one of three linkages to the core protein of 
proteoglycans. Type 1 linkages were fIrst isolated from chondroitin sulphate and consist 
of an O-glycosidic linkage between D-xylose and the hydroxyl group of a serine residue 
(Roden & Smith, 1966), whereas Type 2 linkages are recognised by an N-
glycosylamine linkage between N-acetyl glucosamine and the amide group of 
asparagine and are seen in corneal keratan sulphate (De Luca et al., 1980). Skeletal 
keratan SUlphate exhibits the type 3 linkage which is an O-glycosidic linkage between 
N-acetyl galactosamine and the hydroxyl groups of threonine or serine (Bray et al., 
1967). 
1.3.3 Hyaluronic Acid 
Hyaluronic acid (HA) glycosaminoglycan, is a linear polysaccharide composed of two 
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alternately linked sugars, D-glucuronic acid and N-acetylglucosamine (Fig 1.1a). The 
molecular weight of HA varies from an average low value of 70,000 for bovine vitreous 
humour HA, to 12 X 107 for HA isolated from bovine synovial fluid (Varga, 1955; 
Silpananta et aI., 1968). HA occurs in different concentrations and in different forms in 
tissues, for example, in cartilage, the concentration of free HA is relatively small as it is 
associated with proteoglycans, whereas in synovial fluid it occurs mainly in solution 
(Hardingham & Muir, 1972; Swann, 1978). HA is well known for its viscoelastic and 
joint lubricating properties and has had medical applications as a vitreous substitute in 
retina-reattachment surgery and in the treatment of osteoarthritis (Balazs et ai, 1972; 
Peyron & Balazs, 1974; Derlinger & Balazs, 1980). HA is known to have various 
effects on cell proliferation which may reflect its role in the wound healing process. 
West & Kumar demonstrated that angiogenic HA oligo saccharides (between 3-16 
disaccharides) in vivo, stimulated endothelial cell proliferation and collagen production 
in vitro, whereas bigger oligo saccharides had no effect or inhibited endothelial cell 
proliferation (West & Kumar, 1989; Rooney et al., 1993). Native HA has also been 
reported to have no effect on the proliferation of bovine adrenal capillary cells, 
epithelial cells, smooth muscle cells, fibroblasts and pericytes (Orlidge & D'Amore, 
1986), although size independent inhibition has been shown with rabbit synovial cells 
and 3T3 fibroblasts by Goldberg & Toole, (1987). The difference in findings between 
the latter and those ofOrlidge & D'Amore (1986) may be due to the fact that different 
sources of cells were used and were cultured under different conditions, however there 
may be more fundamental reasons for these findings which will need further research to 
elaborate. HA exists in concentrations between 0.05 and 3mg/ml in adult tissues, but in 
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GENERAL INTRODUCTION 
1.1 INTRODUCTION 
The first written records documenting wound healing come from Ancient Egypt. They 
describe the use of fresh meat, fat, honey and castor oil as dressings or adhesive plaster 
to bring wound edges together. In later years, the Romans irrigated wounds with wine, 
sea water and oil and laid figs on ulcerating wounds (Cohen et ai, 1992). By 1346, 
English soldiers were carrying boxes of spiderwebs to lay across their bleeding wounds 
and circa 1600, Shakespeare described the use of flax and egg-white for bleeding face 
wounds in several of his plays. The materials used for dressings were most commonly 
linen and flax, but, wool, cotton and flannel were also used (Cohen et ai, 1992). 
During the past 25 years the wound dressing market has developed quickly primarily 
due to the work of George Winter (1962) on the effects of occlusive dressings in pigs. 
He developed the criteria for the ideal wound dressing and this resulted in the 
production of many new wound products. He advocated that the ideal dressing should 
(a) maintain a moist environment, (b) remove excess exudate, (c) permit gaseous 
exchange, (d) demonstrate impermeability to microorganisms, (e) demonstrate a low 
level of adherence to the wound and (f) be free from particulate and toxic contaminants. 
Even today, wound management products have incorporated some of these principles: 
some devices are intended as a mechanical barrier for compression or absorption of 
exudates, whereas others are intended to manage the micro-environment of wounds 
(Collyer, 1994). 
1.2 WOUND HEALING 
There are several excellent texts on wound healing (Fowler, D. 1989; Morgan & 
Pledger, 1992; Asmussen & Sollner, 1993). The following section will only attempt to 
summarise these works and introduce new findings where appropriate. 
The healing response can be conveniently separated into 4 major biological 
components: (1) the vascular response, (2) blood coagulation, (3) inflammation and (4) 
formation of new tissue. The four components of wound healing do not occur one after 
the other but overlap to varying degrees and are described in the following sections. 
1.2.1 Vascular Response 
A cutaneous or deep wound is usually accompanied by bleeding and this has the effect 
of cleaning the wound by washing out any foreign bodies which may be present. A few 
seconds later, the blood vessels begin to constrict which prevents further blood loss and 
a clot is formed (Weksler, 1988). Following vasoconstriction, mast cells release 
histamine and serotonin that promote vasodilation to allow the recirculation of blood 
and this results in a local rise in temperature around the wound after about 10 minutes 
(Westaby, 1985). The mast cell components also cause the endothelial cells in the 
vessels to move apart, thereby increasing the permeability of the capillary walls to allow 
erythrocytes, leukocytes, platelets and plasma to move from the blood into the wound 
(Wahl & Wahl, 1992). Finally, the wound becomes oxygen deficient due to vascular 
stasis and the high concentration of CO2 causes the accumulation of fluid in the tissue. 
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1.2.2 Blood Coagulation 
The body creates its own "bandage" by forming a scab. Scab formation is regulated by 
the blood vessel walls, platelets, damaged connective tissue cells and the coagulation 
system and begins when damaged cells release suitable mediators to initiate the 
coagulation cascade (Wahl & Wahl, 1992). When damage occurs to a vessel wall, 
mediators like von Willebrand factor immediately adhere to the collagen exposed on the 
vessel wall and this stimulates platelets to change their shape from flat discs to spherical 
structures with long pseudopods (Sixma & Wester, 1977). With these processes, they 
make contact with each other and accumulate to form a plug. This is mediated by the 
release of Thromboxane A2 which stimulates platelet aggregation (Fowler, 1989). The 
blood clot itself consists of a fibrin and fibronectin mesh in which other blood cells such 
as erythrocytes are caught (Adzick & Longaker, 1992). The clot rapidly dries in air 
thereby protecting the wound from the external environment and preventing further 
blood loss. The deposition of this fibrin matrix is thought to provide a scaffold on which 
inflammatory cells can enter the wound site (Weigel et ai, 1986). 
1.2.3 Inflammation 
The first cells to appear at the wound site are the neutrophils which have the ability to 
phagocytose and release enzymes which break down degenerating connective tissue. 
Their primary role is to create a bacteria free wound and rapidly decrease in number 
when no infection is present (Fowler, 1989). Soon after, monocytes are attracted into 
the wound by chemotactic factors such as Platelet Derived Growth Factor (pDGF) , 
Transforming Growth Factor P (TGFB) and C5a (Ross et al., 1986; Wahl et al., 1987; 
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Marder et aZ., 1985). Once in the wound, the monocytes transform into macrophages 
and reach maximum numbers after 24 hours (Fowler, 1989). The function of the 
macrophage is as a phagocyte-destroying bacteria and cellular debris, however it also 
produces or releases many growth factors needed for the formation of granulation tissue 
(Knighton & Fiegel, 1989). 
In addition to the non-specific defence system, the body also has a specific immune 
response in which antibodies are effective against a specific antigen (Barbul, 1992). 
Antibodies are produced by B-Iymphocytes and are assigned to different 
immunoglobulin classes: IgG, IgA, IgM, IgE and IgD (Roitt, 1980). The 
immunoglobulins circulate in the serum and on recognising an antigen, either bind to it 
or mark it for destruction by phagocytes. In conjunction with B-Iymphocytes which 
produce antibodies, T-Iymphocytes are also involved in specific defence. They do not 
produce antibodies but instead act as "killer cells", identifying and destroying foreign 
cells, thereby fighting infection and encouraging new tissue formation. The immune 
response will not be described further. 
1.2.4 Formation of New Tissue 
To ensure good wound healing, new blood vessels begin to bud from intact vessels and 
grow into the wound, activated by growth factors and other mediators already present in 
the wound (Whalen, 1992). Parallel to this vascularisation, fibroblasts migrate along the 
fibrin matrix, rapidly dividing and producing proteoglycans and collagen fibres 
essential for the stability of the tissue (Morgan & Pledger, 1992). The new vascularised 
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tissue forms small, rounded nodes of tissue on the wound bed known as granulation 
tissue, and appears granular, dark red and shiny. 
Following granulation tissue formation, the fibrin matrix is broken down by the enzyme 
plasmin and fibroblasts transform into fibrocytes or myofibroblasts, the latter being able 
to draw the wound edges together by contraction (Fowler, 1989). At the end of the 
wound healing process, the wound is closed by epithelialisation. This is initiated by an 
increased rate of cell division in the basal layer of the epidermis and migration of the 
resulting epithelial cells towards each other from the wound margins, resulting in the 
defect being covered by a fine layer of skin (Chernoff & Robertson, 1990). Repair is not 
complete until some time after coverage by the epithelium and an increase in the tensile 
strength has been achieved. Remodelling of the new tissue takes months with the 
deposition of type 1 collagen fibrils, resulting in the formation of a scar, which lacks 
some components of normal tissue and it is therefore less functional (Adzick & 
Longaker, 1992). 
1.3 EXTRACELLULAR MATRIX COMPONENTS IN WOUND 
HEALING 
The extracellular matrix (ECM) has an important role in wound healing. In the past, it 
was thought to be an inert support material, providing a scaffold that stabilised the 
physical structure of tissues (Alberts et ai, 1983) The ECM is now known to influence 
adhesion, migration, proliferation and differentiation of cells (Hook et ai, 1982). The 
ECM is composed of two main classes of extracellular macromolecules: collagen and 
glycosaminoglycans. The collagen fibres strengthen and help to organise the matrix, 
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while the gel-like glycosaminoglycans permit the diffusion of nutrients, metabolites and 
hormones between the blood and the tissue cells. Elastin, proteoglycans, fibronectin and 
laminin are also part of the ECM (Alberts et ai, 1983). The relative amounts of the 
different types of matrix macromolecules and the way they are organised within the 
ECM vary with the type of matrix. 
1.3.1 
1.3.1.1 
Collagen 
Introduction 
The collagens are a family of highly characteristic fibrous proteins found in all 
multicellular animals. They constitute 25% of the total protein in mammals and are 
therefore extremely abundant. The polypeptide chains have the repeating structure of 
Gly-X-Y, where X is usually proline and Y hydroxyproline. This sequence does not 
apply to the non-helical domains at each of the collagen molecule. The triple helix 
consists of 3 alpha chains wrapped around each other with each chain containing about 
1000 amino acids, right-handed and rod-shaped (Bailey, 1985). Collagen is responsible 
for many of the essential characteristics of connective tissue, particularly their 
mechanical and biological properties (Bailey & Light, 1989; Gorham S.D., 1991). To 
date, 16 different genetic forms have been isolated and identified. Some of these types 
and their structures are listed in Table 1.1 (Bailey & Light, 1989 ; Martin et ai, 1985 ; 
Summers et ai, 1988). Type I is the major component of most collagen based prosthetic 
materials. 
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1.3.1.2 Synthesis of Collagen 
Synthesis of collagen has been described in many reviews (Duance & Bailey, 1981 ; 
Last & Reiser, 1984; Burgeson & Nimni, 1992), and therefore only a brief account will 
be given here. 
The precursor chains of the collagen molecule are synthesised on ribosomes, transferred 
into the endoplasmic reticulum where the signal sequences are removed, then secreted 
in secretory granules from the Golgi apparatus in its triple helical fonn (Duance & 
Bailey, 1981; Weinstock & Leblond, 1974). The individual collagen molecules then 
spontaneously aggregate to fonn a "quarter-stagger" arrangement to form fibrils. The 
heads of the collagen molecules are staggered along the length of the fibril resulting in 
the characteristic 64 nm spacing of cross-striations (Duance & Bailey, 1981 ). Following 
fonnation of the fibrils, intennolecular cross-linking takes place which stabilises the 
collagen (Eyre, 1985). 
1.3.1.3 Degradation of Collagen 
Collagen degradation is important in the repair or replacement of damaged tissue in 
wound healing. There are three groups of enzymes which are responsible for collagen 
degradation: the metalloproteinases, neutral proteinases and lysosomal cathepsins 
(Duance & Bailey, 1981 ; Sellers & Murphy, 1981). During degradation, collagen 
fragments are generated from the fibre which are then capable of being phagocytosed 
and degraded in lysosomes by acid-proteinases (Bailey & Etherington, 1985) 
Collagen and collagen-derived peptides have been found to serve as chemoattractants 
for fibroblasts and neutrophils in vitro and therefore may function as chemotactic 
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stimuli to effect cell migration to sites of inflammation in vivo (Laskin et ai, 1986; 
Postlethwaite et al., 1978; Albini & Adelmann-Grill, 1985). Such a role for collagen 
peptides may be important in the development of biological dressings. 
1.3.2 Glycosaminoglycans 
Glycosaminoglycans (GAGs) are high molecular weight carbohydrate polymers and are 
important structural elements of the extracellular matrix of animal connective tissue. 
They consist of polymers of repeating disaccharide units that contain a hexosamine and 
either a carboxylate or sulphate ester, or both, which provide the chains with linear 
arrays of anionic groups. The following GAGs are found in mammalian tissues : 
hyaluronic acid, chondroitin 6-sulphate, chondroitin-4-sulphate, dermatan sulphate, 
heparin, heparan sulphate and keratan sulphate and the principal repeating units of the 
individual GAGs are shown in Fig 1.1 
GAGs normally exist covalently bound to core proteins in the form of proteoglycans. 
Table 1.2 shows the five different classes of proteoglycan each differing in GAG 
composition, core protein size or source (Templeton, 1992). Family a proteoglycans 
consist of multiple glycosaminoglycan chains. This family of proteoglycans associate 
with hyaluronic acid to form large aggregates, and reside in the extracellular 
compartment. Aggrecan belongs to this family and has a 220kDa core protein with over 
100 chondroitin sulphate chains and a keratan sulphate-rich region also (Doege et ai, 
1987). Family b proteoglycans are small molecules containing only 1 or 2 GAG chains 
and are found in the connective tissue (Templeton, 1992). Decorin belongs to this 
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family and has a core protein of only 40kDa (Krusius & Ruoslahti, 1986). Family c 
proteoglycans are the basement membrane heparan sulphate proteoglycans which have 
large core proteins (400kDa), but only have 2 to 4 heparan sulphate chains (Templeton, 
1992). Family d are the cell surface proteoglycans such as the mouse mammary 
epithelial proteoglycan, syndecan. Syndecan consists of a 30kDa core protein with a 
hydrophobic transmembrane domain and has chondroitin and heparan sulphate chains in 
the extracellular region (Saunders et ai, 1989). The last family, Family e, are the 
intracellular proteoglycans which include serglycin, a 15-20kDa proteoglycan. 
Serglycin contains either chondroitin, dermatan or heparan sulphates and can be shed 
from the surface of the cell during development (Templeton, 1992). 
Each GAG chain is attached by one of three linkages to the core protein of 
proteoglycans. Type 1 linkages were first isolated from chondroitin sulphate and consist 
of an O-glycosidic linkage between D-xylose and the hydroxyl group of a serine residue 
(Roden & Smith, 1966), whereas Type 2 linkages are recognised by an N-
glycosylamine linkage between N-acetyl glucosamine and the amide group of 
asparagine and are seen in corneal keratan sulphate (De Luca et ai., 1980). Skeletal 
keratan sulphate exhibits the type 3 linkage which is an O-glycosidic linkage between 
N-acetyl galactosamine and the hydroxyl groups of threonine or serine (Bray et al., 
1967). 
1.3.3 Hyaluronic Acid 
Hyaluronic acid (HA) glycosaminoglycan, is a linear polysaccharide composed of two 
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alternately linked sugars, D-glucuronic acid and N-acetylglucosamine (Fig 1.1a). The 
molecular weight ofHA varies from an average low value of 70,000 for bovine vitreous 
humour HA, to 12 x 107 for HA isolated from bovine synovial fluid (Varga, 1955; 
Silpananta et al., 1968). HA occurs in different concentrations and in different forms in 
tissues, for example, in cartilage, the concentration of free HA is relatively small as it is 
associated with proteoglycans, whereas in synovial fluid it occurs mainly in solution 
(Hardingham & Muir, 1972; Swann, 1978). HA is well known for its viscoelastic and 
joint lubricating properties and has had medical applications as a vitreous substitute in 
retina-reattachment surgery and in the treatment of osteoarthritis (Balazs et al. 1972; 
Peyron & Balazs, 1974; Derlinger & Balazs, 1980). HA is known to have various 
effects on cell proliferation which may reflect its role in the wound healing process. 
West & Kumar demonstrated that angiogenic HA oligo saccharides (between 3-16 
disaccharides) in vivo, stimulated endothelial cell proliferation and collagen production 
in vitro, whereas bigger oligosaccharides had no effect or inhibited endothelial cell 
proliferation (West & Kumar, 1989; Rooney et al., 1993). Native HA has also been 
reported to have no effect on the proliferation of bovine adrenal capillary cells, 
epithelial cells, smooth muscle cells, fibroblasts and pericytes (Orlidge & D'Amore, 
1986), although size independent inhibition has been shown with rabbit synovial cells 
and 3T3 fibroblasts by Goldberg & Toole, (1987). The difference in findings between 
the latter and those ofOrlidge & D'Amore (1986) may be due to the fact that different 
sources of cells were used and were cultured under different conditions, however there 
may be more fundamental reasons for these findings which will need further research to 
elaborate. HA exists in concentrations between 0.05 and 3mg/ml in adult tissues, but in 
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healing tissues, this rises to between 4 and 10mglml. After injury therefore, there is an 
influx of HA to the wound site. It was postulated by Weigel et al (1986), that HA 
interacts with fibrin to provide a matrix for cellular infiltration and regulates many 
functions of blood cells in the inflammatory reponse. They also suggested that the 
matrix is degraded as new collagen and glycosaminoglycans are secreted to make a 
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more differentiated matrix (Weigel et aI, 1986). Exogenously added HA is known to 
inhibit leukocyte locomotion (Forrester & Wilkinson, 1981), and this may have 
relevance in healing wounds, as after the inflammatory response, the concentration of 
HA rises thereby restricting further leukocyte invasion. This concept can be clearly seen 
in vitro with tumour cells which have been shown to be protected from attack by 
cytolytic immune lymphocytes by the presence of a cell-surface layer of HA (McBride 
& Bard, 1979). Subsequently, neutrophil adhesion is also inhibited by the presence of 
HA, thereby preventing locomotion of the cells (Forrester & Lackie, 1981). It would 
appear therefore that HA provides a regulatory role in the inflammatory response. The 
potential role of HA and its fragments in wound healing are investigated in this study 
and the results compared with those previously published. 
1.3.4 Chondroitin Sulphate 
The chondroitin sulphates glycosaminoglycans are a family of glucuronic acid 
containing GAGs that include chondroitin sulphate A, C, D, E, H & K which have 
disaccharide units with different sulphation patterns (Figure 1.1 b). In the 1950's, its 
detailed structure was determined by Meyer and his collaborators (Meyer & Rapport, 
1950; Meyer et aI, 1956) and the repeating unit of chondroitin sulphate was found to be 
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very similar to that of hyaluronic acid. It has a glucuronic acid residue linked to a N-
acetyl galactosamine residue, but in contrast to HA, chondroitin sulphate can have 0-
sulphated groups especially at the 4- or 6- position of the N-acetylated residue. 
Chondroitin Sulphate (CS) is a main component of connective tissue and has been 
isolated from many sources, including shark skin and hagfish skin (Akiyama & Seno, 
1981; Seno et ai, 1972). The chains of the chondroitin sulphates are of relatively low 
molecular weight (10,000-20,000) in contrast to HA. However, all exist as proteoglycan 
complexes with an average of 80 chondroitin sulphate chains per proteoglycan complex. 
As an ECM molecule, CS plays a role in wound healing. In vitro, chondroitin sulphate 
appears to have no effect on the proliferation of fibroblasts, however, it has been shown 
to reduce the clotting time of fibrinogen and increase the rate of fibrin polymer 
formation (Westergren-Thorsson et ai, 1991; LeBoeuf et al., 1987). When incorporated 
into a collagen sponge and implanted in the rat lumbar muscle, the sponge containing 
the CS has been shown to have an improved infiltration of fibroblasts at day 14 when 
compared to any other GAG combination and had less inflammatory cells present. 
These findings and the structural similarity with HA may suggest a role for CS and its 
fragments (oligosaccharides) in wound healing and are therefore the subject of research 
reported in this thesis. 
1.3.5 Dermatan Sulphate 
Dermatan sulphates (OS) glycosaminoglycans are composed of alternating 
galactosamine 4-or 6- sulphate and uronate residues (see Figure 1.1c). The uronate 
residues can either be glucuronic acid or iduronic acid and the latter can be ester-
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sulphated at C-2 (Lindahl & Hook, 1978). DS exists as proteoglycans in tissues such as 
skin and articular cartilage (Coster et ai, 1975; Rosenberg et ai, 1985) and is known to 
interact with collagen and fibronectin in the ECM (Scott & Haigh, 1985; Lewandowska 
et ai, 1987). DS oligosaccharides have been found to interact with plasma heparin co-
factor II which results in a dramatic increase in the rate of thrombin inhibition 
(Tollefsen et ai, 1986). Dermatan sulphate has also been shown to inhibit the 
proliferation of fibroblasts in vitro (Westergren-Thorsson et ai, 1991), however, the 
potential role ofDS and its oligo saccharides in wound healing is not investigated in this 
thesis due to time constraints. 
1.3.6 Heparin 
Heparin is also a member of the GAG family. The repeating unit is predominantly L-
iduronic acid, although D-glucuronic acid is present as a minor constituent, and it is 
linked to the N-sulphated hexosamine by an a B{1,4) linkage (Figure 1.1d). Like other 
GAGs, heparin is synthesised as a proteoglycan and is stored in mast cell granules in 
many animal tissues, including connective tissues. The most widely known biological 
properties of heparin are its anticoagulant and anticomplement activities (Barrowcliffe 
et ai, 1978; Almeda et ai, 1983). Heparin has also been reported to have in vivo effects 
on wound healing (McPherson et ai, 1988) and this will be discussed further in 
Chapters 4, 5 & 6. These findings suggest a role for heparin in wound healing and are 
therefore the subject of research reported in this thesis. 
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1.3.7 Heparan Sulphate 
Heparan sulphates are structurally related to heparin, but are the most hetergeneous of 
the GAGs. They contain both glucuronic acid linked to N-sulphated glucosamine and 
iduronic acid linked to N-acetylglucosamine (Figure 1.1e). Heparan sulphates (HS) in 
the form of proteoglycans are found on cell surfaces or in the ECM of all mammalian 
organs and tissues (Klagsbrun & Baird, 1991; Gallagher & Turnbull, 1992). The 
function of proteoglycans are numerous due to the range of binding properties of the 
heparan sulphate chains and variations in structure of the core protein. It is common to 
find 2 or 3 HS chains close to each other attached to serine residues of the polypeptide 
core. The 2 main classes of membrane Heparan Sulphate Proteoglycans (HSPG) are the 
syndecans which are positioned across the membrane and the GPI-anchored glypicans. 
There are no reports in the literature to date of any in vivo effects of hepar an sulphate on 
wound healing, however in vitro, it has been shown, like heparin, to inhibit the 
proliferation of fibroblasts (Ferrao & Mason, 1993). Due to time constraints, heparan 
sulphate was not investigated for its wound healing potential in this thesis. 
1.3.8 Heparan Sulphate & Growth Factor Interactions 
Heparan sulphates are known to be important in the activation of many growth factors 
including the FGFs (fibroblast growth factors), VEGF (vascular endothelial growth 
factor) & EGF (epidermal growth factor) (Jayson & Gallagher, 1997). bFGF and VEGF 
will be discussed here due to their angiogenic role in wound healing and bFGF's ability 
to effect fibroblast proliferation & migration. 
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1.3.8.1 bFGF and HS Interactions 
HS chains bound covalently to membrane proteins are the receptors or co-receptors for 
FGF. The high affinity FGF receptors consist of four closely related gene families 
(FGFRI-4) and there is 72% amino acid homology across the family. 
In cultured capillary endothelial cells, 70% ofbFGF is bound to the extracellular matrix 
HSPG, perlecan, which also has 2-3 HS chains. Perlecan stores growth factors and 
prevent proteolysis and regulates delivery to cells (Aviezer et ai, 1994). It has also been 
found to be the most effective proteoglycan at promoting bFGF action. 
The importance of HS in bFGF activation was seen in Chinese hamster ovary cells 
defective in HS synthesis or when HS synthesis was inhibited in 3T3 fibroblasts with 
chlorate (Stringer & Gallagher, 1996). In all these studies, the response to bFGF was 
restored by adding heparin. 
The minimal binding sequence for HS in bFGF appears to accommodate a 
pentasaccharide sequence [hexuronic acid-GlcNSOJ-hexuronic acid-GlcNS03-IdoA,2S] 
(Salmivirta & Jalkanen, 1995), however high affinity binding and bFGF activation 
requires longer sequences based on the structure (IdoA,2S-GlcNS03)n where n has a 
minimum of 5 (Gallagher & Turnbull, 1992). The requirement for longer sequences to 
activate bFGF suggests that the saccharide must accommodate 2 bFGF molecules to 
create a dimeric form of the growth factor. The dimer is assumed to be necessary to 
them dimerise the receptor and promote cell signalling (Coutts & Gallagher, 1995). 
However, it has been suggested that the longer sequences may act as a template to 
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which the bFGF and receptor bind to promote growth factor function by proximity (Kan 
et ai, 1993; McKeehan et ai, 1994). 
1.3.8.2 VEGF & HS Interactions 
VEGF is a dimeric glycoprotein (34-45kDa) that stimulates endothelial cells, induces 
angiogenesis and increases vascular permeability and it shares similarities in amino acid 
sequence to PDGF and placenta growth factor (Toi, 1998). There have been 4 different 
VEGF transcripts discovered to date : 2 which are largely free to diffuse in tissues 
because of their absent or reduced heparin binding affinity and 2 with high affinity 
heparin binding activity which are cell-associated (Toi, 1998). Flt-l and KDR are the 2 
receptors identified for VEGF at present, and they have been found to be essential for 
the formation of normal vasculature (Tanaka et ai, 1997). They both contain 
intracellular tyrosine kinase domains, however, Flt-l is also known to bind to placenta 
growth factor, unlike KDR. 
As the name suggests, VEGF leads to mitogenesis by endothelial cells, however it also 
is involved in chemotaxis and expression of plasminogen activators and collagenases, 
all of which facilitate the migration of new endothelial cells (Ferrara et ai, 1991). VEGF 
is 50,000 times more potent than histamine in inducing vascular penneability (Dvorak 
et ai, 1995) and it has also been shown to have effects on the migration of monocytes 
and fetal bovine osteoblasts. 
16 
VEGF expression is induced in non-malignant conditions such as in wound repair and 
its expression can be upregulated by other factors such as PDGF, EGF and TNF-alpha 
(Toi, 1998). It is also expressed highly in many tumour types specifically within the 
blood vessels (Berse et ai, 1992). Blocking VEGF activity using monoclonal antibodies 
or antisense constructs can inhibit the growth of tumors in vivo (Kondo et ai, 1993). 
1.3.9 Keratan Sulphate 
Keratan sulphate (KS) was first isolated from bovine cornea by Meyer et ai, (1953) and 
since then, has been found in many other tissues including bovine and human skeletal 
cartilage (Meyer et ai, 1958; Cockin et ai, 1986). Skeletal KS chains occur covalently 
attached to protein in the form of large aggregating proteoglycans, together with 
chondroitin sulphate and numerous O-linked and N-linked oligo saccharides (Figure 
1.1f). 
Type I is corneal KS which is N-linked via glucosamine to asparagine (Baker et ai, 
1969 ; Bray et ai, 1967). Type II is skeletal in which there is an O-glycosidic linkage 
from an N-acetyl glucosamine residue to either serine or threonine (Bray et ai, 1967). A 
possible third type has been isolated from brain tissue (Krusius et ai, 1986), which has 
an O-glycosidic bond between mannose and threonine or serine. All three forms share 
the same repeating disaccharide sequence of galactose linked ~(1,4) to N-acetyl 
glucosamine, these disaccharides being linked by ~(1,3) linkage to one another. Most 
of the N-acetyl glucosamine residues are sulphated at C6, as well as some galactose 
residues (Bhavanandan & Meyer, 1968). Mannose and fucose have also been identified 
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as components of KS. Recently, monoclonal antibodies to skeletal KS have been 
manufactured and used in clinical assays as markers for osteoarthritis. As yet there are 
no reported claims of keratan sulphates being important in wound healing in either in 
vitro or animal studies and are therefore not investigated in this thesis. 
1.3.10 Fibronectin 
Fibronectin is a widely distributed glycoprotein which is found in high concentrations 
in the extracellular matrix and in plasma (Ayad et at, 1994). The structure of fibronectin 
consists of two non-identical subunits covalently linked near the COOH-terminal by a 
pair of disulphide bonds and has a molecular weight of 5.5 x 105 Da (Fig 1.2). In wound 
healing, fibronectin promotes the spreading of platelets at the site of injury, the 
adhesion and migration of neutrophils, monocytes, fibroblasts and endothelial cells into 
the wound area, and the migration of epidermal cells through the granulation tissue. 
Fibronectin also has a role in tissue remodelling by activating phagocytosis of wound 
debris by macrophages, fibroblasts and keratinocytes to phagocytose debris (Grinnell, 
1984). As fibronectin contains heparin, it may also have a potential role in wound 
healing with the GAGs role. Fibronectin is not subject to investigation in this thesis. 
1.4 CLINICAL APPLICATIONS OF ECM MOLECULES 
1.4.1 Collagen 
Collagen has many unique features that make it suitable as a biomaterial. These 
include, high tensile strength, controllable biodegradation and haemostatic properties 
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(Chvapil et ai, 1973), low antigenicity (Chvapil et ai, 1973), low inflammatory and 
cytotoxic responses (Stenzel et ai, 1974), and its ability to promote attachment and 
growth of cells (Doillon & Silver, 1986; Doillon et al., 1988). Due to its 
biocompatibility, collagen has been used both as a topical dressing and as an implant 
material. Collagen can be reconstituted into many physical fOIms and the most 
frequently applied are films (Gorham et ai, 1990; Srivastava et ai, 1990), sponges 
(Doillon & Silver, 1986; Chvapil, 1977) and injectable solutions (McPherson et ai, 
1986ab). Tissues such as skin and tendon which are rich in fibrous collagen are 
generally used as starting materials for reconstituted collagen preparations. Clinical 
uses of collagen include, haemostasis (Stein et ai, 1985; Voormolen et ai, 1987), nerve 
regeneration (Colin & Donoff, 1984), injectable collagen for tissue augmentation 
(DeLustro et ai, 1987), urinary tract surgery (Scott et ai, 1986; Scott et ai, 1988), 
ophthalmology (Hobden et ai, 1988; Phinney et ai, 1988) periodontology (Pitaru et ai, 
1988; Minabe et ai, 1989), repair of the duramater in neurosurgery (Jannetta & Whayne, 
1965; San-Galli, 1989), burn and wound dressings (Yannas & Burke, 1980; Burke et ai, 
1981; Chvapil, 1982) and as cardiovascular protheses (Nimmi, 1988). A summary of 
the different physical forms of collagen and their clinical applications is given in Table 
1.3. 
1.4.2 Collagen & GAG Composites 
Since the introduction of collagen dressings and implants, other ECM molecules have 
been incorporated into the matrix to try and improve the efficacy of the dressing. 
Yannas and Burke and co-workers (Yannas and Burke, 1980; Burke et ai, 1981; 
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FORM OF EXAMPLES OF REFERENCES 
COLLAGEN APPLICATION 
Solution Injectable McPherson et ai, 1988 
Gel Vitreous Body Hobden et a11988; Phinney et 
al,1988 
Injectable DeLustro et ai, 1987 
Powder Haemostat Stein et aI, 1985; Voormolen et 
ai, 1987 
Film Corneal replacement, corneal Hobden et a11988; Phinney et 
shield al,1988 
Wound dressing Srivastava et ai, 1990 
! Patches (aneurysm, bladder) Scott et al1986 
Periodontal treatment Pitaru et ai, 1988; Minabe et ai, 
1989 
Sponge Wound dressing Srivastava et aI, 1990 
Bum dressing Yannas & Burke, 1980: Burke et 
Haemostat aI, 1981; Chvapil, 1982 
Tube Vessel prostheses Nimmi,1988 
Table 1.3 : Physical forms of collagen and their clinical applications 
Dagalakis et ai, 1980) developed a burn dressing from collagen and C6S which 
functioned like artificial skin. It had a bilaminar structure: an outer silastic membrane 
layer and an inner porous layer of a collagenlchondroitin-6-sulphate composite which 
was dehydrothermally crosslinked and then treated with glutaraldehyde. The outer layer 
prevented fluid loss and acted as a barrier to bacteria as well as giving the dressing 
mechanical strength. The inner layer, which was in direct contact with the wound bed, 
had a pore structure which was optimal for cell invasion. Fibroblasts invaded the 
dressing and degraded the collagenlchondroitin-6-sulphate matrix while simultaneously 
laying down new collagen. There appeared to be no inflammatory or foreign body 
response to the dressing and the graft was not rejected in the 10 human patients. A 
similar dermal substitute c?ntaining C6S and collagen was designed by Boyce et ai, 
(1988). Their findings showed that when the dermal substitute was grafted onto full 
thickness burns in human patients, wound contracture was significantly reduced, and 
more rapid and more complete wound healing took place. Wound healing was 
determined by the regeneration of connective tissue from the wound bed and the 
formation of fully stratified and differentiated epidermis. Collagen dressings containing 
hyaluronic acid, up to 2.5%, and fibronectin have been shown to increase L929 mouse 
fibroblast proliferation in vitro, as well as acting as support structures for cells in culture 
(Doillon et ai, 1987 & 1988; Srivastava et ai, 1990). In vivo observations have 
confirmed these results (Srivastava et al., 1990). This study investigated a series of 
collagen-based films and sponges containing 10% CS and 20% HA which were 
implanted into the lumbar muscle of the rat. After 7 days implantation, all materials 
elicited an inflammatory response, however, by 14 days a marked infiltration by 
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neutrophils was apparent with subsequent degradation of existing collagen material. 
The collagen/HA composites evoked a greater inflammatory response than native 
collagen, whereas the collagen/CS composites elicited the least inflammatory cell 
response at day 7 and infiltration by fibroblasts was seen after 14 days implantation. 
The influence of heparin on the wound healing response to collagen implants has been 
investigated by McPherson et ai, (1988). They utilised the rat subcutaneous and guinea 
pig dermal wound models to observe the effect of adding heparin to reconstituted 
bovine dermal collagen. The addition of heparin to these implants resulted in significant 
dose-dependent increase in the degree and extent of fibroblast invasion, but appeared to 
have no effect on vascularisation. The inclusion of heparin in the guinea pig model did 
result in a significantly different pattern of wound healing, as histologically, the 
implants appeared more porous, thereby allowing a greater penetration of granulation 
tissue into the implant. These effects were not observed with chondroitin sulphate or 
hyaluronic acid (McPherson et ai, 1988). Heparan sulphate has also been used to 
augment wound healing. A recent patent application (Bononi, 1992) suggests that a 
topical preparation of collagen and heparan sulphate, in the form of a cream, will 
significantly accelerate the re-epithelialisation process of chronic ulcers experimentally 
induced in the animal and promote the recovery of chronic phlebostatic ulcers in 
humans. Glycagen® is a commercially available collagen dressing containing heparan 
sulphate and chondroitin-4-sulphate. Used as a dressing for gingival wounds, it was 
shown that the GAGs combined with the patient's glycoproteins (mainly fibronectin), 
and resulted in the production of fibrinleukocytic tissue followed by acceleration of 
tissue organisation. The dressing was resorbed by the body and appeared to have no 
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inflammatory effect (Roussille & Barthet, 1991). 
1.4.3 Collagen And Mammalian Cell Composites 
Since the introduction of their first artificial skin, Yannas and Burke have since 
demonstrated the seeding of autologous epithelial cells into their collagen matrices 
before grafting in order to provide a complete skin substitute (Yannas et ai, 1982). 
These grafts were applied to full thickness defects in guinea-pigs. Neovascularisation 
was observed after 10 days, and during the first year post-grafting, collagen deposition 
was determined as being randomly orientated, a feature of normal dermis. A skin graft 
kit has recently been patented which contains epithelial cells and a cross-linked collagen 
sheet carrier (Barlow, 1992). This dressing was developed for use on full and partial 
thickness wounds and deep wounds, where it may restore skin profile. Current work has 
focused on the delivery of fibroblasts to the wound site by seeding into a collagen 
matrix. The fibroblasts, cultured from the wounded patient, should stimulate de novo 
collagen deposition, and granulation tissue formation without initiating a foreign body 
response. Bertolami et ai, (1988) introduced autogenous fibroblasts into a 
collagen/glycosaminoglycan/silastic membrane and applied it to cutaneous wound sites 
in rabbits. This dressing inhibited wound contracture and increased infiltration of 
fibroblasts and peripheral epithelium into the matrix. Doillon et ai, (1988) observed 
the synergistic effects of growing fibroblasts and epithelial cells in a collagen sponge, in 
vitro. Their results demonstrated that epidermal cell replication was enhanced in the 
presence of collagen sponge seeded with fibroblasts. They concluded that this sponge 
may be convenient for clinical applications. 
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1.5 PLANT POLYSACCHARIDES AND CLINICAL APPLICATIONS OF 
WOUND HEALING 
Plants have been used for many years as natural remedies for wound healing but have in 
the main been used in the food industry as thickeners and stabilisers (McDowell, 1977). 
Several plant polysaccharides are structurally similar to the GAG family and therefore 
have been focused on in the study reported here to try and ascertain if they have any 
similar biological activity to GAGs and therefore any advantageous effects on wound 
healing. The polysaccharides which will be discussed are both natural plant 
polysaccharides such as pectin and alginate, and synthetic polysaccharides derived from 
cellulose, for example, oxidised regenerated cellulose. 
1.5.1 Pectin 
Pectin is universally found in the cell walls of green land plants, especially in citrus 
fruits, and has a MW of about 50,000 to 180,000. D-galacturonic acid is the principal 
constituent, but some neutral sugars are also present. Small amounts of D-xylose, L-
arabinose, and D-galactose may be part of the side chains or of accompanying neutral 
polysaccharides. Pectin can be methoxylated to varying degrees and the degree of this 
influences the properties of the molecule, especially the solubility and gelation 
requirements. The structure of pectin can be seen in Figure 1.3( c) and has similarities 
to other polysaccharides such as hyaluronic acid. Pectin is mainly used in the food 
industry as a gelling agent, however it has also found uses as an anti-diarroheal agent 
(Vahouny et ai, 1978), lowering blood serum cholesterol (Johnson & Chang, 1978) and 
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also as an ingredient in an absorbant and curative wound dressing (US Patent 4341207). 
The structural similarities suggest a role for pectin in wound healing and are therefore 
the subject of research reported in this thesis. 
1.5.2 Oxidised Regenerated Cellulose 
Oxidised Regenerated Cellulose (ORC) is a synthetic polysaccharide and is produced 
from cellulose by oxidation with nitrogen tetraoxide in a chlorofluorocarbon solvent 
(Saferstein & Boardman, 1992). The resulting structure can be seen in Figure 1.3(a}. 
The oxidation results in around 83% of the D-glucose units converting to D-glucuronic 
acid residues, giving a structure resembling that of several GAGs. The unconverted 
glucose units are randomly scattered throughout the chain. A secondary oxidation 
pathway exists in which one in ten repeating units carries a ketone carbonyl group on 
the C-2 or C-3 atom. ORC is insoluble in water, but has been found to progressively 
break down in alkaline solutions to oligosaccharide and monosaccharide components 
(Dimitijevich, 1990). Structurally ORC is most closely related to Alginic acid and 
chondroitin-6-sulphate and HA (Fig 1.1 b). 
Oxidised cellulose was first developed in 1943 by Eastman Kodak and first introduced 
as an absorbable haemostat by Parke-Davis as Oxycel in 1944. Oxidised regenerated 
cellulose was first marketed by Johnson & Johnson in 1950 as Surgicel® absorbable 
haemostat. Since then, another haemostat, NuKnit® and an adhesion barrier, Interceed® 
have been launched by Johnson & Johnson. As described previously in section 1.4.2, 
GAGs have been shown to influence wound healing. Since ORC is structurally similar 
to certain GAGs, the role of ORC and its oligosaccharides form part of the study 
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reported here. Further support for a potential role of ORC oligosaccharides have come 
from findings at Johnson & Johnson which have shown that ORC oligosaccharides bind 
growth factors in vitro (pDGF) and mannose-6-phosphate (personal communication, 
Paul Watt, Johnson & Johnson). 
1.5.3 Alginate 
Alginates are naturally occurring polysaccharides which are found in certain species of 
brown seaweed. They are polymers of J3-D mannuronic acid and a-L guluronic acid 
(Fig 1.3b). Alginates are used extensively in the food industry as thickening and 
stabilising agents, but are also widely used in wound management due to their 
haemostatic and absorbant qualities (Odugbesan & Barnett, 1987: Groves & Lawrence, 
1986). Alginates have been used as haemostats and wound dressings since the 1940's. 
Blaine described the benefits of using alginate as haemostats and wound dressings in 
several papers, including their apparent lack of toxicity and ability to be broken down 
by the body (Blaine, 1947; Blaine, 1951). Many commercial alginate products are now 
available and a summary is shown in Table 1.4. Sorbsan™, made from pure calcium 
alginate, has been used in the treatment of burns and donor sites. It was found that the 
alginate dressings allowed half as much blood loss from fresh split-thickness grafts than 
gauze alone, indicating its ability to act as a haemostat and was useful in absorbing fluid 
from heavily exudating wounds. Kaltostat™ contains 20% sodium alginate : 80% 
calcium alginate and can be used on heavily or lightly exudating wounds. Tegagel™ is 
a calcium alginate dressing, but due to the manufacturing process, the fibres are unable 
to expand freely and this limits its absorbancy. A relatively new dressing currently on 
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PRODUCT COMPANY USE 
Algosteril Johnson & Johnson Heavily exudating wounds 
Sorbsan™ Steriseal Packing deeper wounds 
Sorbsan Plus™ Steriseal Heavily exudating wounds 
Sorbsan SATM Steriseal Lightly exudating wounds 
Kaltostat™ Brticair Dry or lightly exudating 
wounds 
Tegagel™ 3M Exudating wounds 
Stop Hemo™ Windsor First aid dressing 
Fibracol* Johnson & Johnson Topical dressing for leg 
Medical ulcers 
Table 1.4: Commercial Alginate Preparations 
the market in the U.K. is Fibracol™, a freeze-dried collagen-calcium alginate sponge 
dressing manufactured by Johnson & Johnson Medical. This dressing combines the 
properties of collagen with calcium alginate (90 : 10 w/w) to provide a scaffold for the 
deposition and organisation of new collagen fibres in the wound (Doillon & Silver, 
1986). The collagen-alginate dressing performed as well as Kaltostat™ in the treatment 
of leg ulcers in clinical trials, however it was preferred for its ease of removal and non-
adherence to the wound (personal communication, Johnson & Johnson Ltd, 1996). 
Alginates are not fully biodegradable and this has been demonstrated in some studies 
which have noted immune responses occurring in their presence, such as encapsulation 
and giant cell formation (Blaine, 1951) as well as granuloma formation (personal 
communication, Johnson & Johnson Ltd., 1996). Alginates are not part of the 
investigation in this study as they are marketed by Johnson & Johnson as wound 
healing products. 
1.5.4 Other Plant Derived Polysaccharides 
Many other plant polysaccharides are recognised for their biological activity. Lentinan, 
a polysaccharide from a Japanese mushroom has been reported to have strong anti-
tumour activity (Chirara et ai, 1970), whereas immunostimulating activity has been 
shown by the polysaccharide AlP, extracted from the roots of Angelica acutiloba and is 
used as a potent adjuvant (Zhu et ai, 1982). Sulphated polysaccharides such as those 
extracted from marine algae show anticoagulant activity (Forwell, 1956). Johnson & 
Johnson Ltd. have published a patent on sulphated ORC (sORC) and have shown that 
sulphated ORC oligosaccharides can bind growth factors, have anti-coagulant properties 
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and exhibit chemotactic effects which are very similar to the properties of heparan 
sulphate (Harvey, Light & Watt, UK Patent No.9613683.3). Anti-inflammatory activity 
has been demonstrated by polysaccharides extracted from Aloe vera as well as 
polysaccharides 101 and 103, isolated from medicinal plants of the Asteraceae and 
Tiliaceae families. No. 101 stimulated the healing of the gastric mucosa in rats with 
experimental ulcers 01 enkata Rao, 1992). 
1.6 Other Animal & Microbial Polysaccharides And Their Clinical 
Applications 
1.6.1 Introduction 
Many reports exist in the literature regarding the uses of other naturally occurring 
polysaccharides as well as those produced by bacteria. The following sections give a 
brief account of their uses only as they will not form of part of the investigation 
reported in this thesis. 
1.6.2 Chitin & Chitosan 
Chitin is a natural structural component of shellfish and is extracted from the shells of 
crab, lobster and shrimp (Klokkevold et ai, 1991). Next to cellulose, chitin is the most 
plentiful natural polymer and is both biodegradable and non-toxic as its breakdown 
products are the natural metabolites glucosamine and N-acetyl glucosamine (Fig 1.4a & 
l.4b; Crescenzi, 1994». The main use of chitin is in the production of chitosan, which 
has a similar structure to cellulose. The molecular weight of chitosan is between 0.8 and 
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Figure l.4(b): Chitosan 
1.5 x 106 Da and is a linear polymer of N-acetyl-D-glucosamine (Klokkevold et ai, 
1991). Chitin and chitosan have many applications in the food, cosmetic, water 
treatment and phannaceutical fields and most interestingly, the medical field. The 
biomedical applications of chitosan include its uses to deliver drugs (Thanoo et ai, 
1992; Chandy & Shanna, 1991», manufacture non-allergenic contact lenses (protan 
Ltd.), and accelerate wound healing (Kyocera Corp., 1992; Saintigny et ai, 1993) 
1.6.3 Microbial Polysaccharides 
Microbial polysaccharides exhibit a wide range of primary structures, some of which 
are exclusive to the microbial world while some exhibit structures similar to 
biopolymers from human, animal or vegetal sources. Large amounts of exocellular 
polysaccharides can be produced by microbial cell lines and are therefore cost effective 
and have potential relevance in industry (Crescenzi, 1994; Minami, 1993; Tanioca 
1993). The principal industrial microbial polysaccharides and their uses are shown in 
Table 1.5 and are listed in order of decreasing industrial production. 
1.7 GROWTH FACTORS IN WOUND HEALING 
Although growth factors are not the subject of this study, it is important to understand 
this area as the role of these polysaccharides in wound healing might be via binding to 
growth factors. Exogenous additions of oligosaccharides may playa key role in 
protecting and/or regulating the role of growth factors in wound healing and these are 
discussed in the following sections. 
Cohen & Levi-Montalcini isolated factors from tumour cells, snake venom and mouse 
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BIOPOLYMER COMMON APPLICATION 
MICROBIAL 
SOURCE 
Dextran Leuconostoc spp. Pharmaceuticals, 
chemical gels 
Xanthan Xanthomonas Tertiary oil recovery, 
campestris food additives, textiles 
Gellan Pseudomonas elodea Food additives, physical 
gel fluids 
Sc1eroglucan Sclerotium spp. Drilling fluids, rheology 
modifier 
Succinoglycan Pseudomonas spp. Drilling fluids, rheology 
modifier 
Curdlan Agrobacter spp. Physical gel fluids, food 
additives 
Pullulan Aureobasidium Films for food uses 
pullulans 
Welan Alcaligenes spp. Rheology modifier, 
drilling fluids 
Table 1.5 : Industrial Microbial Polysaccharides. 
Taken from: Polysaccharide Science and Technology: 
Development & Trends, Crescenzi, V. (1994), TRIP, 2, March Issue. 
submandibular salivary gland, which exhibited growth and differentiation-related 
activities in neural ganglia and ectodermal epithelium (Levi-Montalcini, 1987). To be 
classed as a growth factor, a biological molecule must be (i) a polypeptide that has the 
ability to bind to the specific receptors on the target cell surface (ii) be able to elicit a 
specific response induced by its binding to the receptor and (iii) be removed along with 
the receptor from the cell surface (pittelkow, 1991). Several growth factors have been 
identified in tissue extracts or fluid from various types of wounds, such as TGF13, FGF 
and PDGF, and their functions are discussed below. 
1.7.1 Platelet Derived Growth Factor (PDGF) 
When platelets aggregate in the wound clot, they release PDGF which is stored in the 
alpha granules of the platelets. PDGF has been found to be mitogenic for fibroblasts, 
smooth muscle cells and glial cells (Grotendorst, 1992; Ross et ai, 1974; Kohler & 
Lipton, 1974; Westermark & Wasterson, 1976) and stimulates cell replication by acting 
in tandem with factors such as insulin and somatomedins in the serum. Despite the lack 
of animal models of chronic wounds PDGF has been shown recently to be more 
effective than others in reversing states of impaired wound healing in animals 
(Zederfeld, 1993). PDGF, like TGFp has the ability to enhance healing and the tensile 
strength of incisional wounds (pittlekow, 1991). In full thickness pig skin wounds, 
PDGF has also been shown to stimulate healing without increasing inflammation, 
therefore it appears to act as an anti-inflammatory agent by inhibiting the production of 
complement proteins (Circolo et ai, 1990)). 
Recombinant PDGF has been tested in a randomised phase 1111 double-blind study in 
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patients with type IIIIIY pressure sores, being topically applied daily. After 28 days, the 
PDGF-treated sores had reduced in size to 6.4% of their initial volume compared with 
21.8% in the placebo group (Robson et aI, 1992). PDGF has also been incorporated into 
various biomaterial matrices, such as fibronectin, fibrin, hyaluronic acid, chondroitin 
sulphate and collagen and its effect on in vitro fibroblast behaviour analysed (Roy et aI, 
1993). The results showed that PDGF enhanced replication when incorporated into both 
fibrin and hyaluronic acid. 
1.7.2 Transforming Growth Factor Beta (TGF8) 
TGFB has been purified from human platelets, serum, embryonic tissue and bovine 
kidney, with the human kind being known as TGFB) (pittelkow, 1991). This growth 
factor is a homodimeric, disulphide-bonded molecule with a molecular weight of 
25kDa. Additional forms TGFB2_S have subsequently been discovered by DNA library 
screening and cloning. TGFB was originally discovered to be secreted by human 
keratinocytes in culture (Shipley et aI, 1986) and has since been found to be stored in 
the alpha granules of platelets from which it is released during coagulation and de-
granulation (Pittelkow, 1991). TGFB is involved at all stages in the wound healing 
process. Following tissue injury, TGFB is released from the platelets and after the influx 
of monocytes to the injury site and their subsequent conversion to macrophages, further 
amounts of TGFB are released which facilitate in the recruitment of more inflammatory 
cells, debridement of tissue by macrophages and granulation tissue formation (Wahl et 
ai, 1987). During the formation of granulation tissue, TGFB has been demonstrated to 
increase the expression of fibronectin, the fibronectin receptor, various types of 
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collagen, proteinase inhibitors, and is involved in the contraction of collagen by 
fibroblasts which aids wound closure (Dijke & Iwata, 1989; Montesano & Orci, 1988). 
TGFB is also known to bind to the core proteins of several proteoglycans (Templeton, 
1992). 
Studies with TGFB have shown it stimulates granulation tissue formation in pig 
excisional wounds pre-treated with glucocorticoids, and in conjunction, at higher doses, 
appears to inhibit epithelialisation (Quaglino et aI, 1990; Shipley et al. 1986). In 
incisional wounds, TGFB improves the wound's tensile strength, if only transiently 
(pittlekow, 1991). Recombinant forms of TGFB can now be generated and one these, 
TGFB2• has recently shown promise in the treatment of full-thickness macular holes in 
the retina where it improved vision by flattening the surrounding neurosensory retinal 
detachments (Glaser et aI, 1992). 
1.7.3 Fibroblast Growth Factors (FGF) 
The two major members of this family are basic FGF and acidic FGF and are 
composed of single chain peptides with a molecular weight of 1.5 x 104 Da (pittelkow, 
1991). Both types share 55% gene homology but have structural differences which give 
them different biological activities. Basic FGF is a mitogen for melanocytes, fibroblasts 
and keratinocytes and acidic FGF also stimulates fibroblast and keratinocyte replication 
(Shipley et aI, 1986). In addition, the FGF family are also potent stimulators of 
angiogenesis in many tissues (pittlekow, 1991). 
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The FGF family are also known to be heparin binding growth factors as discussed in 
section 1.3.7.1. It is suggested that basic FGF is bound to heparin or heparan sulphate 
proteoglycans in the basement membrane and is secreted only when the cells are 
disrupted by an injury to the tissue (Whalen & Zetter, 1992). 
Over the last decade, many animal studies have been carried out in order to determine 
the effects of the addition of exogenous growth factors to experimentally induced 
wounds. A single application of FGF at the time of injury has been shown to stimulate 
epithelialisation in pigs (Hebda, 1990). Another study by Broadley et ai, (1989), 
demonstrated that antibodies to basic FGF retarded the early stages of the wound 
response in rats implanted subcutaneously with polyvinyl alcohol sponges. It has also 
been shown that FGF acts as an anti-inflammatory agent and this may promote the next 
stages of the wound healing process to develop. Recombinant bFGF has been topically 
administered to patients suffering from type IIIIIV pressure sores. The results from this 
study demonstrated that patients treated with bFGF had a faster rate of wound closure, 
and a higher number of healed wounds than those treated with a placebo (Robson et ai, 
in press). bFGF has also been shown to facilitate early dermal and epidermal wound 
healing when coated onto a collagen matrix (Marks et ai, 1991). 
1.8 WOUND MANAGEMENT 
1.8.1 Introduction 
As the aim of this study was to develop a wound dressing with an active 
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oligosaccharide component, it is of interest to discuss the likely target wounds such a 
dressing would be used to treat. Although such a dressing will not be likely to affect the 
underlying cause of the wounds that these dressings would be used to treat, it is hoped 
that they would reduce the time to healing and prevent hospital time. 
1.8.2 Leg Ulcers 
Leg ulcers have been reported in the literature as far back as the eighteenth and 
nineteenth centuries and were described as a "severe affliction" and a "loathsome 
disorder" (Loudon, 1982). The main causes in those times of this chronic condition 
were infection and malnutrition, i.e. scurvy. Today, the main cause of ulcers in the 
Western world is venous insufficiency, although there are many other contributory 
factors such as, poor arterial blood supply, malignancy and infection (Morison, 1991). 
Recent studies in the UK and Europe suggest that 1 % of the popUlation develop ulcers, 
and 20% of these people have an open ulcer at anyone time. It is therefore a common 
complaint especially in the older population where it has been found to be particularly 
prevalent in women over the age of 65 years (Dale et ai, 1983). Ulcers are notoriously 
slow to heal. 50% are open for more than a year, but 10% are still open after 5 years. 
Lack of healing in these cases is caused by several factors such as, not correcting the 
underlying cause of the ulcer, poor mobility, malnutrition, tissue damage and infection. 
1.8.3 Decubitus Ulcers 
Pressure sores (decubitus ulcers) also occur frequently in patients subjected to 
prolonged bedrest like quadriplegics and paraplegics who suffer skin loss due to the 
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effects of localised pressure. 
1.8.4 Diabetic and Arterial Ulcers 
Arteriosclerotic or diabetic disorders of blood flow can lead to the development of 
gangrene due to the deprivation of vital nutrients and this leads to necrosis. 
1.8.5 Treatment of Chronic Wounds 
A chronic wound is by definition a wound that will not heal or cannot heal. Poorly 
healing wounds appear to be a failure of the process of cell replication and the 
underlying blood flow and therefore enhancement of the growth signal has been one 
way forward in healing these wounds (Hunt & La Van, 1989). 
Collagen dressings, described earlier in this introduction, have been employed in an 
attempt to encourage healing of wounds, but the extent of healing with collagen alone 
has not satisfied medical standards (Silver et ai, 1988). Many growth factors of which 
some are described in Section 1.7, have been added to collagen matrices in an attempt 
to promote and accelerate the migration of cells into the wound site and encourage the 
deposition of new collagen. The high cost of these growth factors however, will be 
likely to result in an expensive product and would limit the number of patients who may 
benefit from it. Despite the continued development of new dressings, a product which is 
both effective at promoting wound healing and economical to produce, is still being 
sought. For this reason, this study was initiated to try and determine potential active 
agents that could potentially stimulate wound healing and provide Johnson & Johnson 
with a proprietary product and leading market position regarding wound dressings. 
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CHAPTER 2 : MATERIALS AND METHODS 
2.1 PREPARATION OF OLIGOSACCHARIDES 
2.1.1 Preparation of Hyaluronic acid (HA) & Chondroitin Sulphate (CS) 
Oligosaccharides by Enzymatic Digestion 
HA (MW 750 kDa, Lifecore, USA) and CS (MW 40-80kDa, Type C from shark 
cartilage, Sigma, England) were dissolved at IOmglml in O.1M sodium acetate buffer 
pH 5.4 containing 0.15M NaCl. After incubating at 37°C for 30 minutes, Type V 
sheep testicular hyaluronidase (2400U/mg, Sigma, England) was added at 0.25mglml. 
Aliquots were taken out at various time intervals into glass test-tubes and immediately 
immersed in a boiling water bath for 10 mins to stop the enzyme activity. After 
cooling, to room temperature, each sample was filtered through a 0.45J.lm syringe filter 
to remove any debris including enzyme, then dialysed against 3 changes of distilled 
water using dialysis tubing (Spectra-Por 6 MW cut-off 1000 Da) to desalt the 
preparations. Finally, the samples were freeze-dried. The above method was adapted 
from West & Kumar, 1989. 
2.1.2 Preparation of HA Oligosaccharides by Sonication 
A 10mglml HA solution, made in dH20, was sonicated using a Kontes Micro Ultrasonic 
Cell Disrupter, KT 50, setting 20, for varying lengths of time to produce degraded HA 
samples (Rehakova et ai, 1994; Personal communication - Paul Watt). The probe was 
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cooled on ice after each round of sonication to prevent thermal degradation of the 
sample. No further preparation was required. 
2.1.3 Separation and Purification of HA Fragments by Gel Filtration 
Separation of hyaluronic acid digests into oligosaccharide fractions of varying sizes was 
performed using a Biogel P6 column (1000 x 3Omm, Pharmacia, Sweden) equilibrated 
with 50mM ammonium acetate buffer pH 5.0. The void volume was determined using 
blue dextran (Sigma, Dorset, England) at a concentration of 10mglml. The hyaluronic 
acid samples were applied to the column in 30ml of the eluting buffer (lmglml 
hyaluronic acid) and eluted at 1 ml min-1 and 3ml fractions collected using an automatic 
fraction collector. This method was adapted from Cowman et aI, 1984. 
2.1.4 Preparation of ORC Oligosaccbarides Fragment 1 (MW Range S -
40kDa) 
Insoluble ORC fabric (Surgicetl)) was obtained from Johnson & Johnson Medical Inc. 
New Jersey, USA. Fragment 1 was prepared by Peter Doyle at Johnson & Johnson 
Medical, Stirling as follows : a 20mglml suspension of ORC fabric in 6M sodium 
hydroxide was prepared and incubated at 37°C for 45 minutes. The reaction was 
stopped by the addition of concentrated hydrochloric acid until no further precipitation 
ofORC occurred. The suspension was then centrifuged at 15,000 rpm for 10 minutes. 
The pellet was dialysed against water using a SpectraIPor® membrane with a molecular 
weight cut-off of 1000 Da. The salt concentration was estimated by comparing the 
addition of 0.5ml of 0.25M silver nitrate to a 0.1 % (w/v) sodium chloride and a 
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10mg/ml solution of ORC. This was carried out in glass test tubes and the precipitates 
formed following the addition of silver nitrate were compared visually to assess the 
level of salt in the ORC solution. After 3 days the salt concentration was estimated to be 
an acceptable level of less than 0.1 % (w/v). The ORC was then freeze-dried and used 
for in vitro studies. Molecular weight was determined as described in section 2.2.7. 
2.1.5 Preparation of ORe Oligosaccharide Fragment 2 (MW Range 
-40kDa) 
0.5g of ORC fabric was placed in 50ml of O.IM sodium bicarbonate solution and placed 
in a water bath at 37°C for 15 minutes. The reaction was stopped by the addition of 
concentrated hydrochloric acid until precipitation of ORC was completed. The 
suspension was centrifuged at 15,000 rpm for ten minutes and dialysed using 
SpectraIPor® membrane (MW cut-off 1000Da) for 3 days against water. The salt 
concentration was estimated as described previously in section 2.1.4. After 3 days the 
salt concentration was estimated to an acceptable level of less than 0.1 % w/v. The ORC 
was then freeze-dried and used for in vitro studies. Molecular weight was determined as 
described in section 2.2.7. 
2.1.6 Preparation of Pectin OUgosaccharides by Alkali Hydrolysis 
A 10mg/rnl solution of pectin (High Methoxyl pectin, HP Bulmer) in 6M sodium 
hydroxide was prepared and incubated at 37°C for 45 minutes after which the reaction 
was stopped by the addition of concentrated hydrochloric acid until precipitation of 
pectin occurred. The suspension was then centrifuged at 15,000 rpm for 10 minutes. 
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Dialysis of the pellet against water was then carried out using Spectra/Por® membrane 
with a molecular weight cut-off of 1000 Da. The salt concentration was estimated by 
comparing the addition of 0.5ml of 0.25M silver nitrate to a 0.1 % (w/v) sodium 
chloride solution with the precipitate formed on its addition to a 10mg/ml solution of 
pectin. After 3 days the salt concentration was estimated to an acceptable level of less 
than 0.1 % w/v. The pectin was then freeze-dried and used for in vitro studies. 
2.2 Molecular Weight Determinations of Polysaccharides 
Different methods to determine the molecular weights of various polysaccharides were 
assessed in this study in order to obtain the most reliable method for each 
polysaccharide. 
2.2.1 Molecular Weight Estimation by Viscometry 
The relative viscosity was measured using an Ubbelohde suspended level viscometer 
(Figure 2.1a), secured in a water bath using a retort stand. The method was developed 
by Fermentech Ltd., Edinburgh and was calibrated for the molecular weight 
determination of HA. The method was therefore limited in its use with other 
polysaccharides and their fragments, but was however, used in this study as a 
comparison to other available methods. The temperature of the water was kept constant 
at 25°C ± 0.5°C. Using a syringe and 0.45J,lm filter, 13ml of PBS was dispensed into 
tube A of the viscometer. Then, with a dampened finger over tube B, PBS was sucked 
up tube C using a pipette filler until the meniscus was in the bulb above mark 1. After 
removing the pipette filler and finger, the time taken for the liquid to travel to mark 2 
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Figure 2.1: The Ubbelohde suspended level viscometer 
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Figure 2.1 (b) Calculation of HA molecular weight by the Ubbelohde viscometer 
was measured and was repeated until 3 readings fell within 0.2 seconds of each other 
(To). Using a new syringe and a new 0.45J.1m filter, 4.5ml of a Img/ml solution of 
polysaccharide was loaded through tube A, then with a finger over tube B and the 
pipette filler on tube C, air was blown through the solution to achieve adequate mixing. 
Tube B was then covered again and the solution sucked up until the meniscus was 
above mark 1. After removing the pipette filler and finger, the time taken for the 
solution to reach mark 2 was measured and repeated until three readings were within 
0.2 seconds of each other (TJ This method has proved to be efficient at measuring 
large molecular weight, viscous solutions, however it has limitations when the 
molecular weight falls. Another drawback of this method is that it must be calibrated 
for each different polysaccharide and this is time consuming. 
The calculation for determining molecular weight by this method is shown in Figure 
2.1(b) 
2.2.2 Molecular Weight Determinations ofHA, CS and ORC 
by HPLC. 
A Kontron HPLC system was used (models 45Omtz, 422, 425, 430). Two gel 
permeation columns were run in series : the first was a 10J.lm "Aquagel" (Jones 
Chromatography, Strathaven, Scotland) and the second a TSK gel G300pwxl 
(Anachem, Luton, England). The size exclusion columns were eluted with 5mM 
tetrabutylammonium phosphate (Sigma, Dorset) in dH20 at a flow rate of ImVmin-l • 
This method was developed by Peter Doyle at Johnson & Johnson Medical. 
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Calibration of the column was perfonned using dextrans with molecular weights of 
1200, 11700,47250,97000 and 326000 Da (Crawford Scientific, Strathaven, Scotland), 
with detection of the polysaccharides using a refractive index detector with the range 
equal to 0.2 x 10-3 AR!. Molecular weight was detennined by running standard curve of 
the dextrans and comparing the elution time of the oligosaccharides to the standard 
curve. A example of a standard curve is shown in Figure 3.6. This method has its 
limitations with polydisperse polysaccharides as sharp defined peaks cannot be obtained 
therefore the weight estimations are not accurate. This method, however has its 
strengths at separating out the purer oligosaccharides as shown in Chapter 3. 
2.2.3 Molecular Weight Determination ofHA Oligosaccharides 
by Pulsed Amperometric Detection 
Hyaluronic acid fragments were sized using anion exchange chromatography with 
pulsed amperometric detection. The equipment was a Dionex Bio LC with a Carbopac 
PAl column. The flow rate was I mUmin with a gradient eluant system as shown in 
Table 2.1. The gradient system was developed by Cathy Scott, University of Stirling. 
HA was dissolved at Imglml in 18 mn deionised, filtered water and degassed 
thoroughly before injection. 
Pulsed Amperometric Detection (Dionex) had limitations in that there were that no 
standards available to compare the molecular size to and so only qualitative data was 
obtained and was compared to those obtained by other methods. Another limitation of 
this method was that sulphated molecules could not be applied to this particular 
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Time (min) %200mMNaOH % 200mM NaOH + 
750mMNaOAc 
0 100 0 
1 100 0 
2 100 0 
90 0 100 
90.1 0 100 
120 0 100 
120.1 100 0 
Table 2.1 : Gradient eluant system for Dionex chromatography of anionic 
polysaccharides. The flow rate was ImVmin with a high pressure 
limit of 1800 psi and a low pressure limit of 300 psi. 
column. 
2.2.4 Molecular Weight Determination ofHA Oligosaccharide by NMR 
Hyaluronic acid oligosaccharides were prepared and examined as follows. Samples 
were dissolved in 0.5ml 99.8% 2H20, buffered to pH7 with lOmM sodium phosphate 
mixture and referenced with sodium 3-trimethylsilyl eH41 propionate as internal 
standard. After microfiltration through 0.451lm nylon filters, samples were dried using a 
rotary concentrator and exchanged several times with 0.5ml 99.8% 2H20 and then once 
with 99.6% 2H20. IH-NMR spectra at 400 MHz were obtained at 23°C on a JEOL GSX-
400 spectrometer fitted with a 5mm probe. All chemical shifts are given relative to 
internal 3-trimethylsilyl [2H41 propionate at O.Oppm. NMR was carried out by Dr. 
Thomas Huckerby, University of Lancaster, England. The number of protons were 
calculated from this method thereby giving an accurate measurement of molecular 
weight. 
NMR gives an accurate characterisation of the samples, however its limitations are in 
the amount of time needed to prepare the samples for analysis, the availability of the 
machine and the skill to interpret the data. 
2.2.5 Molecular Weight Determination by Chemical Analysis 
Chemical analysis is a rough tool used to determine molecular weight. It is a quick, 
easy and effective method. 
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2.2.5.1 Uronic Acid Content 
Uronic Acid was determined by using the modified assay of Bitter & Muir (1962). A 
stock solution (0.025M) was prepared consisting of 9.5g sodium tetraborate dissolved 
in 1 litre of concentrated sulphuric acid. To a Iml sample, 5ml of the tetraborate-acid 
solution was added. After thorough mixing, the solution was heated for 10 minutes in a 
boiling water bath and cooled to room temperature. 0.2ml of 0.125%(w/v) Carbazole 
(Sigma, Dorset) was prepared in absolute ethanol was added to the solution. The 
resulting solution was heated for 15 minutes in a boiling water bath, cooled, then the 
absorbance read at 53Onm. Carbazole solutions are sensitive to light and were stored 
therefore in dark bottles during use. Analyses were performed on a Cecil 2020 
spectrophotometer using glucuronolactone standards from 0 - 0.2 J.1mollml. 
2.2.5.2 Estimation of N-Acetylamino Sugars 
Reducing sugars were determined by a modified method of Elson & Morgan (1933). A 
0.7M solution of boric acid was prepared and the pH raised to 9.2 with potassium 
hydroxide. A dimethylaminobenzaldehyde (DMAB) solution was also prepared by 
dissolving 109 of DMAB (Sigma, Dorset) in glacial acetic acid containing 12.5% (v/v) 
concentrated HCl. This was diluted 10 fold in glacial acetic acid before use. To a 
0.5ml sample was added O.lml of the Boric acid solution, followed by heating in a 
boiling water bath for 5 minutes. After cooling on ice, 3ml of diluted DMAB was 
added and mixed thoroughly and the test tubes incubated at 37°C for 20 minutes. After 
cooling, the tubes were read immediately at 586nm. N-acetylglucosamine and N-
acetylgalactosamine were used as standards at between 0 - 0.2J.1mollml. All analyses 
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were carried out on a Ceci12020 spectrophometer. 
2.2.5.3 Estimation of Number of Repeating Units in HA and CS 
The number of repeating disaccharide units present in any HA and CS chain can be 
estimated by measuring the amount ofuronic acid (method 2.2.5.1) and reducing power 
(method 2.2.5.2) present in the sample. The ratio of uronic acid to reducing N-
acetylglucosamine and N-acetylgalactosamine (J.1mol/ml) is an estimate of the 
molecular weight of the sample. 1 disaccharide unit is equal to 400 Da. From this the 
number of disaccharide units can be detennined as follows: 
Uronic acid Cllmol/ml) 
Reducing Power 
= Average no. of disaccharide units 
per chain 
2.2.6 Molecular Weight Determination ofHA and CS Oligosaccharides 
by PAGE 
Gel electrophoresis and densitometry were employed to determine molecular weight. 
The problems encountered by this method were mainly due to the polydispersity of the 
polysaccharides (Le.) long smears obtained on the gel. The method chosen was more 
accurate at determining the higher molecular weight samples. The small 
oligo saccharides were too small to run on the gel and were estimated to have much 
higher weights than determined by another other method. Gels were prepared as 
described by Cowman et ai, (1984) to final concentration of 20% (w/v) 
acrylamide/0.67% NN'-methylene bis-acrylamide (Table 2.2). The concentrated buffer 
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1. lOx Reservoir Buffer (pH 8. 3) 
1M Tris 
O.OIM di-sodium EOTA 
Add 6M HCI until pH rises to 8.3 
2. Stock acrylamide separating gel 
20% acrylamide : 0.67% bisacrylamide 
3. Separating gel (10%) 
25ml of20% acrylamide/O.67% bisacrylamide stock solution 
25ml ofO.2M Tris/HCI/0.OO2M EOTA 
0.3ml of 10% ammonium persulphate solution 
85~1 TEMEO 
4. Sample Buffer 
0.2 % Bromophenol Blue in 1 x running buffer 
5. Stain 
0.5% Alcian Blue in 2% acetic acid 
6. Destain 
2 % acetic acid 
Table 2.2 Solutions for Polyacrylamide Gel Electrophoresis of HA & CS 
Fragments 
stock contained 0.2M-TrisIHClIO.002M-disodium EDTA, pH8.3. Equal volumes of 
these two solutions were mixed at room temperature and deaerated for 15 minutes. For 
polymerisation, 0.6ml of 10% (w/v) ammonium persulphate in water (freshly prepared) 
and 0.17ml of NNN'N'-tetramethylethylenediamine were added per 100ml of gel 
solution. The gels (15cm long and 14cm wide) were cast between glass plates spaced by 
perspex strips. The gels were overlayed with buffer to prevent drying out and allowed to 
polymerise overnight at room temperature before use. Samples containing 150 flg of 
material in less than 50 fll volume were mixed with a one-tenth volume of 0.2% (w/v) 
Bromophenol Blue (dissolved in 2M-sucrose in O.1MTrisIHClIEDTA buffer) and 
applied to the gel. The mobility of Bromophenol Blue matched that of a chondroitin 
sulphate digest with approximately 13 repeating units (Cowman et ai, 1984). The 
reservoir buffer was O.IM TrisIHClIEDTA. Gels were electrophoresed at 125V for 20 
min and then at 250V for approximately 1.5h. The gels were stained in 0.5% (w/v) 
Alcian Blue in 2% (v/v) acetic acid for 45 mins, then destained for 15 mins in 2% (v/v) 
acetic acid. Photographs were then taken of gels. Molecular weight estimations were 
carried out as described in section 2.2.8. 
2.2.7 Molecular Weight Determination ofORC OUgosaccaharides and 
Pectin by PAGE 
Solutions used in the preparation of these polyacrylamide gels are shown in Table 2.1. 
The method was developed for ORC by Peter Doyle, Johnson & Johnson}. The gels 
were cast between glass plates spaced by perspex strips as above and were overlaid with 
buffer and allowed to polymerise overnight at room temperature. 20111 aliquots of 
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1. Reservoir Buffer (pH 8.3) 
O.IM Tris 
ImM EDTA 
Raise to pH 8.3 with 6M Hel 
2. Stock acrylamide separating gel 
20% acrylamide : 0.67% bisacrylamide 
3. Separating gel 
25ml of 20% acrylamide/O.67% bisacrylamide stock 
25ml of water 
70~.Ll TEMED 
O.4ml of 10% ammonium persulphate solution 
4. Sample buffer 
3ml of glycerol 
19m9 EDTA 
0.25ml of running buffer 
Img of Bromophenol Blue 
5. Stain 
0.1 % Alcian Blue in 7% acetic acid 
6. Destain 
7 % acetic acid 
Table 2.3 Solutions for Polyacrylamide Gel Electrophoresis of ORC and 
Pectin Fragments 
approximately lOmglml of the standards (Section 3.1.6) and 10mglml of each ORC 
sample were dissolved in the sample buffer then added to the gel. The gels were run at 
150V for approximately 4 hours, after which they were stained with 0.5% (w/v) Alcian 
Blue in 7% (v/v) acetic acid for 45 minutes, then destained with 7% (v/v) acetic acid. 
Calculation of molecular weight was carried out as described in section 2.2.8. 
2.2.8 Densitometry Analysis of Polysaccharides 
Polysaccharides invariably produce smears when run on polyacrylamide gels (Cowman 
et aI, 1984). In order to help analyse the molecular weight range of these 
oligo saccharides, the gels were analysed by densitometry. Images of the gels were 
captured using a Nikon TV camera onto the Apple McIntosh program "Optilab®" using 
a method developed by Derek Silcock, Johnson & Johnson. The program then 
calculated the most dense area of each smear and displayed the smear as a graph of 
pixel intensity. The closer the value to 0, the more dense the area. The captured image 
was calibrated to ensure that measurements taken represented those on the actual gel. 
This method gave an measurement of the peak molecular weight of the dispersed 
polysaccharide smear. 
2.3 CELL CULTURE 
2.3.1 Cell types 
(a) L929 mouse connective tissue fibroblasts, kindly donated by Dr. S. Srivastava, 
Bioengineering Department, University of Strathclyde. 
4S 
(b) Bovine Aorta Endothelial Cells (BAEC), kindly supplied by Prof. Mark 
Ferguson, Department of Cell and Structural Biology, University of Manchester. 
(c) Rat Wound fibroblasts were isolated at Johnson & Johnson Medical 
Biolpolymer Group (see section 2.3.3) 
(d) Human skin fibroblasts, kindly supplied by Dr. Michael Edwards, Department 
of Dermatology, University of Glasgow. 
(e) 3T3 Swiss Mouse fibroblasts, kindly supplied by Prof. Birgitt Lane, University of 
Dundee. 
2.3.2 Cell Culture Reagents 
Dulbecco's modified Eagle's medium (DMEM) containing 10% (v/v) Fetal Calf Serum 
(PCS) was used to maintain all the cell types. This was supplemented with 1 % (v/v) 
penicillin/streptomycin solution, 1% (v/v) glutamine and 9mM sodium bicarbonate (all 
Gibco BRL, Paisley, Scotland). Hank's balanced salt solution (HBSS) without calcium 
and magnesium (Gibco BRL, Paisley, Scotland) was used to wash cell mono layers 
before trypsinisation. The trypsin solution was prepared by diluting lOx concentrated 
trypsin-EDTA (Gibco BRL, Paisley, Scotland) with HBSS to give a single strength 
solution (Ferrao & Mason, 1993). 
Methylene Blue powder and 100% Leishman's stain were both obtained from Sigma 
Chemicals, Dorset. 
2.3.3 Isolation of Rat Wound Fibroblasts 
The cells were isolated by the method of Finesmith et ai, 1990. Adult Wistar male 
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rats, aged 3 months, were each implanted with 4 polyvinyl alcohol sponge discs 
beneath the panniculus carnosus, next to the body musculature, as previously 
described (Davidson et ai, 1985), while under pentobarbitone anaesthesia (45mg/kg). 
At 14 days post-implantation, the animals were sacrificed by CO2 asphyxiation. The 
sponges were placed in DMEM containing 20% (v/v) FCS, amphotericin (25/lg/ml, 
GmCO BRL, Paisley, Scotland), penicillin/streptomycin (lOOOU/ml, GmCO BRL, 
Paisley, Scotland) and placed on ice. Under sterile conditions, the encapsulated 
adventitia was removed and the sponges were cut into small sections (l-2mm2) using a 
scalpel and scissors. The minced sponges were placed in DMEM containing 10% (v/v) 
FCS, 200 units of bacterial collagenase (Type IA) and penicillin/streptomycin (lOx) 
and incubated at 37°C for 4 hours. The sponges were agitated by pipetting and the 
supernatants were centrifuged at l200rpm for 5-10 minutes. The pellets were 
resuspended in DMEM with 20% (v/v) FCS, lOx penicillin/streptomycin and placed in 
75cm3 flasks. The cells were grown in standard cell culture DMEMllO% (v/v) FCS after 
the first passage and were maintained as described in sections 2.3.6 & 2.3.7. 
2.3.4 Isolation of Human Skin Fibroblasts 
Isolation of human skin fibroblasts was carried out by Dr. Mike Edwards, Dept. of 
Dermatology, University of Glasgow. 
Small skin biopsies from the forearm were taken from healthy volunteers. The skin 
samples were placed in DMEM containing 20% (v/v) FCS, amphotericin (25/lg/ml, 
GmCO BRL, Paisley, Scotland), penicillin/streptomycin (lOOOU/ml, GIBCO BRL, 
Paisley, Scotland) and placed on ice. Under sterile conditions, the skin samples were 
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minced finely with curved scissors and added to a solution of DMEM containing 10% 
(v/v) FCS, 200 units of bacterial collagenase (Type lA, Sigma Chemicals) and 
penicillin/streptomycin (lOx, Gibco Ltd) and incubated at 37°C for 4 hours. Every 30 
mins, the mixture was agitated by pipetting and then the supernatants were centrifuged 
at l200rpm for 5-10 minutes. The pellets were resuspended in DMEM with 20% (v/v) 
FCS, lOx penicillin/streptomycin and placed in 75cm3 flasks. The cells were grown in 
standard cell culture DMEMllO% FCS after the first passage and maintained as 
described in sections 2.3.6 & 2.3.7. 
2.3.5 Isolation of Bovine Aorta Endothelial Cells 
Isolation of BAEC cells was carried out by Prof. Mark Ferguson's group at The 
University of Manchester. Fresh aortas were transported from the abattoir to the 
laboratory within one hour. Fat and other loose connective tissue were removed from 
the aorta, then it was cut length ways and the inside surface was washed with copious 
amounts of sterile phosphate buffered saline. The aorta was laid on a flat surface and 
the inside was gently scraped with a sterile scalpel. The scraped material from one aorta 
was suspended in 4 ml of collagenase dispase solution (lmg/ml in serum free DMEM) 
and incubated at 37°C for 45 minutes. The cell suspension was transferred to a plastic 
tube and centrifuged at 600 x g for 10 minutes. The enzyme solution was removed by 
vacuum aspiration and the cell pellet was resuspended in DMEM supplemented with 
10% serum. The cell suspension was transferred to a 75cm3 cell culture flask and 
incubated at 37°C and 5% CO2, The medium was replenished after 24 hours and 
thereafter at 3 day intervals. The cultures were found to be confluent within 3-5 days. 
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2.3.6 Maintenance of cells 
All cell types were grown in 25cm3 flasks and incubated at 37°C in an atmosphere 
containing 95%Oi 5%C02• The cells attached to the plastic surface under these 
conditions to form a monolayer. 
2.3.7 Trypsinisation of Cells 
Medium was aspirated from the confluent cell monlayers and 5ml of HBSS added for 
5 minutes before being removed. Iml of trypsin solution (section 2.3.2) was added to 
the flask and incubated at 37°C until all of the cells had rounded and detached from 
the flask surface. The cell suspension was then transferred to a sterile centrifuge tube 
and centrifuged at lOOOrpm for 5 minutes. The supernatant was then aspirated and 
the cells resuspended in an appropriate volume of culture medium, containing 10% 
(v/v) FCS and 10% (v/v) DMSO. Iml aliquots were transferred to cryovials, placed in 
the freezer tray and left overnight in the liquid nitrogen vat. The vials were then 
transferred to a permanent position in the racking system. 
2.3.8 Recovery of Frozen Cells 
Frozen cells were removed from the liquid nitrogen vat and placed in water at 37°C. 
Immediately after the vial had thawed, the cells were transferred to a culture flask and 
5ml of DMEM with lO%(v/v) FeS was added drop by drop. The cells were 
incubated overnight to allow attachment. The medium containing the cryopreservative 
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(DMSO) was aspirated and replaced with fresh medium containing 10%(v/v) PCS and 
the cells allowed to grow to confluence. 
2.4 CELL CULTURE ASSAYS 
2.4.1 Standard Curves 
For each cell type, a standard curve of cell number versus absorbance at 650nm was 
constructed. Cells were seeded at 0-9x104 cells/200j.l1 per well in Dulbecco's Modified 
Eagles Medium (DMEM) containing 10% fetal calf serum (FeS), with six replicates for 
each density. The cells were allowed to attach for 4 hours, then the plates were fixed 
with methanol (section 2.4.2) and then assayed by the methylene blue method described 
in section 2.4.4. The mean and standard deviation of the absorbance measurements at 
650nm were plotted against cell number. Standard curves are shown in Chapter 3 for all 
cell types used in this study. 
2.4.2 Methanol Fixation of Cells 
100 j.ll of methanol was placed into each well containing attached cells. After 5 mins, 
the methanol was removed by inverting the plate onto tissue paper. The plates were 
air dried before any further assays were carried out. 
2.4.3 Proliferation Assay 
A modified version of that described by Ferrao & Mason, (1993) was used. Cells were 
seeded at 5000/200j.l1 per well in DMEM containing 10% (v/v) FCS and were left to 
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attach for 4 hours at 37°C/5%C02• The cell number was obtained by using the method 
described in section 2.4.5. Following attachment, the medium was discarded and 
replaced with 200, . .tl of serum-free DMEM and left to incubate overnight. After 
disposal of the medium, 200J.lI of oligosaccharide solutions were added at various 
concentrations to the wells in DMEM containing 2%(v/v) FCS (6 replicates of each), 
and left to incubate for 1, 2 and 3 days. Cells were fixed with methanol (section 2.4.2) 
following incubation. The wells were then assayed for proliferation by the methylene 
blue method described in Section 2.4.4. 
2.4.4 Methylene Blue Assay for Measurement of Cell Proliferation 
A modified version of the Oliver et ai, (1989) method was employed. 100J.ll of 0.1 % 
(w/v) methylene blue in 10mM Borate Buffer pH 8.4 was dispensed into each well 
containing methanol fixed cells, with a multichannel pipette and left to stain for 30 
minutes. Excess dye was discarded by overturning the plate into a large beaker and the 
plates washed four times with 300J.ll of 10mM borate buffer. 1 00~1 of 20% Ethanol in 
O.IM HCI was then added to each well to elute the dye from the cells. The plate was 
placed in a plate reading spectrophotometer (Dynatech MR5000) where the absorbances 
of each well were read at 650nm (~so). The percentage of proliferation was calculated 
by assuming the average absorbance of the control values to be 100% and therefore 
the average absorbance of the samples would be directly proportional to the 100%. 
2.4.5 Cell Counting Using a Haemocytometer 
The method used was taken from Sigma Biosciences Catalogue, p20t. Cells were 
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detached from the plastic by firstly washing with Hank's Balanced Salt solution 
(Gibco BRL, Paisley, Scotland) for 5 mins, followed by the addition of 40~.1l of 
trypsin-EDTA solution to each well. The plate was incubated at 37°CI5%COz until 
the cells detached from the surface. An aliquot was then taken and placed under the 
coverslip on the Neubaeur improved haemocytometer (Fisons, England). The cells 
were counted on the grid and expressed as the number of cells per ml. The calculation 
is shown below : 
Cells per ml = average count per square x dilution factor x 104 
2.4.6 Chemotactic Assay to Measure Cell Migration 
A modified version of Postlethwaite et ai, (1978) was employed to measure cell 
migration. 
A suspension of cells was prepared at 400,000 per ml in serum-free DMEM following 
trypsinisation as described in section 2.3.7. Oligosaccharides were dissolved at 
different concentrations in serum-free DMEM and 2SJ.d of each concentration placed 
in the bottom wells of a Neuroprobe microwell chemotaxis chamber, in triplicate. A 
polycarbonate filter with the relevant pore size for the type of cells being used (8Jlm 
for fibroblasts), was placed carefully on top of the bottom wells and the gasket seal 
placed between the filter and the top section of the chamber. This was pre-incubated 
for 10 mins at 37°C after which SOJlI of the cell suspension was added to each of the 
top wells and incubated for the required period for each cell type (fibroblasts - 3.Sh). 
DMEM alone was used as a negative control, while the positive control was 10pg/ml 
Transforming Growth Factor ~ (TGF~), (Sigma). The filters were then removed 
52 
carefully with forceps, fixed with methanol (section 2.4.2) and then dipped into 100% 
Leishman's stain for 10 mins. Cells were then counted in 20 fields of view for each 
sample at x40 magnification on the light microscope. 
2.5 ASSAYS TO DETERMINE THE EFFECTS OF 
OLIGOSACCHARIDES & POLYSACCHARIDES ON WOUND 
HEALING IN ANIMAL MODELS 
2.5.1 Introduction 
Polyvinyl Alcohol Sponges containing potential active factors were implanted 
subcutaneously in rats to establish the ability of the polysaccharides & 
oligosaccharides to influence wound healing and allow a comparison to the in vitro 
data obtained for the same factors. The subcutaneous model was chosen as it allowed 
multiple sample analysis on each animal and an animal licence was easily obtained for 
this type of minor surgery. The following methods were employed to carry out and 
analyse this study. 
2.5.2 Polyvinyl Alcohol Sponge Implantation 
Adult Wistar male rats, aged 3 months, were each implanted with 4 polyvinyl alcohol 
(PVA) sponge discs beneath the panniculus carnosus, next to the body musculature, as 
previously described (Davidson et ai, 1985), while under pentobarbitone anaesthesia 
(45mg/kg). PV A sponges were manufactured by Unipoint Industries Inc., North 
Carolina, USA, as an implant material used to fill cavities in reconstructive and other 
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types of surgery. Discs of 10 x 3mm were cut and sterilised by autoclaving, and 
implanted in five rats using the subcutaneous implant model. l00J.l1 of polysaccharide 
solutions were injected directly into the implanted sponge through the skin and was 
carried out 3 days post-implantation. The rats were sacrificed by CO2 asphyxiation 
followed by cervical dislocation at 7 and 10 days and the sponges sectioned by wax 
histology to visualise the invasion of the sponge by cells (see section 2.7). 
2.6 Processing of PV A Sponges 
Embedding, cutting and staining of PV A sections was carried out by staff at the 
Department of Pathology, Stirling Royal InfIrmary, Stirling, Scotland. 
Firstly the sponges were cut in half and embedded in paraffin. Sections were then cut 
at 3um on a Reichert-Jung 2040 microtome. The sections were placed on gelatin 
coated slides and placed in an oven at 56°C to melt the wax. They were then dipped in 
a series of alcohol washes to remove the wax. The sections were air dried until 
staining was carried out. 
2.7 STAINING OF PYA WAX SECTIONS 
2.7.1 Histological Staining of PYA Wax Sections with Haemotoxylin & Eosin 
(H&E) 
Staining of PYA sections was carried out at the Stirling Royal InfIrmary as follows. 
Each slide was dipped in Mayer's haematoxylin (Sigma, England) for 5 mins and 
rinsed with tap water until the water ran clear. The slides were then dipped in a 1 % 
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solution of eosin (Sigma, England) for 8 -10 secs and again washed with Tris 
Buffered Saline pH 7.4, (TBS) until the water ran clear. They were air-dried before 
observing under the light microscope (Nikon Optiphot, Japan). 
2.7.2 Visual Analysis of H & E Stained Histological Sections 
Sections were examined by light microscopy at both low and high power 
magnifications (Nikon Optiphot, Japan). The degree of granulation tissue formation, 
inflammation, blood vessel formation and fibrin content was examined for each 
sponge in triplicate. Granulation tissue formation was assessed by the presence of 
fibroblasts and new connective tissue laid down and these were identified by the 
presence of pink areas on the slide (nuclei were bluelblack), visualised under the 
microscope at x40 magnification. 
The sponges containing potential actives were compared against controls containing 
PBS only and were graded overall with a negative, zero or positive score and this 
grading was carried out by 2 or 3 independent assessors. There were up to a 
maximum of five animals used per sample with replicates of each sample on each 
animal. A total of 10 scores were therefore obtained at each time point. From this 
data, it was hoped that if any polysaccharide had stimulated granulation tissue 
formation, the majority of the scores would be positive and that the 2 or 3 
independent assessors would all achieve the same overall result. Statistical analyses 
were carried out on the results obtained as described in section 2.8, however the 
method was not validated. 
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2.7.3 Anti-Sera Used for Immunocytochemical Analysis 
Antibody staining of the H & E wax sections was also carried out to observe the 
presence of laminin, monocytes & macrophages and endothelial cells. This analysis 
would give an indication if inflammation was present, if blood vessels had formed and 
if laminin had been deposited. 
To observe laminin, a polyclonal rabbit anti-Iaminin (Serotec) was used as the 
primary antibody followed by sheep anti-rabbit IgO-FITC conjugate (Serotec). 
Monocytes and macrophages were visualised using a mouse monoclonal mouse anti-
rat monocyte/macrophage antibody, MeA 341 (Serotec), followed by a rabbit anti-
mouse IgO FITC conjugate (see section 2.7.3). The presence of endothelial cells in 
the sections was detected using a mouse monoclonal antibody MCA 276 (Serotec) 
followed by a rabbit anti-mouse-FITC conjugate. 
2.7.4 Immunocytochemistry Using Fluorescently Labelled 
Antibodies 
Wax embedded sections were prepared by staff at Stirling Royal Infmnary as 
described in section 2.6 and retained for immunocytochemistry. Firstly, the wax was 
melted in an oven at 56°C. The slides were then dipped in xylene for five minutes to 
remove the wax. This was followed by rehydration of the sections in decreasing 
concentrations of isopropanol (100%, 95% & 70%) with the slides bathing for 3 min 
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in each concentration. Following a fmal rinse in distilled water, the slides were placed 
in a bath containing 0.05M Tris buffered saline, pH 7.4 (TBS) for 5 mins. The 
sections were then labelled with 20J.11 of 1125 dilution in TBS of MCA 341 or MCA 
276 antiserum for one hour or 11200 and 11500 of rabbit anti-Iaminin for one hour in 
a humid chamber. The antiserum was decanted and followed with three one minute 
TBS washes. The sections were then incubated with 20J.11 of rabbit anti-mouse IgG-
FITC conjugate, diluted to 1150 in TBS or a 1140 dilution of sheep anti-rabbit IgG-
FITC for one hour in a humid chamber. The conjugate was decanted and sections 
washed in three changes of TBS for one minute each. Sections were mounted using 
permanent aqueous mounting medium. Sections were visualised immediately by 
fluorescence microscopy using a Nikon fluorescent lamp and Nikon Optiphot 
Microscope (Japan). Photographs were taken using Kodak 400 ASA film. This 
method was developed by Johnson & Johnson. 
2.S STATISTICAL ANALYSES 
2.S.1 Methylene Blue Proliferation Assay 
Statistical analysis was carried out using the Apple Maclntosh™ program, Multistat™. 
The sample data was entered into the program and an unpaired Student's t-test 
performed. This is a parametric test that tests the null hypothesis that two sets of data 
come from the same population, taking into account the standard deviations and 
numbers of items of the two groups. 
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t = mean difference I SEM of differences x (n-l) 
Where: SEM = standard error mean; n = number of samples 
A confidence level of 95 % was selected, therefore if the calculated probability was 
p < 0.05, the Null hypothesis was rejected and the sample mean was therefore 
significantly different from the control mean. 
2.8.2 Chemotaxis Assay 
The Apple MacIntoshTII program, MultistatTII, was also used for analysing data from 
this assay. Means and standard error of the means were calculated for each sample in 
triplicate. An unpaired student's t-test was then applied to the data and if p < 0.05, 
the Null hypothesis was rejected and the sample mean was therefore significantly 
different from the control mean. 
2.8.3 Histological Data 
Statistical analysis was carried out using the Apple MacIntosh™ program ExceF". The 
sample data was entered into the program and an unpaired Student's t-test performed. 
This is a parametric test that tests the null hypothesis that two sets of data come from 
the same popUlation, taking into account the standard deviations and numbers of items 
of the two groups. 
A confidence level of 95 % was selected, therefore if the calculated probability was 
p<0.05, the Null hypothesis was rejected and the two samples were considered to be 
significantly different. 
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CHAPTER 3 : PREPARATION OF POLYSACCHARIDE FRAGMENTS 
3.1 Introduction 
It has been suggested from previous studies that HA oligosaccharides between 3 and 16 
disaccharides in length are angiogenic in vivo and stimulate the proliferation of 
endothelial cells in vitro (West & Kumar, 1989). These results indicated a possible role 
for the breakdown products of HA in wound healing as the proliferation of endothelial 
cells in new blood vessel formation is an important step in the healing process. This 
work initiated the idea of investigating the effect of other HA-like polysaccharides, such 
as other GAGs and plant polysaccharides, on the proliferation and migration of cells 
involved in the wound healing response. This would be carried out by investigating 
both in vitro and in vivo models, and characterising the specific size of fragment or 
fragments which are bioactive. Johnson & Johnson Medical Biopolymer Group were 
interested in developing new wound dressings containing bioactive molecules to 
stimulate the healing of chronic wounds, particularly leg ulcers. Amendments to an 
existing filed patent including data generated in this study has now resulted in a granted 
UK patent (Harvey, Light & Watt), No. 9206492. Polysaccharides, including those 
derived from plants, were cited in the patent for their use in the treatment of chronic 
wounds. This chapter details the methods by which oligosaccharide fragments of 
selected polysaccharides were generated and characterised. 
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3.2 Production and Analysis of Hyaluronic Acid and Its 
Oligosaccharides 
Initially it was thought prudent to produce HA oligo saccharides and test whether these 
were in fact bioactive as described by other observers (Gorham et ai, 1974; Cowman et 
ai, 1984). It was hoped that the HA products produced in this study would serve as 
positive controls for subsequent experiments with other polysaccharides. 
3.2.1 Molecular Weight Determination of Intact HA 
Molecular weight estimation of the starting material was determined both by 
polyacrylamide gel electrophoresis (pAGE) (Maniatis et ai, 1975; method 2.2.6) and 
viscometry (section 2.2.1; Fermentech Ltd., Edinburgh). Molecular size estimation was 
important, frrstly, to compare PAGE and viscometry methods and secondly, to compare 
values of molecular weight calculated with those detailed by the manufacturer. The 
manufacturer of the HA used in this study, Lifecore Inc., claim their HA to have an 
average MW of 750,OOODa, as estimated by viscometric analysis. 
3.2.2 PAGE of Undigested HA 
PAGE is an established method used for the separation of polymeric GAGs (McDuffie, 
1981; Nader et ai, 1981). The use of PAGE for the separation of these polymers, 
however, yields rather diffuse bands, resulting from charge density and molecular size 
heterogeneity (Cowman et ai, 1984). For the purpose of this study, PAGE was used to 
give an approximate value of molecular size estimated by running dextran sulphates of 
known molecular weights simultaneously on the gel. Dextran sulphates with average 
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molecular weights of 5, 40 and 500kDa were run alongside undigested HA as molecular 
weight indicators. Fig 3.1 demonstrates the profiles obtained for the dextran sulphate 
standards. Molecular weights were estimated by measuring the most densely stained 
area of the band using a densitometer (method 2.2.8). Fig 3.2 demonstrates that 
undigested HA travelled from 0 cm to 0.22cm on the gel which suggests that its 
molecular weight is greater than that of the 500kDa dextran standard which travelled 
0.29cm. This result shows therefore that by using PAGE, HA has a molecular weight of 
greater than 500kDa. PAGE analysis of such large molecular weight polysaccharides is 
clearly not accurate, however, this method is useful when trying to obtain information 
about the fragmentation ofHA polymers. 
3.2.3 Molecular Weight Estimation ofHA by Viscometry 
Fermentech Ltd., also a supplier of HA, supplied a validated method to size HA 
samples by viscometry (method 2.2.1). Using this method, Lifecore HA was determined 
to have an average molecular weight of 828kDa using the formula in Figure 2.1 (b). 
PAGE could only give a value of >500kDa for the weight of the undigested polymer, 
whereas viscometry gave a more precise measure. Subsequently, in this study, the 
molecular weight of undigested HA was considered therefore to be 828kDa. The 
manufacturers value and the value obtained in this study may be different due to a 
number of reasons. Firstly, the method used to calculate the molecular weight may have 
been different and also the type of viscometer used may have varied. It is also possible 
that different batches of HA produced have variations in molecular size. The 
limitations of using viscosity as an estimation of molecular size will be discussed later 
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Figure 3.1 Polyacrylamide gel electrophoresis and densitometry SC, lQS of 
dextran sulphate standards. Lane a-I Omg/ml 500kDa 
dextran sulphate (20}..11 loaded), Lane b - 10mg/ml 40 kI a dextran 
sulphate (20)..11 loaded), Lane c - 10mg/ml 5 kDa dextran sulphate 
(20i-.d loaded). The scans run from left to right on the gn.ph and the 
most dense areas are represented by the lowest numbers on the 
scale. 
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in the chapter. 
3.3 Depolymerisation of HA 
Depolymerisation of HA can be carried out by several methods including, enzymatic 
digestion (Gorham et ai, 1974), chemical hydrolysis (Rowley & Halliwell, 1982: 
Swann, 1969) and sonication (Rehakova et ai, 1994). One of the most controllable 
method however, has been shown to be the addition of testicular hyaluronidase which 
breaks the HA into repeating units of glucuronic acid and N-acetylglucosamine 
(Gorham et ai, 1974). Testicular hyaluronidase is specific for the BI-4 bond between the 
N-acetylglucosamine and glucuronic acid residues in the HA chain. Molecular sizing of 
these repeating structures can be determined by a colorometrlc test which measures 
average number of disaccharide units per chain, and this can be easily converted into the 
equivalent molecular weight (see methods 2.2.5.1- 2.2.5.3). 
3.4 Hyaluronidase Digestion of HA 
In order to generate potentially bioactive fragments, it is necessary to depolymerise the 
intact HA molecule. Sections 3.4.1 to 3.6 describe a number of these methods and the 
types of oligosaccharides produced. 
Hyaluronic acid was digested by hyaluronidase over a time course of 24 hours in order 
to establish the rate and degree of HA breakdown. Table 3.1 shows the digestion of 
10mglml HA with O.25mglml testicular hyaluronidase (2400U/mg) at 25°C as 
measured by detennining the ratio of uronic acid to reducing N-acetylglucosamine 
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Incubation Vronic Ratio Average 
Time acid/reducing VA: Molecular 
N-acetyl reducing Weight (Da) 
glucosamine NAG 
o mins 
- - 828,000* 
5 mins 19.8/1.94 10: 1 4000 
10 mins 32.3/1.93 17 : 1 6800 
15 mins 23.112.43 10: 1 4000 
30 mins 22.012.67 8:1 3200 
45 mins 20.2/2.83 7: 1 2800 
60 mins 24.9/3.14 8 : 1 3200 
90 mins 33.7/3.27 10 : 1 4000 
120 mins 21.8/3.9 6 : 1 2400 
3 hrs 24.6/4.36 6 : 1 2400 
4 hrs 28.4/5.27 5 : 1 2000 
5 hrs 27.9/5.45 5 : 1 2000 
6 hrs 30.8/6.14 5 : 1 2000 
24 hrs 22.3/10.06 2: 1 800 
* Molecular weight measured by viscometry (Method 2.2.1) 
Table 3.1 Digestion of IOmg/ml HA (MW 828 kDa) with 0.25mg/ml testicular 
hyaluronidase (2400U/mg) over a 24hr time period at 25°C. The 
table shows the average molecular weights of each aliquot as 
determined by uronic acid and reducing N-acetylglucosamine 
content (Method 2.2.5). 
present in the samples. Digestion of HA was extremely rapid under these conditions, 
falling from an average molecular weight of 828,000 Da to an average of 4000 Da 
(equal to 10 disaccharide units), after only 5 minutes. After the 24hr digestion period, 
the average molecular weight had dropped to 800 Da, equivalent to 2 disaccharides. 
This result supports that reported in the literature (Gorham et ai, 1974). It must be 
stressed, however, that the values obtained for the molecular weights of the HA digests 
were an average and other sizes of HA oligosaccharides were present in the samples 
also as shown by the large smears obtained on gels and densitometric analysis (Fig 3.2). 
3.4.1 Depolymerisation of HA by Sonication 
Previous in-house studies carried out by Johnson & Johnson Medical Biopolymer 
Group suggested a role for sonication in the depolymerisation of HA, however it was 
apparent from these studies that the lowest molecular size obtained by this method was 
approximately 50,000Da using dextran sulphate standards (P.Watt, personal 
communication;). Due to time constraints however, this work was not taken any further, 
but it is unlikely that small oligosaccharides would be generated by this method. Ross et 
ai, (1993) and Rehakova et ai, (1994) have also reported that sonication is effective at 
producing HA oligo saccharides in the range of 80,000 -1.38 x106 Da as determined by 
gel filtration. 
In this study two samples ofHA were sonicated (method 2.1.2) for (a) 4 x 8 secs and (b) 
8 x 8 secs and their molecular weights estimated by viscometry (method 2.2.1). The 
HA sample which was sonicated for 4 x 8 secs had an apparent molecular weight of 
739 kDa, therefore sonication for this length of time resulted in only a small decrease in 
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the average molecular weight of the HA. Sonication for 8 x 8 sees, however, resulted in 
a reduction of the average molecular weight to 500kDa. Sonication for longer periods of 
time would degrade the HA further however, time constraints made it impossible to 
develop this work further. Sonication therefore appears to produce HA solutions with 
lower molecular weights than the starting material, however, as this project requires 
very small oligosaccharide fragments, sonication was deemed an unsuitable method for 
the desired purpose. 
3.5 Isolation of Selected OJigosaccharides 
West & Kumar (1989) suggested that oligo saccharides between 3 and 16 disaccharides 
were bioactive both in vitro and in vivo. For this reason, the aim of this study was to 
produce discrete sizes of HA for use as both molecular weight markers and bioactive 
agents. The 24h HA digest was chosen for separation of HA oligo saccharides because it 
contained a range of sizes from 2 disaccharide upwards (see section 3.4). 
3.5.1 Separation ofHA Oligosaccharides by Gel Chromatography 
Separation of oligosaccharides from the 24hr HA digest was carried out by gel 
chromatography, using a Biogel P6 column (method 2.1.3), which separates molecules 
with molecular weights of between 1000 and 6000 Da (Bio-Rad, Watford, UK). 
The oligosaccharides produced were susbsequently analysed by chemical analysis 
(method 2.2.5) to determine their molecular weight. It was discovered however, that 
the eluant used during the separation (ammonium acetate, pH 5.0) interfered with the 
measurement of reducing N-acetylglucosmine. A study was then carried out to 
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determine the effect of the buffer and this is shown in Fig 3.3. In order to resolve this 
interference problem, it was therefore necessary to remove the ammonia and acetic acid 
by freeze-drying the samples and then resuspend them in water. The results of the study 
demonstrate that when samples were dissolved in ammonium acetate the detection ofN-
acetyl glucosamine at AS86 was much lower than those samples dissolved in water or 
freeze-dried and resuspended in water. 
Chromatographic separation of the 24hr HA digest on a Biogel P6 column, resulted in 
the detection of 4 discrete oligosaccharides by measuring the amount of uronic acid 
detected in each tube (Figure 3.4). Recovery of HA fragments compared to total HA 
(30mg) loaded was not quantitated but visual inspection suggested the presence of only 
a few milligrams per peak thereby indicating some high molecular weight HA 
remaining. The Vo suggests that no high MW HA was present, however it may have 
eluted before the blue dextran standard and therefore has not been recorded. 
3.5.2 Molecular Weight Determination of Individual Peaks by 
Chemical Analysis 
The molecular weight of each oligosaccharide peak was determined by the ratio of 
uronic acid to reducing N-acetylglucosamine. The ratios (Table 3.2) indicated that peaks 
1 and 2 were both hexasaccharides, peak 3 was a tetrasaccharide and peak 4 was a 
disaccharide. Peaks 1 and 2 eluted very close to each other and so it is possible that they 
were in fact a single broad peak and not two separate ones. 
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Figure 3.3 : The effect of ammonium acetate on the detection ofN-
acetylglucosamine (NAG) as detennined by absorbance at 586nm. 
The graph shows the effect of dissolving NAG in water (.), 
ammonium acetate (.) or ammonium acetate followed by freeze-
drying and resuspending in water (.6.). 
Peak Number Ratio ofUronic acid Ratio No. of 
1 
2 
3 
4 
Table 3.2 
: reducing N-acetyl disaccharides 
glucosamine 
(Jlmollml) 
1.54/0.53 2.9: 1 3 
2.28/0.88 2.6: 1 3 
2.75/1.55 1.8:1 2 
0.32/0.3 1 : 1 1 
Molecular weight estimations of eluted peaks from Biogel P6 gel 
permeation chromatography (Fig 3.4). Molecular weights were 
determined by the ratio of uronic acid to reducing N-acetyl glucosamine 
(Method 2.2.5.2). 
Figure 3.4 : Separation of oligo saccharides produced by digestion of HA (MW 
828kDa) by hyaluronidase for 24hr. Approximately 30mg of sample 
was applied to a column (1000 x 30mm) ofBiogel P6, and eluted with 
50mM ammonium acetate, pH 5.0. 3ml fractions were collected, 
analysed for uronic acid content (method 2.2.5.1) and absorbance read 
at 530nm. 
3.5.3 Molecular Weight Determination by Dionex Chromatography 
Standards for the Dionex were not readily available as it was in fact the aim of this 
experiment to produce them. The information obtained from the Dionex therefore 
served only to confirm that the samples had different molecular weights but no size 
estimation could be undertaken (Fig 3.5) 
3.5.4 Further Characterisation of Peak 3 by HPLC 
Further molecular weight characterisation was carried out on peak 3, which was the 
biggest peak collected and provided enough freeze-dried material for analysis. Peak 3 
was analysed by HPLC(method 2.2.2). Dextran standards with molecular weights of 
1200, 11700,47250,97000 and 326,000 Da were used to calibrate the column (Fig 3.6). 
The results of this analysis suggested that peak 3, with a retention time of 16.16 mins, 
had a molecular weight of 1200 Da. which represented a hexasaccharide (Fig 3.7). This 
result was contradictory to the chemical analysis which indicated that peak 3 was a 
tetrasaccharide (Table 3.2). As HA standards were not available commercially, 
dextrans were used as the best alternative. It is possible however that they may have 
given inaccurate estimations of molecular weight due to the presence of sulphate groups 
which HA molecules do not possess. 
3.5.5 Molecular Weight Determination olPeak 3 by NMR 
In an attempt to obtain a more accurate measure of molecular weight of Peak 3, analysis 
by Nuclear Magnetic Resonance (NMR) was performed (method 2.2.4). This type of 
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analysis has been used previously to determine the molecular weight of polysaccharides 
(Huckerby et ai, 1990). NMR analysis confirmed that peak 3 was a tetrasaccharide 
(Figure 3.8). The original chemical analysis method was therefore deemed the more 
accurate in estimating the molecular size of the peaks. 
3.6 Preparation of Polydisperse HA Digests 
Although these studies have shown how selected small molecular weight HA 
oligosaccharides can be isolated, the amount, however, of purified oligo saccharides 
produced by these procedures was in microgram quantities, and although they are useful 
molecular weight markers, there was an insufficient quantity to study their effects on 
wound healing in vivo. As it was the intention of this study to determine the effects of 
these polysaccharide fragments in vivo and on cells in vitro, it was decided that future 
studies should be carried out using crude enzymatic digests which would not be purified 
further as they could be produced in much higher yields. 
HA digests with three different ranges of sizes were prepared using the method 
described in method 2.1.1. Undigested HA was incubated: (1) without hyaluronidase to 
give a control sample of high molecular weight (828kDa) (2) with hyaluronidase for 5 
mins to give an intermediate size range and (3) with hyaluronidase for 24h to give a 
digest containing small oligo saccharides (see section 3.4). 
3.6.1 Molecular Weight Determination of HA by Viscometry 
The molecular weight of the undigested HA sample was determined to be 828kDa by 
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Figure 3.8 
I I l~--.---r--'--I--r I , 
b 5 ~ 3 2. 1. 0 
: HI - NMR spectra of HA oligosaccharide (peak 3) eluted by gel permeation chromatography llsillg 
llsing Biogel P6. Spectra were obtained at 23°C on a lEOL GSX-400 spcctropholllcter. The intcrnal 
standard was sodium 3-trimcthylsilyl [21-14] propionate. 
viscometry as described previously in section 2.2.1. Viscosity measurements on the 5 
and 24h digests were not be carried out as such low molecular weight species have 
negligible viscosity. 
3.6.2 Molecular Weight Determination ofHA by Chemical Analysis 
The approximate size of the oligo saccharides was estimated by chemical analysis, 
measuring the ratio of uronic acid content to reducing N-acetylglucosamine (method 
2.2.5.3)(Table 3.3). The molecular weight of the undigested HA sample, however, could 
not be analysed by this method as too few reducing groups are present in the undigested 
sample. 
3.6.3 Molecular Weight Determination ofHA by PAGE Analysis 
In addition to reducing N-acetylglucoasminelUronic acid ratio which gives an average 
MW, the molecular weights of the digests were determined by polyacrylamide gel 
electrophoresis and densitometry. These methods have been described previously in 
section 3.2.2 & Figs 3.2. PAGE measurement of molecular weight was chosen because 
of similar analysis carried out on sulphated GAGs (see later) reported by Turner & 
Cowman (1984), who observed the formation of a ladder-like set of bands for partial 
testicular hyaluronidase digests of chondroitin-4-sulphate and chondroitin-6-sulphate. 
The electrophoretic gel and densitometric scans both showed that each digest contained 
a range of sizes of HA which decreased in size as the incubation time increased (Table 
3.4; Fig 3.2). Dextran sulphate standards with defined molecular weights of 5, 40 and 
500 kDa were included in the electrophoretic gel to give an indication of the molecular 
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Sample Distance to most dense area Approximate MW (kDa) 
(cm) 
Dextran sulphate 500kDa 0.29 500 
Dextran sulphate 40kDa 10.44 40 
Dextran sulphate 5kDa 13.34 5 
Undigested HA 0-0.22 >500 
HA (5 min digest) 4.5 -7.8 >40,<500 
HA (24h digest) 9.57 -40 
Table 3.4 : Molecular weight estimations ofHA digests by comparison to the 
distance travelled by dextran sulphates on a 10% polyacrylamide gel. 
Distances to the most intense blue staining were measured by 
densitometry (method 2.2.8). 
Incubation Time of Uronic acidIN-acetyl Average no. of Approx. Molecular 
HA glucosamine disaccharide units weight (Da) 
(J.lmollml) 
Omins 
- -
828,000 • 
5mins 30/6.2 5 2000 
24h 21111.77 2 800 
• Molecular weight analysis by viscometry 
Table 3.3 : Digestion of 1 Omglml HA (MW 828kDa) with 0.25 mglml testicular 
hyaluronidase (2400U/mg) at 5 mins and 24h incubation periods at 
25°C. The table shows the average molecular weights of each aliquot as 
determined by uronic acid and N-acetyl glucosamine content. 
(Method 2.2.5). 
weights of the digests (Table 3.4; Fig 3.1). Charge to mass ratios however, also affect 
mobility of polysaccharides and it has been shown that sulphated GAGs migrate quicker 
than non-sulphated GAGs (Turner & Cowman, 1984). This effect must be remembered 
when comparing the dextran sulphate and HA gel scans. Ladders were not obtained 
during this study, but instead polydisperse smears were observed. Due to the presence 
of smears, the distance from the top of the gel to the most dense area of the of the HA 
bands were measured by densitometry to give a molecular size range compared to those 
obtained for dextran sulphate (Table 3.4; Fig 3.2). 
The results from PAGE suggest much greater molecular weights for each digest than 
using chemical analysis as might be expected due to the smaller oligosaccharides 
running off the bottom of the gel, however PAGE followed by densitometric analysis 
demonstrates the presence of a range of molecular weights and therefore an average has 
been calculated from the range. Inaccuracies in the PAGE method for MW estimation 
may also have occurred due to the difference in charge to mass ratios of the dextran 
sulphate standards and HA. 
3.6.4 Conclusion 
Chemical analysis of molecular size by measuring the ratio of uronic acid to reducing 
N-acetylglucosamine has previously been reported to give accurate molecular weight 
determinations so long as the HA has first been partially depolymerised (Gorham et ai, 
1974). In conclusion, as PAGE loses the smaller oligosaccharides off the bottom of the 
gel, chemical analysis, which measures all molecules present, is a more accurate method 
of analysis. Further evidence for the accuracy of chemical analysis of purified fragments 
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is shown in section 3.4, where NMR analysis of a suspected tetrasaccharide (value 
obtained by chemical analysis) gave the same value. 
A summary of the methods used to determine molecular weight and the results obtained 
for the different oligosaccharide preparations are shown in Table 3.7a. 
In conclusion, oligo saccharides of HA could be produced by several different methods, 
giving various molecular weights ranges. The weight of the oligo saccharides could also 
be determined by various methods, some more accurate than others. For cruder 
fractions, a simple hyaluronidase digestion was fine, however, purification was required 
to give fragments of a specific size. 
The amount of pure HA fragments isolated was not sufficient for animal studies, 
therefore the crude oligosaccharide fragments produced were retained to examine their 
effect on cell proliferation & chemotactic ability in vitro. Similar work was reported by 
West & Kumar (1989) when they examined the effect of a range of HA 
oligosaccharides on endothelial cell proliferation in vitro. It was hoped that their effect 
on cells in culture would give an indication as to their ability to effect cells in vivo. 
3.7 Production and Analysis of Chondroitin Sulphate and its 
Fragments 
3.7.1 Introduction 
Chondroitin sulphate (CS) has a very similar structure to that of HA (Chapter 1 , Fig 
1.1) and its role in wound healing has been previously documented (LeBoeuf et ai, 
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1987; Westergren-Thorsson et ai, 1991). As reported in section 1.4.2, CS has been used 
in medical devices such as burn dressings, and so its potential activity in a wound 
healing situation has already been recognised but not proven. The involvement of CS in 
the wound healing response and its structural similarities to HA led to the decision to 
depolymerise the polysaccharide to investigate the effects of small CS oligosaccharide 
on wound healing. 
Like HA, CS can be depolymerised by testicular hyaluronidase (Knudson et ai, 1984) as 
it also contains 81-4 bonds between the N-acetylgalactosamine and uronic acid residues 
comparable to HA. 
3.7.2 Molecular Weight Determination of Intact CS by Viscometry 
Molecular determination of the starting material was important in order to establish the 
degree of depolymerisation over a time course. Viscosity measurements as used for the 
determination of undigested HA molecular weight, could not be used, as the starting 
viscosity of the CS was too low to be measured accurately by this method. 
3.7.3 Molecular Weight Determination of Intact CS by HPLC 
Analysis of intact CS by HPLC (method 2.2.2) was employed, using a dextran sulphate 
standard with the molecular weight range of 40-80 kDa. The manufacturer, Sigma, 
estimated the molecular weight of the CS by HPLC analysis to be between 40 and 80 
kDa. The HPLC trace (Fig 3.9) demonstrates the presence of 3 peaks for the dextran 
sulphate which correspond to the range of molecular size from 40 to 80 kDa within the 
sample tested. Dextran sulphate peak 1 contained the high molecular weight fragments 
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HPLC analysis of (a) lOmglml dextran sulphate with a molecular weight of 
between 40 and 80 kDa and (b) 10mg/ml chondroitin sulphate C. Two columns 
were run in series - a 10 ~m "Aquagel" and a TSK G~OOpwxl and were eluted 
with 5 mM tetrabutylammonium phosphate at a flow rate of I ml/min '. UV 
absorbances were measured at 21 Onm. 
followed by peaks 2 & 3 which contained smaller fragments respectively. The CS 
HPLC trace matches well with the DS trace thereby indicating the CS to indeed be 
within the range of 40 to 80 kDa as indicated by Sigma. 
3.7.4 Molecular Weight Estimation of Intact CS by PAGE 
PAGE of undigested CS was also attempted (Fig 3.10a), but accurate estimations from 
the polydisperse smear were difficult. Densitometry calculations of the smear indicated 
the undigested CS to be greater than 40 kDa but less than 500 kDa. 
Following molecular weight analysis by several different methods, the results indicated 
the most accurate measurement (i.e most similar to the manufacturer's value) to be by 
HPLC. The next step was then to depolymerise the intact CS by hyaluronidase 
treatment into oligosaccharide fragments as already carried out on intact HA (section 
3.6). 
3.8. Preparation of Polydisperse CS Digests 
Crude CS digests using 3 size ranges were produced as follows (method 2.1.1) : (1) 
undigested CS incubated without hyaluronidase to give a control sample of high 
molecular weight (40-80kDa), (2) incubation with hyaluronidase for 5 mins to give an 
intermediate size range and (3) incubation with hyaluronidase for 24h to give a digest 
containing small oligosaccharides. 
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3.8.1 Molecular Weight Estimations of CS Oligosaccharides by 
Chemical Analysis 
Chemical analysis shows the decrease in molecular size of CS as the incubation time 
increases (Table 3.5). After 5 minutes, the oligosaccharide has a molecular weight in the 
range of 4 kDa and after 24hrs this has decreased to 2 kDa. 
3.8.2 Molecular Weight Estimations orcs Oligosaccharides by PAGE 
Comparison of the smears obtained for CS and the dextran sulphate standards on 
PAGE, suggest the Smin and 24h digests to have molecular weights of between 40-500 
kDa and -40 kDa respectively (Table 3.6 & Fig 3.10). PAGE results have previously 
shown that small oligo saccharides run off the bottom of the gel (section 3.6.3), 
however, it still provides a useful visual assessment of the degree of polydispersion and 
comparison of the molecular weight changes between samples. A summary of the 
methods used to measure molecular weight are shown in Table 3.Th. 
As in the case of the HA fragments, it was the intention of this study to investigate the 
effects of these fragments in animal models, however, there was an insufficient amount 
of material to carry out the in vivo studies, so like HA, in vitro studies were carried out 
only. 
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Incubation time of Uronic acidIN- Average no. of Approx. Molecular 
CS acetlygalactosamine disaccharide units Weight (kDa) 
(J.lmollml) 
Omins 
- -
40-80 kDa· 
5 mins 2011.96 10:1 4kDa 
24h 16/3.04 5:1 2kDa 
• Molecular weight estimation by HPLC 
Table 3.5 : Molecular weight estimations ofCS digests by chemical analysis of 
uronic acid concentration and N-acetyl glucosamine content 
(method 2.2.5). 
Sample Distance to most dense area Approximate MW (kDa) 
(cm) 
Dextran sulphate SOOkDa 0.29 SOO 
Dextran sulphate 40kDa 10.44 40 
Dextran sulphate SkDa 13.34 5 
Undigested CS 2.47-7.83 >40,<500 
CS (S min digest) S.22-10.44 >40,<500 
CS (24h digest) 10.44 40 
Table 3.6: Molecular weight estimations of CS digests by comparison to the 
distance travelled by dextran sulphates on a 10% polyacrylamide gel. 
Distances to the most intense blue staining were measured by 
densitometry (method 2.2.8). 
(a) 
Digest Viscometry PAGE Chemical HPLC 
Analysis 
Undigested HA 828kDa >500kDa N/A N/A 
HA 5 min digest N/A 40-500kDa 2kDa N/A 
HA 24h digest N/A -40kDa 0.8 kDa 0.8-1.2 kDa 
(b) 
Digest Viscometry PAGE Chemical HPLC 
Analysis 
Undigested CS N/A 40-500kDa N/A 40-80 kDa 
CS min digest N/A 40-500kDa 4kDa N/A 
CS24h digest N/A 40kDa 2kDa N/A 
Table 3.7: Summary of (a) HA and (b) CS molecular weight determinations by 
different methods. 
3.9 Preparation and Analysis of Plant Polysaccharides and Their 
OJigosaccharides 
3.9.1 Introduction 
Certain plant polysaccharides have structures similar in many ways to animal 
polysaccharides (see chapter 1, section 1.5). Several of these plant polysaccharides were 
chosen to determine if their breakdown products had any wound healing bioactivity in 
vitro and/or in vivo. 
The polysaccharides tested were Oxidised Regenerated Cellulose (aRC) and pectin. 
aRC was chosen due to its structural similarity to HA (see Figure 1.3) whereas pectin 
shares similarities with chondroitin sulphate HA (Fig 1.3). Both these polysaccharides 
have also been clinically used in the treatment of wounds (see chapter 1, sections 1.5.1 
& 1.5.2), although aRC's main role is help in haemostasis and to prevent adhesion. 
3.9.2 Oxidised Regenerated Cellulose 
As stated in the introduction (chapter 1, section 1.5.2), aRC is a derivatised 
biopolymer produced from cellulose by oxidation with nitrogen tetraoxide in a 
chlorofluorocarbon solvent, and consists of 83% glucuronic acid residues (Saferstein & 
Boardman, 1992) (section 1.5.2). This material possesses a structural resemblance to 
GAGs, in that it contains uronic acid residues. aRC is both patented and manufactured 
by Johnson & Johnson Inc. as a haemostat and a barrier to adhesion. Recently a patent 
has been filed (Doyle, 1996) on aRC fragments and collagen-aRC composites 
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covering the potential bioactivity of ORC and its fragments. ORC and its fragments are 
therefore of great significance to Johnson & Johnson in that they may have a potential 
role in wound healing that previously has not been identified. 
3.9.3 Molecular Weight Estimation ofORC 
ORC is produced as an insoluble knitted fabric and its molecular weight in this form 
cannot be determined. ORC can be solubilised in alkali as shown previously by 
Saferstein& Boardman (1992). Due to the lability of ketone groups, however, the 
polymer begins to depolymerise even before it dissolves which leads to the formation of 
fragments - some with terminal aldehyde groups and others containing ketone groups. 
Resorption of ORC in the body occurs by the beta elimination process and the resulting 
fragments can then be removed from the blood by the kidneys or metabolised into CO2 
and H20. The formation of small oligosaccharide fragments of ORC by solubilisation in 
alkali was attempted in this study by using a strong alkali - 6M NaOH, and a weak 
alkali - O.1M NaHC03 (method 2.1.4 & 2.1.5). It was hoped solubilisation of ORC using 
2 different strengths of alkali would produce fragments of ORC with different 
polydisperse molecular weight ranges. Depolymerisation by this method involves the 
addition ofORC to alkali followed by the addition ofHCI to stop the reaction and bring 
the pH back to 7.0. Precipitation of the ORC follows at pH 7.0. The potential problem 
with this method is that addition of HCI may not stop the depolymerisation reaction. 
For the purpose of this study however, the degree of polymerisation of the ORC is not 
important. The aim was to demonstrate if either of the depolymerised solutions of ORC 
were bioactive. Further studies however could be devised to ensure that 
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depolymerisation is stopped by HCI by taking aliquots of ORC at varying time points 
after the addition of HCI and separating on PAGE to detect changes in molecular size. 
Following the solubilisation ofORC in NaOH and NaHC03, the molecular weight of the 
2 fragment ranges was determined by PAGE (method 2.2.7. Figure 3.11 shows that 
solubilisation with 6M NaOH yields fragments with a smaller range of molecular 
weights than that obtained using O.IM NaHC03 • The smears of polydisperse ORC are 
visible on the electrophoretic gel, however, the difference in molecular size between the 
two treatments is clearly apparent. Average molecular weight estimations of 
depolymerised ORC by comparison to those of dextran sulphate standards (Fig 3.11) 
gave average molecular weights of between 5 and 40kDa tor the NaOH treated sample 
and about 40kDa for the NaHC03 treated sample, however, the inaccuracies of PAGE at 
estimating the molecular size of small polysaccharides has already been discussed and 
additional methods of estimation were sought. Measurement by viscosity was 
impossible due to the low initial size of the sample. For this study, the two ORC 
preparations were given the names ORC 1 (solubilised in 6M NaOH) and ORC 2 
(solubilised in O.1M NaHC03) and further investigation into the sizing of the these 
molecules was noted as potential future work. For this study, no further purification was 
attempted and all future studies were conducted with the 2 crude fragment ranges. 
3.9.4 Pectin and its Oligosaccbarides 
Pectin (Figure 1.3c) is an abundant plant polysaccharide and was investigated in this 
project as Johnson & Johnson have patent protection for anionic plant polysaccharides 
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which may be used in collagen based wound healing devices (UK Patent: Harvey, Light 
& Watt, No.9206492), and so as pectin is readily available and inexpensive, any 
bioactivity shown in vitro or in vivo would be beneficial to the company in the search 
for new, innovative products. 
3.9.5 Molecular Weight Estimation of Pectin 
HP Bulmer manufacture the high methoxyl pectin used in this study, and give a typical 
molecular weight value of between 500 and 750 kDa for this product as estimated by 
HPLC analysis. The average molecular weight of pectin in this study was estimated by 
viscometry and PAGE and gave average values of 645 and 500 kDa respectively (Fig 
3.12a). Both these values fall within the manufacturer's limits, and although PAGE has 
been shown to be inaccurate at estimating low molecular weight polysaccharides, it 
seems a good method for estimating the size of large polysaccharides. 
Depolymerisation of pectin was attempted using 6M NaOH as shown previously by 
ORC. This work, however, was not completed and only preliminary data is reported 
here. Degradation by 6M NaOH of pectin can be detected on PAGE as shown in Figure 
3.12b. Further studies would be needed to optimise this reaction and investigate the 
conditions to produce full degradation of the polysaccharide. 
A molecular weight estimation was calculated by PAGE for the alkali treated sample to 
give a molecular range (Fig 3.12b). The results indicate the molecular size range of the 
alkali treated pectin to be between 40 and 500kDa. The degraded pectin was retained for 
future bioactive studies. 
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3.10 Preparation and Storage of Polysaccharides & Their Fragments 
for In Vitro Testing 
All the polysaccharides and fragments described in the previous sections were dialysed 
against water to remove any salts which may interfere with cell culture, using Spectra-
Por 6 tubing with a MW cut off of 1000. They were then filtered through a 0.45 urn 
filter to remove precipitated enzyme (when necessary), freeze-dried and stored at 4°C 
prior to in vitro/in vivo testing. 
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CHAPTER 4 
THE EFFECT OF POLYSACCHARIDES ON THE PROLIFERATION 
CULTURED CELLS 
4.1 Introduction 
The in vitro effect of polysaccharides and their fragments on the proliferation and 
chemotaxis of cells involved in the wound healing process was carried out in an attempt 
to ascertain their potential effect in vivo. Proliferation of cells such as fibroblasts 
(postlethwaite et ai, 1978), endothelial cells (Marks et ai, 1991) and epithelial cells 
(Marks et ai, 1991) during wound healing, is of the utmost importance in order to 
restore cell loss due to injury i.e. damaged skin, blood vessels and connective tissue. 
Cells such as epithelial cells need to proliferate to restore the epidermis and protect the 
healing wound underneath. Chemotaxis of cells such as fibroblasts towards the site of 
injury is therefore also necessary to ensure that the damage is repaired by laying down 
new collagen to give the healing wound strength and also are involved in the 
contraction of the wound itself (postlethwaite et ai, 1978). This response is mediated by 
signals in the wound attracting the specific cells required. 
It was hoped that any stimulation above control values of proliferation or chemotaxis of 
various cell types in the presence of polysaccharides in vitro, might indicate a potential 
role for these materials in the healing of chronic wounds in vivo and speed up the 
healing process. 
79 
Figure 4.1 Photographs of the various cell types used in this study. 
All cells were stained with 0.1 % m thylene blue in 
10mM borate buffer pH 8.4 as describ d in Methods. 
(a) L929 fibroblast, (b) Bovine aortic endoth lial cells, 
(c) Rat wound fibroblasts and (d) human demlal 
fibroblasts. Magnification x 40. 
The polysaccharides prepared as described in Chapter 3 were examined for their in vitro 
effect on the proliferation and chemotaxis of several different types of cells. Fibroblasts 
were the first cell type tested as they are essential to the repair of damaged tissue at the 
wound site where they lay down new collagen, produce growth factors & proteoglycans 
and draw the edges of the wound together (Lynch et ai, 1989; Morgan & Pledger, 
1992). The second cell type employed in this study were endothelial cells, which line 
the blood vessels. The formation of blood vessels (angiogenesis) by endothelial cells at 
the wound site is an important stage in the wound healing process as new vessels bud 
from intact vessels and grow into the wound giving it a new blood supply (Fowler, 
1989; Morgan & Pledger, 1992), thereby providing the area with oxygen. Epithelial 
cells were not investigated in this study as it was felt that in chronic wounds, fibroblasts 
and endothelial cells were the cell types which initiated the wound healing process and 
so they should be studied first. Photographs of the cell types used in these experiments 
are shown in Figure 4.1 (except 3T3 cells which were not photographed) attached to 
tissue culture plastic and stained with methylene blue dye to visualise the cells (method 
2.4.4). The sources of the cells were as follows: (a) L929 mouse fibroblasts, (b) Rat 
wound fibroblasts, (c) Human skin fibroblasts, (d) Bovine aortic endothelial cells 
(BAEC) and (e) 3T3 Swiss mouse fibroblasts Mixed sources of cells were used in order 
to assess differences between species. Mouse L929 and 3T3 cells and BAEC cells were 
readily available and were used for this reason. Rat skin fibroblasts were isolated during 
this project and were thought to be a good cell type to study as the results could be 
compared to in vivo rat data later in this study. The only source of human cells available 
was skin fibroblasts. It was hoped that these cells would give an indication to what may 
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be happening to these cells in vivo, however it is recognised that different human cell 
types would be needed to give results which could be compared to human wound 
healing. 
4.2 Cell Proliferation 
4.2.1 Assessment of Cell Counting Methods 
The measurement of cellular proliferation can be determined by several different 
methods. The most widely used assay depends on the incorporation of [3H] Thymidine 
into dividing cells where the total amount of eH] Thymidine incorporated at the end of 
the proliferation experiment is measured, or, the percentage of labelled cells counted by 
autoradiography and microscopy (West & Kumar, 1989). Other cell counting methods 
include colorometric techniques using dyes such as MIT (3-[ 4,5-Dimethylthiazol-2-yl]-
2,5-diphenyltetrazolium bromide), (Carmichael et ai, 1987; Vistica et ai, 1991» and 
Neutral Red (Triglia et ai, 1991; Fautz et ai, 1991) which are most commonly used as 
indicators of cell death, as the dyes are only taken up by living cells. The methods 
mentioned above, although accurate cell counting methods, are time consuming due to 
the incubation times needed to take up the dyes, which renders them unacceptable for 
the large numbers of samples to be screened in this study. As a result of this, alternative 
methods were sought for the measurement of cellular proliferation. 
Cell counting using a counting chamber such as a haemocytometer, was the first method 
chosen to be assessed (method 2.4.5). Cell counting using a haemocytometer requires 
the cells to be detached from the surface of the well in a 96 well plate, followed by 
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counting on a grid marked on the surface of the counting chamber. The number of cells 
present are expressed as the number per ml. This method, however, is time consuming 
and only small numbers of samples can be analysed at the one time. 
The second method to be assessed was that of Oliver et ai, (1989) using the Methylene 
Blue dye binding assay (method 2.4.4). The methylene blue assay was described by 
Oliver as a rapid and convenient method for counting cultured cells in microwell plates 
and was used in Oliver'S paper to assess the effect of growth factors on cell 
proliferation. The methylene blue assay therefore had the potential in this study to allow 
the rapid screening of many samples. The Methylene Blue dye binding assay (method 
2.4.4) operates on the principal that the basic dye will bind to the negatively charged 
molecules within the cell. Addition of He I in Ethanol, with a pH less than 2, allows the 
acid groups to be protonated, liberating the Methylene Blue dye into the elution solvent 
and a single absorption peak observed at ~so has been reported to be an accurate and 
reproducible reflection of the cell number stained with the dye (Oliver et, ai, 1989; 
Horobin, 1982), however this method has not been validated. 
4.2.2 Comparison of Methylene Blue Dye Binding to Haemocytometer 
Counting 
L929 fibroblasts were the initial cell type used for these studies as they were readily 
available, grew quickly and passaged well. L929 cells were used to compare the 
linearity of the methylene blue and cell counting methods over a range of cell densities. 
Cells were seeded between 0 and 6xl04 per well in 96 well plates and the data obtained 
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used to construct standard curves. Cells seeded at higher densities (above 6 x 104) were 
found not to fall on the linear scale and their absorbance readings after staining with 
methylene blue were greater than the values detectable on the plate reader, therefore a 
maximum density of 6 x 104 was used. 
The methylene blue assay demonstrated excellent linearity (R=0.999) over the whole 
range of cell densities tested (Fig 4.2a) and at the same time showed good 
reproducibility with a standard deviation of less than 5% between replicates. This result 
indicates that a linear correlation exists between cell number and dye binding. 
The cell counting chamber assay however, displayed a lower degree of linearity with a 
correlation coefficient of only 0.878 (Fig 4.2b). The graph also demonstrates that the 
number of cells counted by this method was much lower than the initial number seeded, 
however, this was probably caused by incomplete detachment of the cells from the 
surface of the plate during the trypsinisation procedure. The standard deviation between 
replicates was found to be ±15%, which is much greater than that shown by the 
methylene blue assay. Direct cell counting on the haemocytometer may also be less 
accurate due to the small sample size (40J.11) taken for the measurements, as any small 
error in counting using the grid would therefore be multiplied in the calculation and 
result in an even greater degree of error. 
In conclusion, comparison of the two methods revealed the methylene blue dye binding 
assay to be the most rapid and reproducible at measuring cell numbers and was 
therefore employed in this study as the standard method for the screening of the effect 
of polysaccharides on cellular proliferation. 
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Figure 4.2 (a) The linear relationship between cell number and methylene 
blue dye binding. The absorbance of the dye was measured 
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the number of cells seeded in a 96 well plate against the 
number counted after trypsinisation in a haemocytometer. 
The standard deviation was < 15 %. 
4.3 Standard Curves of Fibroblasts and Endothelial Cells 
Standard curves showing the linearity between methylene blue dye binding and cell 
number were constructed for all cell types available for the study. The cell types 
employed were fibroblasts from various sources (see section 4.1) and endothelial cells. 
Fibroblast cell lines (L929 and 3T3), primary fibroblasts (rat wound fibroblasts, human 
dermal fibroblasts and primary bovine aortic endothelial cells) were obtained and all 
were tested for linearity with methylene blue over a range of cell densities. All cell 
types tested, with the exception of rat wound fibroblasts, showed a linear relationship 
between cell number and dye binding over the ranges tested, with correlation 
coefficients of > 0.99 in all cases (Figs 4.3; 4.4; 4.5; 4.6b). Rat wound fibroblasts 
showed a linear relationship up to 1.9 x 104 cells with r = 0.959 (Fig 4.6a), however, 
above this concentration, the cells began to detach from the surface of the plate. For in 
vitro studies, therefore, a low initial cell number of rat wound fibroblasts would have to 
be used in order to prevent detachment at high concentrations. Rat Wound Fibroblasts 
were the most closely related cell type on which to measure the effect of 
polysaccharides in an in vivo rat wound healing model, however, these cells proliferated 
very slowly in culture and in fact not enough cells were able to be generated for the 
screening of polysaccharide fragments in the time period available. Rat wound 
fibroblasts were therefore omitted from this study. The human dermal fibroblasts 
however were a good cell type to investigate as the in vitro results obtained in this study 
could correlate with any clinical wound healing studies undertaken in the future. 
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The standard curves for the various cell types indicated the variation in absorbance 
values between different cell types, for example, at a cell concentration of 5x 1 04 cells 
per well, the absorbance value at ~so for L929 fibroblasts was 1.04, whereas 3T3 
fibroblasts and BABC endothelial cells had absorbances of 0.88 and 0.75 respectively. 
The difference in absorbance between different cell types is therefore due to variations 
in the amount of dye binding to the cells, and it can be concluded from this observation 
that different cell types have varying amounts of negatively charged groups such as 
phosphate, DNA and charged groups in proteins, within the cell (Oliver et ai, 1989). 
4.4 Effects of Polysaccharides and Fragments on Cell Proliferation 
The proliferation of different cell types in the presence of various polysaccharides 
prepared as described in Chapter 3 were assessed by the methylene blue assay. Cells 
were seeded at 5000 per well and were left to attach overnight in DMEM containing 
10% FCS. The cells were then starved for 24h in the absence of serum to increase their 
sensitivity to the polysaccharides added in the experimental procedure. The 
polysaccharides were added to the cultured cells at various concentrations and were 
diluted using 2% FCSIDMEM (see section 2.4.3). 
4.5 Heparin 
Heparin is an anionic polysaccharide predominantly containing the repeating unit L-
iduronic acid, although D-glucuronic acid is present as a minor constituent, and it is 
linked to the N-sulphated hexosamine by a 0(1,4) linkage. Heparin has previously been 
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shown to inhibit the proliferation of several cell types in culture, including human lung 
and dermal fibroblasts (Ferrao & Mason, 1993; Westergren-Thorsson et ai, 1991), 
vascular smooth muscle cells (Hoover et ai, 1980), cervical epithelial cells (Wright et 
ai, 1985) and glomerular mesangial cells (Groggel et ai, 1990), and has also been 
shown to stimulate granulation tissue formation in vivo (McPherson et ai, 1988). 
Heparin was, therefore, used in this study as a control to which the other 
polysaccharides could be compared, as any similarity to the effect of heparin in the in 
vitro situation may give an insight to the potential of the polysaccharide digests 
prepared in chapter 3 to effect wound healing in vivo. 
4.5.1 The Effect of Heparin on Cell Proliferation 
Six concentrations of heparin between 0.01 - 500J.lg/ml were examined for their effect 
on proliferation over a 5 day incubation period, and were tested on L929 fibroblasts, 
bovine aortic endothelial cells (BABe) and 3T3 fibroblasts. Previous evidence on the 
effect on heparin on the proliferation of human lung and dermal fibroblasts 
demonstrated a significant inhibition (Westergren-Thorsson et ai, 1991; Ferrao & 
Mason, 1993). In this study, both L929 and 3T3 fibroblast proliferation were also 
significantly inhibited by the addition of increasing concentrations of heparin (Figs 4.7a 
& 4. 7b). The inhibitory response seen in this study by the addition of heparin was 
maximal at the highest concentration of heparin (500J.lg/ml) in both cell lines, however, 
significant inhibition was also seen to a lesser extent at 10 and 100J.lg/ml. Proliferation 
was inhibited by 45% and 57% respectively for L929 and 3T3 fibroblasts, therefore, 
heparin had varying effects on different cell lines. The difference in the degree of 
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by -p < 0.05 and •• 1> < 0.001. 
inhibition may be due to the presence of more heparin receptors on 3T3 cells. BAEC 
cells however, were unaffected by the addition of increasing concentrations of heparin 
(Personal communication - E. Lorimer) and suggests two possibilities (i) that heparin 
can be taken up by the cell and processed without causing an effect on the growth 
characteristics of the cell or, (ii) that no intemalisation of heparin is taking place at all. 
4.6 Effect of HA And Its Oligosaccharides on Cell Proliferation 
The next polysaccharide to be investigated was HA and its fragments. Previous 
evidence claimed that certain sized fragments of HA stimulated the proliferation of 
BABC cells and induced angiogenesis in the chick chorioallantoic membrane (West & 
Kumar, 1989 ; West et ai, 1985). This study focused on the effect of crude HA digests 
on the proliferation of various cell types in an attempt to correlate the results with 
previous findings and provide new evidence for the effect ofHA fragments on other cell 
sources. 
HA digests (undigested, 5mins and 24h) were prepared and characterised as described 
in Chapter 3 and were tested for their effects on the proliferation of various cell types. 
Undigested HA isolated from umbilical cord, has been shown previously to have no 
effect on the proliferation of human dermal fibroblasts (Ferrao & Mason, 1993). Similar 
effects were seen in this study with HA (MW 828kDa) from Lifecore Inc., for dermal 
and also L929 fibroblasts (Figs 4.8a & 4.9). BABC cells however demonstrated 
stimulation of proliferation (p<0.05) after 2 and 3 days incubation at 100 J.l.glml 
undigested HA (Fig 4.8b). In order to confirm this result, a further experiment was 
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undertaken using a reduced level of serum (0.4%) to eliminate firstly the possibility of 
stimulation of BAEC cells being due to the presence of serum and secondly to increase 
the sensitivity of the cells to the added polysaccharide. The results indicated (Fig 4.10) 
that at day 1 & 2, significant stimulation was apparent at 100 Jlg/ml as seen in the 
original higher serum experiment and, therefore, supports the previous finding. 
Stimulation appeared later in the high serum experiment and this may be due to factors 
present in the serum causing a lag in the proliferation which is overcome by the second 
day. The lower concentrations ofHA in both experiments, however, had no significant 
effect on proliferation. Future studies would be worthwhile to investigate the effect of 
concentrations higher than 100 Jlglml to see if the response seen in this experiment was 
the optimum to be obtained'. Higher concentrations of HA, however, have been found 
to cause high background readings for the methylene blue assay due to non-specific 
binding of the polysaccharide to tissue culture plate (personal communication, 
E.Lorimer). The problem of background staining when using concentrations ofHA over 
Img/ml however, could be overcome by carrying out a different cell counting method 
such as one of those described in Section 4.2. 
Two other HA digests (5 mins and 24h) were also prepared and characterised, as 
described in Chapter 3, and were tested for their effect on cell proliferation. These 
digests were chosen as they were within the same molecular weight range as those 
investigated by West & Kumar (1989). Both HA (5 mins) and HA (24h) samples had no 
significant effect on the proliferation ofL929 fibroblasts, but the HA (S min) digest did 
however stimulate the proliferation of both human dermal fibroblasts and BABC cells 
(Figs 4.11b & 4.13a). HA (Smin digest) had the greatest effect on the proliferation of 
88 
human dennal fibroblasts at day 3 of incubation, where stimulation was seen at 1, 10 
and 100Jlglml (Fig 4. 13 a). BABe also showed a stimulation of proliferation at day 1 but 
only at a concentration of 100Jlglml (Fig 4.11 b). The 24h digest, however, had no effect 
on human dennal fibroblasts or BABe cells (Figs 4.12b & 4.13b). Future work could 
involve investigation of higher concentrations of HA digests to detennine if increasing 
the dose of HA causes an increase in the proliferation of the cells. Interestingly, there 
are apparent differences in the ability of HA (5 mins) to stimulate the proliferation of 
fibroblasts from different sources, whereas undigested HA exhibited no effect on either 
L929 or human dennal fibroblasts. Differences in stimulatory activity on cells isolated 
from different sources may be due to the number of specific receptors on the surface of 
the cells (Culty et ai, 1992). Differences in receptor number has been demonstrated by 
actively proliferating 3T3 cells in culture which have been shown to contain HA 
receptors, however, other cells such as corneal and stomach epithelial cells notably lack 
HA receptors (Alho & Underhill, 1989). HA is known to have a six sugar sequence 
which binds to the HA receptor on the surface of the cell (Underhill & Toole, 1979; 
Allio & Underhill, 1989), therefore, this suggests that L929 cells may lack HA 
receptors, or that those present may be of low affinity. A lack of HA receptors on the 
cell surface would stop the entrance of HA into the cell and, therefore, prevent any 
intracellular effect, however on the contrary, the receptors may actually be present on 
the surface but the endocytosis and subsequent processing of HA may have no effect on 
the proliferation of the cell. 
In summary, the results obtained in this study demonstrate that HA digested for 5 mins 
has the ability to stimulate the proliferation of both BABe and human dennal 
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fibroblasts whereas undigested HA was shown to stimulate BAEC proliferation only. 
West & Kumar (1989) demonstrated that specific size ranges of HA oligosaccharides 
had an in vitro effect also. Their study however used three fractions of HA containing 
>16 disaccharides (Fl), 10-16 disaccharides (F2) and 3-10 disaccharides (F3). The 
results obtained in their study can be compared to the results mentioned above. BAEC 
cells were stimulated in this study by the 5 min digest ofHA and in West & Kumar's 
study, the F2 & F3 both had the same effect. HA oligosaccharides between 4 and 25 
disaccharides in length, have also been shown in vivo to stimulate angiogenesis in the 
chick chorioallantoic membrane (West et ai, 1985). The size range of F3 and HA (5 
min) overlap, therefore, the two results are comparable. HA (5 mins) also stimulated 
human dermal fibroblasts to proliferate, however F3 in the West & Kumar paper did not 
have any stimulatory effects on any other cells tested, including fibroblasts. They also 
found undigested HA to have no effect on fibroblast proliferation as shown also in this 
study, however, at concentrations greater than 200 uglml, they found undigested HA to 
inhibit BABC proliferation whereas BAEC were stimulated at 100 uglml in this study. 
Further studies using higher concentrations of undigested HA would need to be carried 
out in order to determine if BAEC cells would be inhibited at that level as described by 
West & Kumar. 
4.7 The Effect of Chondroitin Sulphate & Its Oligosaccharides on Cell 
Proliferation 
Chondroitin sulphate (CS) has a very similar structure to that of HA (Chapter 1 , Fig 
90 
1.1) and its role in wound healing has been previously documented (LeBoeuf et aI, 
1987; Westergren-Thorsson et aI, 1991. The involvement of CS in the wound healing 
response and its structural similarities to HA led to the decision to depolymerise the 
polysaccharide to investigate the effects of small CS oligo saccharides on wound 
healing. 
Three different size ranges of CS were prepared and characterised as described in 
Chapter 3. The fractions were: undigested CS and CS digests (hyaluronidase digested 
for 5 mins and 24h). This produced oligosaccharides in the range of 40-80 kDa, 4kDa 
and2kDa. 
Undigested CS had no effect on L929 fibroblasts or BAEC cells at 0.1-100 Jlg/ml (Fig 
4.14), but demonstrated a significant stimulation of proliferation of human dermal 
fibroblasts (p<0.05) at concentrations of 10 and 100Jlg/ml after incubation for 48h (Fig 
4.15). The stimulation of human dermal fibroblast proliferation by undigested CS, 
compares with that found with HA (5mins), and indicates that a specific size range of 
oligosaccharides may be present in both undigested CS and HA (5 min) digest which 
promotes the stimulation of dermal fibroblasts. Further analysis of the specific size 
ranges was not attempted as material was in short supply and time was limited. 
Hyaluronidase digested 100 ug/ml CS (5mins and 24h) also stimulated the proliferation 
of L929 cells at Day 2 to 56% and 30% above control values respectively (Figs 4.16 & 
4.18), however, higher concentrations of each digest should be investigated in future 
work in order to determine if a dose response effect is apparent. Human dermal 
fibroblasts were stimulated to proliferate by CS (5min digest) at all concentrations 
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serum and incubated for 2 days. (b) BAEe cells cultured in 
2 % serum and cultured for 3 days. Results are the mean of 6 
analyses at each concentration ± SEM. Significant differences 
are indicated by ••• p < 0.001. 
tested (0.1-100 Ilglml) and showed an increase in stimulation as the concentration 
increased (Fig 4.19). BAEC cells were less sensitive to the addition of CS (5mins 
digest), but did however show stimulation of proliferation at 100 Ilglml (Fig 4.17a). A 
further experiment was carried out with BAEC and CS (5mins) using a lower 
concentration of serum (0.4%) in the medium in an attempt to reduce the chance of the 
serum being the stimulating factor. Reducing the serum concentration in this way 
actually improved the response of BAEC cells to CS (5 mins) as both the 10 and 100 
Ilglml concentrations ofCS (5mins) stimulated the cells to proliferate to 9% and 103% 
above control levels (Fig 4.17b). CS (24h) had no effect on the proliferation of human 
dermal fibroblasts or BABC cells (Figs 4.18b & 4.20). 
The CS digests results clearly demonstrate a difference in the ability of undigested CS 
and digested CS samples to affect the proliferation of a range of different cell types. 
Overall, the CS (Smin) digest stimulated the proliferation of all the cells tested and 
therefore would appear to contain the necessary size range of oligo saccharides for this 
purpose. Comparing the results of the CS digests with those obtained for HA, it appears 
that both S min digests have best capacity to stimulate the proliferation of cells, 
however, the HA (5 min) digest had an average MWrange of2 kDa, and the CS (S min) 
digest had an average MW range of 4 kDa. Further work would be required to isolate 
individual oligosaccharides to determine which one was causing the stimulation of 
cells. Future experiments will be discussed later in the thesis. 
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4.8 The Effect of Oxidised Regenerated Cellulose Fragments on Cell 
Proliferation 
Polydisperse ORC fragments (ORC 1 - low molecular weight, (range between 5 and 
40kDa) ; ORC 2 - higher molecular weight (average of range 40-500kDa) were 
prepared as described in Chapter 3. The effect of six concentrations of each sample 
(0.01 - 1000 Jlg/ml) on the proliferation ofa variety of cell types was then measured. 
4.8.1 ORe (1) - Low Molecular Weight Fragment Range 
As can be seen from Figure 4.21, ORC (1) inhibited the proliferation of both L929 
fibroblasts and BABC cells. The proliferation of L929 fibroblasts was inhibited to a 
maximum of 35% at an ORC (1) concentration of Img/ml after 24h incubation, 
however significant inhibition (25%) was also seen at this time with 100 Jlg/ml ofORC 
(1). Endothelial cell proliferation was also inhibited by the addition of ORe (1) at 
concentrations above lOJlg/ml. When, however, 3T3 fibroblasts and human dermal 
fibroblasts were assessed for their response to the addition of ORC (1), a stimulation 
effect was apparent in both cell types. Stimulation was not detected until Day 5 of 
culture in the 3T3 cell assay, however, at this time point, both the 10 Jlg/ml and 100 
Jlg/ml concentrations significantly increased the rate of proliferation (Fig 4.22). All 
concentrations of ORC (1) had stimulatory effects on human dermal fibroblasts at Day 
1 (Fig 4.23). The results demonstrate that different cell types have different responses to 
ORe (1) and furthermore, there are distinct differences in the response of fibroblasts 
from different sources. 
93 
o 
; 55~--------------------~ c 
o 
u 
.... 
(J) 
C 
«I 35 
0) 
«I 
C 
o 
~ 15 
2 
o 
.... 
0. 
'0 -5 
c 
.g 
:e 
-§ -25 -+--......---.--~-~--..---i 
~ o 
(5 
.... 
.... 
c 
0 
u 
-(J) 
c: 
.~ 
0) 
«I 
c 
0 
. .;:: 
<t1 
.... g 
(5 
.... 
0. 
-0 
c: 
0 
~ 
:e 
.s::: 
c: 
~ 0 
Figure 4.21 
50 
40 
30 
20 
10 
0 
-10 
0.01 0.1 10 1001000 
J-Lg/ml ORC 1 
(b) 
* * 
0.01 0.1 10 100 1000 
. J-Lg/ml ORC 1 
The effect of ORC 1 on the proliferation of (a) L929 
fibroblasts and (b) BAEC endothelial cells. Results are means 
+ SEM of six replicates. Significant differences are indicated 
by·P < 0.05 and -" < 0.01 (analysis by student's unpaired 
t-test). 
50 
0 
!:: 
c 40 0 
Q 
en 30 c 
·co 
Cl 
ro 20 
c 
.Q 
al 10 
.... 
2 
- 0 0 
.... 
a. 
~ 0 
-10 
Figure 4.22 
0.01 
~ 
.. 
0.1 10 100 1000 
jlg/mlORC 1 
The effect of increasing concentrations of ORC 1 on the 
proliferation of 3T3 fibroblasts. The data are the mean of six 
replicates at each concentration + SEM. Significant differences 
from control are indicated by -1> < 0.01 and --1> < 0.001 
(analysis by student's unpaired t-test). 
120 ...,.------------------, 
o 
... 
-c: 
o 
u 
-... 
c: 
... 
01 
'" c: 
o 
';J 
'" 
100 
80 
60 
~ 40 
-o 
.... 
a. 
Figure 4.23 
20 
*** 
0.01 0.1 10 100 1000 
ug/ml ORC 1', 
The effect of ORC 1 on the prolifera~ion of Human dermal 
fibroblasts. Results are expressed as means + SEM of six 
replicates. Signiticant differences are indicated by .p < 0.05, 
•• p < 0.01 and ••• p < 0.001 
4.8.2 ORe (2) - Higber Molecular Weigbt Fragment Range (40kDa-
500kDa) 
ORC (2) demonstrated stimulation of proliferation with each cell type tested. At day 5 
of incubation, both L929 fibroblasts and BAEC cells were stimulated to proliferate up 
to 72% above control levels at Imglml ORC (2). A dose response effect was evident for 
both cell types as indicated by increased stimulation of proliferation as the 
concentration of ORC 2 increased. The results are shown in Figure 4.24. 3T3 fibroblasts 
and human dermal fibroblasts both showed stimulation of proliferation (Figs 4.25 & 
4.26), however, this was apparent at day 1 which was much earlier than the effect 
shown by L929 and BAEC cells. 
The results from both ORC fragments (Table 4.1) indicate that they have different 
effects on the proliferation of L929 and BAEC cells, however, both fragments stimulate 
the proliferation of 3T3 cells and human fibroblasts. It may not be surprising as the two 
samples contain different fragment sizes, thereby giving rise to differing effects on the 
proliferation of cells. 
ORC 1 and heparin inhibited L929 fibroblast cell proliferation to varying degrees. ORC 
1 also inhibited the proliferation ofBAEC unlike heparin at similar concentrations. 
The two ORC fragments were then used in in vivo studies (see Chapter 6). They were 
chosen specifically because at the time of carrying out the animal work, they were the 
only samples which had been fully assessed in vitro and the results observed in vitro 
had similarities to those shown by heparin, which was also being investigated in the 
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ORC(1) ORC(2) 
L929 Fibroblasts -35% +72% 
BAEC Endothelial Cells -26% +72% 
3T3 Fibroblasts +35% +46% 
Human Dermal Fibroblasts +80% +65% 
Table 4.1 : The effect ofORC (1) and ORC (2) on the proliferation ofL929 
cells, BABC cells, 3T3 cells and human dermal fibroblasts. Stimulation 
of proliferation is indicated by (+), and inhibition by (-). 
animal model. 
4.9 The Effect of Pectin on Cell Proliferation 
The plant polysaccharide, pectin, was also examined for its effect on cellular 
proliferation. Pectin was selected for testing due to the structural similarities it 
possesses with other polysaccharides such as the GAGs and ORC (see Chapter 1, Figure 
1.3c; section 3.9.4) as well as it being cheap, which is commercially attractive. In this 
study due to time constraints and availability of cells, only L929 fibroblasts and BAEC 
cells were tested. 
Concentrations of pectin between 1-1 000 ~g/ml were tested for their effect on L929 
fibroblast proliferation. The data shows (Fig 4.27a) that only 1000 ~g/ml pectin 
stimulated the proliferation of L929 fibroblasts (10% above control level). Higher 
concentrations of pectin, however, were found to gel when the fixative was added at the 
end of the incubation time. To overcome this problem, an experiment was carried out 
using other fixatives to observe if the gelation was due to the methanol alone. Table 4.2 
illustrates the different fixatives which were employed and the results that followed. 
The conclusions from this experiment were that 1 % Glutaraldehyde in HBSS should be 
used in future studies to fix pectin samples as addition of it caused no gelation of the 
polysaccharide. When BAEC cells were assayed, stimulation of proliferation was 
evident at day 1, however, significant stimulation was only apparent at the 1 000 ~g/ml 
concentration at 17% above control levels. The data is shown in Figure 4.27h. 
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Figure 4.27 
(a) 
1 
(b) 
. . . 
" 
10 100 1000 10000 
Jl.g/ml pectin 
10 100 1000 10000 
Jlg/ml pectin 
The effect of increasing concentrations of pectin on the 
proliferation of (a) L929 fibroblasts incubated for 1 day and 
(b) BAEC endothelail cells incubated for 2 days. Data are the 
mean + SEM of six replicates. Significant differences are 
indicated by "p < 0.05 and •• "p < 0.001. 
FIXATIVE EFFECT ON PECTIN 
Methanol Gel formation 
1 % Glutaraldehyde in HBSS No gel formation 
1 % Formaldehyde + 1 % Gel formation 
CaClz in water 
Table 4.2: Effect of different fixatives on pectin gelation 
The results indicate that only high concentrations of pectin used in this study had any 
effect on cellular proliferation. The results also show a similarity to those shown by 
ORC (2) with L929 and BAEC cells. 
Pectin is a relatively cheap and easily produced polysaccharide and, therefore, the need 
for high concentrations to have any possible effect in an in vivo wound healing situation 
may not be a particular financial disadvantage. Further studies, however, were carried 
out on pectin fragments to discover if they had any effect on cell proliferation as seen 
with other polysaccharide fragments 
4.10 The Effect of Degraded Pectin on Cell Proliferation 
Degraded pectin, produced by alkali hydrolysis (see section 2.1.6) as previously 
described in Chapter 3, was tested for its effect on the proliferation of L929 fibroblasts 
and BAEC endothelial cells. Over a concentration range of 1-1000 J,lg/ml, no significant 
effect on proliferation was measured in these cell types. The results shown by degraded 
pectin (Fig 4.28) indicated that breakdown of the molecule resulted in the loss of its 
effect on proliferation of cells. This effect may be caused by the molecule having a 
different conformation to the undigested pectin after treatment with alkali, or perhaps 
the receptors on the cell surface do not recognise the pectin fragments. 
4.11 Discussion 
Due to the known in vivo effects (McPherson et ai, 1988) and in vitro effects of heparin 
demonstrated in this study, it was used as a comparator to which all the polysaccharide 
digests were compared (section 4.5). Comparing the proliferation results of heparin to 
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The results are expressed as the mean + SEM of six replicates. 
the other polysaccharides tested, only ORe (1) showed similar characteristics, as it 
inhibited L929 cell proliferation, however ORe (1) stimulated 3T3 cells unlike heparin. 
Previous evidence from West & Kumar (1989) suggests that inhibition can be due to the 
size of the molecule. They found that smaller oligosaccharides, in their case HA, were 
required in higher concentration to cause inhibition than the larger fragments. They also 
suggested that high concentrations of polysaccharide may also cause inhibition and this 
was evident with undigested HA at concentrations above 400J.1g/ml. Wright et ai, 
(1989) also reported that cells which have been growth arrested are more sensitive to 
growth inhibition and this was been demonstrated with heparin in smooth muscle cells. 
The inhibition shown by heparin and in this study may be due to its excessively high 
concentrations when incubated with the cells. This may have been worsened by the cells 
being in a state of growth arrest before their addition. In the case of ORC, the 
explanation is more difficult. In both L929 and BABe cells, the inhibition shown by 
ORC 1 may be due to the same factors as discussed above for heparin, however, ORC 2 
(the bigger of the two fragment ranges produced) showed stimulation of all cell types. 
With the Human Dermal Fibroblasts and 3T3 cells, both ORC fragments stimulated 
proliferation, therefore, these cells have been able to either intemalise the ORC without 
detriment to themselves or have bound the ORC to receptors on their surface. It is, 
therefore, possible that cells have different tolerances to each other for the concentration 
of polysaccharide added and the size range of the sample. 
From the results, it is impossible to predict if any oligosaccharide may have a similar in 
vivo effect on wound healing as heparin, as the mechanism of action may be different, 
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therefore, the following chapter investigated the differences in the chemoattractive 
ability of the oligosaccharides to cells. This would give an indication if the 
oligosaccharides had further similarities to heparin. 
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CHAPTERS 
CHEMOATTRACTION OF CELLS TO POLYSACCHARIDES 
5.1 Introduction 
In wound healing, it is imperative that cells migrate in to the wound area from the 
periphery and begin the process of healing. In order for this to occur, factors must be 
present at the wound site which attract the cells by a chemical signal and cause them to 
migrate into the wound area. Chemoattraction of cells toward a chemical signal is well 
documented for leukocytes (Forrester & Wilkinson, 1981) and fibroblasts (Albini & 
Adelmann-Grill, 1985; Postlethwaite et ai, 1987). 
The objective of this chapter was to investigate the ability of the polysaccharides and 
fragments produced in Chapter 3 to stimulate the in vitro migration of fibroblasts 
through a 8J.Lm polycarbonate filter in a 48 well Boyden Chamber. The results of these 
studies would, in conjunction with the proliferation data in Chapter 4, allow a choice of 
oligosaccharide that might have the best in vivo possibility in terms of wound 
stimulation. 
The assay was carried out as described in Method 2.4.6. Each sample was tested in 
triplicate and each experiment carried out in duplicate. Results were expressed as the 
mean ± standard error of duplicate experiments (Figs 5.1 & 5.2). 
5.2 Chemoattraction of L929 Fibroblasts to Heparin 
Heparin is a sulphated polysaccharide with a similar structure to HA and CS, and has 
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Figure 5.1 
FigLUe 5.2 
L929 fibroblasts which have chemotactically moved 
through an 8f..lm polycarbonate filter. Stained with 
Leishman's stain, magnification x10 
L929 fibroblasts which have chemotactically moved 
through an 8f..lm polycarbonate filt r. tained with 
Leishman's stain, magnification x40 
been shown to encourage the invasion of fibroblasts into a collagen/heparin matrix 
when implanted subcutaneously in rats (McPherson et ai, 1988). Heparin therefore was 
tested first for its direct effect on the migration of fibroblasts in vitro to try to compare 
with previous findings by other reporters in vivo (McPherson et ai, 1988). Four 
concentrations of heparin from 0.1-100 Jig/ml were tested. Controls containing 
Dulbecco's Modified Eagle's Medium (DMEM) alone and a positive control of 10 
pg/ml TGFB per well (postlethwaite et ai, 1987) were used. The results showed (Fig 
5.3) significant stimulation of migration (p<0.05) at 0.1-10 Jig/ml, with the effect tailing 
off as the concentration of 100 Jig/ml was reached. The negative charge of the heparin 
molecule does not seem to effect its ability to attract fibroblasts. This result suggests 
that heparin may have a role at low concentrations, at encouraging fibroblast migration 
and this may be relevant in the wound situation where application of heparin may 
influence recruitment of fibroblasts into the wound area to deposit collagen and remodel 
the wounded area together (Lynch et ai, 1989; Morgan & Pledger, 1992). Comparing 
the chemoattraction data of heparin to the proliferation data in Chapter 4, it is clear that 
migration of L929 cells is not significant when the concentration of heparin goes above 
100 Jig/ml which correlates with the inhibition of the proliferation seen above the same 
concentrations. This suggests that concentrations lower than 100 Jig/ml may be useful 
in vivo. 
In vivo studies were carried out with the heparin to assess its effect in the rat wound 
healing model and the results of this will be discussed in Chapter 6. 
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The effect of increasing heparin concentrations on the migration of L929 fibroblasts. Cells were counted 
in 20 unit fields at x40 magnification in triplicate. Results are the means ± SEM of 60 replicates. 
Significant differences are indicated by *p < 0.05 and ***p < 0.001. 
5.3 Chemoattraction ofL929 Fibroblasts to HA and Its Oligosaccharides 
As shown in Figure 5.4, undigested HA with a MW of 828,000 Da had no significant 
effect on the migration of L929 fibroblasts at the concentrations tested. It has been 
reported previously that undigested HA also inhibits leukocyte locomotion (Forrester & 
Wilkinson, 1981). In the in vivo wound healing situation, the inhibitory effect of 
undigested HA would be undesirable as migration of leukocytes to the wound site is 
necessary at the initial stages of wound healing when an inflammatory response is 
mounted. Previous evidence from cancer studies has also demonstrated that a cell 
surface layer ofHA can protect tumor cells from attack by cytolytic lymphocytes and so 
this may impede the cellular defence mechanism and permit the growth of tumors 
(McBride & Bard, 1979). 
The results obtained for the migration of fibroblasts in this study (Fig 5.4) suggests that 
the presence of undigested HA at the wound site would not improve the normal 
migration of fibroblasts into the area and therefore would not be able to overcome any 
detrimental effect of HA on leukocyte migration and subsequent lack of granulation 
tissue formation. The proliferation data in Chapter 4 also shows no effect on 
proliferation of L929 cells by undigested HA, therefore, this sample was not included in 
the in vivo study. 
When the 5 min and 24h HA digests were tested for their effects on the migration of 
fibroblasts, it was observed that they both had similar effects as the undigested HA 
sample (Fig 5.4). At the concentrations tested, there was no significant effect on cell 
migration through the polycarbonate filter, thereby suggesting that different size ranges 
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The effect of increasing concentrations of HA and its oligosaccharides on the migration of L929 
fibroblasts. Cells were counted in 20 unit fields at x40 magnification in triplicate. Results are the means 
± SEM of 60 replicates at each concentration . 
of HA oligosaccharides, including the undigested are not chemotactic for L929 
fibroblasts in vitro . The results for the effect of HA on the migration of L929 cells 
correlate with proliferation results for the same cell line as none of the HA fragments 
tested were found to have any effect at all on this fibroblast cell line (see section 4.6) 
and so were not included in the in vivo study. 
S.4 Chemoattraction of L929 Fibroblasts to CS and Its Oligosaccharides 
Three different preparations of CS were prepared and molecular weights determined as 
described in section 3.6. The samples were then tested for their ability to attract L929 
fibroblasts through an 8flm polycarbonate filter. The samples examined were 
undigested CS, a 5 min digested preparation and a 24h digested CS preparation. 
Each digest was tested for chemoattraction at concentrations between 0.1 and 100 
flglml. Like undigested HA, undigested CS had no effect on L929 fibroblast migration 
at the concentrations tested (Fig 5.5). Analysis of the oligosaccharide fragments 
prepared from CS also demonstrated no effect on fibroblast migration (Fig 5.5). CS has 
been reported also to have no significant effect on the migration of neutrophils 
(Forrester & Wilkinson, 1981), due to the highly charged nature of the molecule. Its 
lack of effect therefore on fibroblast migration may be due to repulsion of the charges 
on the fibroblast cell surface with those on the CS molecule. 
In comparison to the proliferation results (Chapter 4), CS (5 mins) and CS (24h) had no 
effect on L929 cell migration but stimulated proliferation of these cells in culture. 
Perhaps higher concentrations of CS fragments would be needed to stimulate L929 cell 
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The effect of increasing concentrations of chondroitin sulphate and its digests on the chemoattraction of 
L929 fibroblasts through a 8~m polycarbonate filter. Cells were counted in 20 unit fields at x40 
magnification in triplicate. Results are the mean ± SEM of 60 replicates. 
migration or simply, the CS fragments may not be chemoattractive. Further 
investigation would be needed to assess the effect of higher concentrations, and so it 
was decided not to include CS or its fragments in the in vivo study. 
5.5 Chemoattraction ofL929 Fibroblasts to ORC Fragments 
Both fragment sizes (1 & 2) were examined for their effect on the migration of L929 
fibroblasts. The assay was carried out under the same conditions as described 
previously, however, only three concentrations of each fragment (1-100 J.lg/ml) were 
tested in this experiment. 
The results for the ORC 1 fragment illustrate a similar effect to that shown by heparin 
(Fig 5.6). Significant migration (p<0.05) was seen at the lowest concentration, however, 
as the concentration increased, migration decreased to control values at 10 J.lg/ml and at 
100 J.lg/ml, migration was inhibited significantly (p<0.05) by the ORC fragment. 
The ORC 2 fragment however had no effect on cell migration at the concentrations 
tested as shown in Fig 5.7. These results indicate that a difference in molecular weight 
causes a change in the ability of the ORC to attract fibroblasts through the filter, with 
the smaller fragment (ORC 1) being the more attractive to fibroblasts. Like heparin, 
ORC (1) inhibited L929 cell proliferation and stimulated the migration of the same 
cells. These results, along with the cell inhibition data, indicate that ORC and heparin 
have comparable in vitro characteristics. Given the acknowledged role of heparin in 
wound healing in vivo, it strongly suggests that ORC (1) should be tested under similar 
conditions to those of heparin in animal models. 
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Figure 5.7 : The effect ofORC (2) on the migration ofL929 fibroblasts. Cells were counted in 20 unit fie~ds at x40 magnification in triplicate. 
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5.6 Chemoattraction of Fibroblasts To Pectin 
Undigested rapid set pectin was tested in vitro for its chemoattractive properties. Four 
concentrations between 0.1 and 100 J.lglml were examined and their effect on cell 
migration is shown in Fig 5.8 Pectin stimulated the migration of fibroblasts at 1, 10 & 
100 J.1g1ml, but had no effect at the lowest concentration at 0.1 J.1g1ml. However, the 
overall stimulatory effect was very small and was not dose related. Due to time 
constraints, the performance of pectin fragments was not investigated further. 
5.7 Discussion 
Chemoattraction of specific cells (ie. fibroblasts) into the wound healing site is the first 
step in the wound healing process. If therefore the speed of recruitment of these cells 
could be increased, then faster healing may occur. The results described above indicate 
that heparin, ORC 1 and pectin can attract fibroblasts, however, HA and CS appear not 
to in this study. Differences in structure may account in part for the variation in ability 
to attract fibroblasts as the monosaccharide residues in both HA and CS are joined by 
B(1,3) bonds, whereas pectin, ORC and heparin (in part) are joined by 1,4 bonds. The 
structure of the molecules containing the B(1,4) bonds only therefore may be more 
attractive to the fibroblasts and allow receptor binding to take place as the cells travel 
through the filter. Variations in charge are also a possible explanation for differences in 
chemoattractiveness, however, the more acidic polysaccharides did not seem to repel 
cell movement. 
The results from both the in vitro cell proliferation and migration studies using ORC 
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The effect of pectin on the migration of L929 fibroblasts. Cells were counted in 20 unit fields at x40 
magnification in triplicate. Results are the means + SEM of 60 replicates. Significant differences are 
indicated by ***p < 0.001 
were sufficiently encouraging to suggest a possible similar mode of action as heparin. 
For this reason ORC 1 was chosen for animal studies initially, however, ORC 2 was 
also included, as it expressed similar effects on proliferation as ORC 1 on different cell 
types and only differed in its effect on migration. 
lOS 
CHAPTER 6 
6. IN VIVO ACTIVITY OF SELECTED POLYSACCHARIDES 
6.1 General Introduction 
A chronic animal model as such does not exist except in the case of the human and for 
practical and ethical reasons other models must be found. Impaired models do exist, 
however, these were not readily available and the appropriate animal licence and 
expertise were also not available. For this reason a simple acute subcutaneous rat model 
was chosen. Although this model has its limitations it was hoped that differences 
between controls and "active" agents could be identified in this model. The rat 
subcutaneous model (method 2.5.2) was constructed by implanting subcutaneously a 
biologically inert matrix made from polyvinyl alcohol (PV A) into the belly of the rat 
followed by injection of the active factor into the matrix. The rat subcutaneous model 
described above has been used successfully in previous studies to assess the potential of 
certain growth factors to affect wound healing (Davidson et ai, 1985). 
From the previous chapters described thus far in this thesis, it was apparent that ORC 
oligosaccharides had similar in vitro effects to heparin both in proliferation and 
migration studies and so this chapter describes the action of heparin and ORC on the rat 
subcutaneous implant model. Future studies may look at the other oligosaccharides 
produced, however, due to time constraints and limits to the number of animals 
available, these studies were not possible at the time. 
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6.2 Introduction to the Study 
In this study, heparin and ORC (I) & (2) were chosen for in vivo in the rat subcutaneous 
implant model. Heparin was the first polysaccharide tested for its effect on the healing 
response in an animal model as previous evidence (McPherson et ai, 1988) suggested 
that addition of heparin to a collagen suspension which was subsequently injected into 
guinea pig dermal wounds, produced an infiltration of fibroblasts and elicited the 
formation of granulation tissue as compared to the collagen alone. This study used an 
inert matrix to inject the potential active oligosaccharide into as the effect of the 
oligosaccharide on its own was to be assessed first before including it within a collagen 
matrix. 
The in vitro study documented in Chapter 4 supported previous in vitro results (Ferrao 
& Mason, 1993; Westergren-Thorsson et ai, 1991). This study will attempt to confirm 
previous in vivo results (McPherson et ai, 1988) using a different animal model. 
ORC (I), like heparin, inhibited the proliferation of L929 fibroblasts and was 
chemotactic to L929 cells and so it was felt that since its in vitro effects were similar to 
heparin, it may behave like heparin in vivo. ORC 2 was also included as it expressed 
similar effects on proliferation of certain cells as ORC 1 and only differed in its effect 
on migration. 
6.3 Rat Subcutaneous Implant Model 
The rat subcutaneous implant model (method 2.5.2) was used as it is easy to carry out 
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and assess the results. Another advantage is that both the control and the test sample can 
be assessed on the same animal. Other models, such as the pig full-thickness wound are 
available, however, it is expensive to set up this kind of experiment and trained staff are 
needed to carry out the surgery. The pig model does provide a better chronic wound 
model as full-thickness skin sections are cut out, whereas in the rat, the test samples are 
placed under the dermis between the panniculus carnosus and the body musculature. 
The rat subcutaneous model used in this study gives an indication of the invasion of 
cells such as fibroblasts in the inert PV A sponge, as well as any vascularisation taking 
place. The degree of inflammation caused by adding a foreign substance can also be 
detected by the number of white blood cells present. The pig model, however has 
benefits in that the degree of granulation and re-epithelialisation can be observed in the 
healing wound. In this study however, this initial aim was to discover if recruitment of 
cells in to the PV A matrix could be aided by the test oligosaccharides. Future work 
could look at the effect of any successful samples in conjunction with collagen in the rat 
model or in the pig model. 
After completion of the experiments carried out as described in Method 2.5.2, the PV A 
sponges were removed, wax-embedded and sectioned according to Method 2.6. Each 
sample was sectioned in triplicate and stained with haemotoxylin to visualise cell nuclei 
(blue-black colour) and eosin to visualise cell cytoplasm and connective tissue 
(pink)(method 2.7.1). Microscopic analysis of the samples was undertaken to assess the 
degree of inflammation by the presence of monocytes, neutrophils and macrophages 
(Method 2.8). 
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6.4 In Vivo Activity of Heparin 
Three concentrations of heparin (1, 10 & 50 Ilg/ml) were used in this study and each 
concentration was injected into 5 rats for comparison at day 7 and day 10 after 
wounding. Low concentrations of heparin (1,10 & 50 Ilg/ml) were used in this study as 
previous results using amounts of heparin up to 30% w/w of the matrix resulted in 
severe haemorrhaging in the rats (personal communication K. Broadley). Data from 
Chapters 4 & 5 suggested that heparin at concentrations less than 10 llg/m1 would be 
the most effective to use, however it was thought that during injection into the rat, some 
heparin may be lost into surrounding tissue and so higher concentration were included 
to take this into account. The results (Table 6.1; method 2.8) indicated that treatment 
with the 1 ug/ml sample of heparin had no effect on granulation tissue formation at Day 
7, but had an overall inhibitory effect at Day 10 by visual analysis, however, statistics 
show that neither day 7 or 10 were significantly different from each other (p = 0.5). The 
10J1g/ml sample however demonstrated visually a stimulation of granulation tissue 
formation at Day 10 where there was no apparent effect at Day 7. Statistical analysis 
confirmed a significant difference between the two days (p = 0.05). The 50 J1g/ml 
injection of heparin demonstrated visually a convincing stimulatory effect on the 
formation of granulation tissue at both 7 and 10 days, although neither day was 
significantly better than the other by statistical analysis (p = 0.34). The histology slides 
were independently assessed by two other observers and their results are included in 
Table 6.1. (also see Fig 6.1). The photographs in Figure 6.1 clearly show a difference 
between the control sponge and that injected with SOIlg/ml heparin. Two control 
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Day of sacrifice & No. of animals Observer No.1 Observer No.2 Avenge ratios of Effect 011 wOUld 
concentration of Ratios Ratios Observers healing 
heparin Pos Neg Zero Pos Neg Zero Pos Neg Zero 
7 days at 1 J.1g1ml 4 1 3 4 4 1 3 2.5 2 3.5 No effect 
10 days at 1 Jlglml 5 3 5 2 3 5 2 3 5 2 Inhibitory 
7 days at 10 Jlglml 4 2 4 2 1 2 5 1.5 3 3.5 No effect 
10 days at 10 J.1g1ml 5 6 2 2 5 1 4 5.5 1.5 3 Stimulatory 
7 days at SO Jlglml 5 4 2 4 5 2 3 4.5 2 3.5 Stimulatory 
10 days at 50 J.1g1ml 4 6 1 1 6 0 2 6 0.5 1.5 Stimulatory 
--
Table 6.1 : Histology results for heparin at 1, 10 & 50 Jlglml which was injected subcutaneously into rats with PV A sponges. Results 
are expressed as positive, negative or zero ratios after comparison of control values to experimental samples. Positive ratios 
showed better granulation tissue formation than controls, negative ratios were the converse and zero ratios were no different 
to controls. 
---
Figure 6.1 Influence of heparin on th Ii mlati n f gr nu I ti n ti u 
in vivo. (a) PBS and (b) heparin at 50 ~.glml w r implant d in 
the rat subcutaneous mod I and harv t d at I d p t-
implantation as describ d in th M th d . Ma ni ri ati n 1. 1 . 
photographs and 2 test photographs were taken per animal and this is an example of the 
results obtained. 
It is difficult to quantify these results as the analysis was subjective, however an overall 
impression can be formed on the ability of the polysaccharides to enhance the formation 
of granulation tissue. Future work may investigate the ability of Image Analysis to carry 
out the analyses in a quantitative fashion which would allow the method to be validated 
and therefore reproducible. 
6.5 In Vivo Activity of ORe Fragments 1 & 2 
6.5.1 Introduction 
ORC fragments, derived from the Johnson & Johnson product, Surgicel® were also 
tested on the rat subcutaneous implant model as they demonstrated comparable in vitro 
characteristics to heparin( excluding ORC 2 which was used as a comparator to ORC 1 
(see chapter 4). Sponges injected with ORC (1) were unfortunately sectioned in the 
wrong orientation by Stirling Royal Infirmary and so could not be analysed 
histologically. ORC (2) at concentrations of 1 and 10J-lglml were chosen based on the 
proliferation results (chapter 4). The use of ORC in vivo was not expected to cause any 
adverse effects on the animal (Daniels et aI, 1981), as it both a haemostat and an 
adhesion prevention barrier. The doses used here are clinically much lower than when 
used in these indications. 
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6.5.2 Results 
The histology results obtained for the ORC 2 fragment by two independent assessors 
indicated that there was a high degree of inter animal variation (Table 6.2). This was 
particularly obvious in the 1 J.lglml Day 7 and the 10J.lglml Day 10 results. Indeed in the 
latter data set, two of the five animals exhibited a distinct inhibitory effect whilst 
another two indicated the fragment to be stimulatory. There was also an obvious intra 
animal variation, although this was not as distinct as the variation between animals. In 
many of the animals, there were differences in the extent of cellular invasion between 
the sponges implanted at the top of the rat and those at the bottom, although this 
observation was not restricted to either of these areas. Visual analysis claimed the 
1 J.lglml sample of ORC (2) to have an overall stimulatory effect on granulation 
formation, however, statistical analysis of results obtained at day 7 and day 10 proved 
there was in fact no difference to control levels (p = 0.34). 
6.6 Immunostaining of PV A Sponges 
6.6.1 Introduction 
In order to improve subjective assessment of 'newly' formed granulation tissue on a 
gross basis, it is believed that the ability to assess the cell types present in these tissues 
would give a better insight into the response to the agents added into the sponges (eg) 
inflammatory versus matrix components (i.e) collagen and fibroblasts. For this reason 
immunostaining of the sectioned sponges was carried out. 
No method existed previously to immunostain wax-embedded sections of PV A sponges 
and so this had to be developed in this study. A range of antibodies at different dilutions 
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Day of sacrifice No of animals Observer No.1 Effect on wound 
and concentration Ratios bealing 
of ORe (2) Pos Neg Zero 
7 days at 1 Ilg/ml 4 5 3 0 Stimulatory 
10 days at 1 J,lg/ml 5 2 3 5 
No effect 
7 days at lOJ,lg/ml 4 3 3 2 
No effect 
10 days at lOllglml 5 4 5 1 
No effect 
Table 6.2 : Histology results for ORe (2) at 1 & lOllglml which was injected 
subcutaneously into rats implanted with PV A sponges. Results are 
expressed as positive, negative or zero ratios after comparison of 
control values to experimental samples. Positive ratios showed better 
granulation tissue formation than controls, negative ratios were the 
converse and zero ratios were no different to controls. 
were employed to discover the optimal concentration for detection of the above 
components (methods 2.7.3 & 2.7.4) 
6.7 Detection of Cells by Immunocytochemistry 
Immuncytochemical analysis was carried out on sections of PV A control samples and 
PYA + 50 J.lglml heparin sections (as in Figure 6.1}.Various dilutions of the primary 
antibodies (rabbit anti-Iaminin (Serotec), MeA 341 (Serotec) for monocytes and 
macrophages & MCA 276 (Serotec) for endothelial cells) were added. The 
appropriate secondary antibodies which were labelled with FITC were added after a 
suitable incubation period. For each sample a control containing the secondary 
antibody only was also included (method 2.7.4). 
The controls containing the secondary antibody alone however demonstrated a high 
background staining and this posed difficulties for picking out fluorescent cells due to 
the non-specificity of the secondary antibody. Further studies would involve 
detennining ways to reduce the non-specific binding. One method could to block the 
sections with non-immune serum from an animal, such as sheep, before antibody 
staining in order to block some of the non-specific binding sites. Optimising the 
antibody dilutions used for these sections could also be developed as time was limited 
in this study for that specific purpose. Fluorescence levels detected in this study were 
very low with exposure times of up to 2 minutes. This suggests that binding of the 
antibodies to the cells was poor and so further development of incubation times and 
methods for improving the penneability of the cells to the antibody could be carried out 
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to optimise this technique. 
6.8 Conclusions 
The result of the subcutaneous implant study indicated that at concentrations of 10 and 
SOug/ml, heparin did stimulate the formation of granulation tissue within the PV A 
sponge. This effect was also observed by McPherson et ai, (1988) in the guinea pig 
dermal wound model using collagen suspensions containing heparin at 300ug/ml of 
suspension. This study, however, demonstrated an effect on granulation tissue 
formation at much lower concentrations of heparin than McPherson used, but this may 
be due to the different sources and molecular weight of the heparins used or even the 
difference in species used for the study. 
McPherson injected the heparin in conjunction with collagen suspension. Previous work 
he carried out suggested that injecting less than 30J.lglml of heparin would have no 
effect on cell invasion and injecting more than 3mg/ml heparin would cause 
haemorrhaging in the animal. It is likely therefore, that this study could have 
investigated higher concentration of heparin without having a detrimental effect and 
may even have given better cell invasion that shown at SOJ.lglml heparin. 
The ORC (2) results were so variable that no conclusions could be made unless the 
experiment was repeated. The trend demonstrated by the results, however, suggested 
that the ORC had no effect on granulation tissue formation at the concentrations tested. 
Given additional time, it would have been interesting to take this study further by 
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looking at different doses of the polysaccharides and also looking at impaired animal 
models such as the diabetic mouse model. It would also have been exciting to 
investigate the in vivo effects on the other polysaccharide fragments prepared, such as 
chondroitin sulphate as the 5 min digest in particular had a significant effect on the 
proliferation of cells in vitro. Future work might also entail validating the method of 
histological assessment by using image analysis software. 
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CHAPTER 7 : CONCLUSIONS 
A number of studies both in vitro and in vivo have suggested a possible role of 
oligosaccharides in wound healing processes (West et ai, 1985; McPherson et ai, 1988; 
West & Kumar, 1989; Westergren-Thorsson et ai, 1991; Ferrao & Mason, 1993), 
however little is still known about the possible effects of these and other 
oligo saccharides on cells that are directly involved in the wound healing process. The 
present study has investigated the actions of several different intact GAGs, together 
with oligo saccharides generated from the intact molecules, both on cells in vitro and in 
animal models. The study also included the assessment of some GAGs previously 
investigated by other groups in order to compare them to those isolated in this study. 
The aim was to select a bioactive oligosaccharide which could assist in, or stimulate the 
healing of chronic wounds. The main thrust of these studies was to assess the 
bioactivity of the oligo saccharides per se, although sometime was spent on the delivery 
of these moieties from PV A sponges in animal models. 
Previous work by West & Kumar (1989) showed that HA oligosaccharides with a size 
range between 3 and 16 disaccharide units in length stimulated the proliferation of 
BABe cells. This effect was also seen in this study with HA (Smin) fragments with a 
average size range of 5 disaccharides and with CS (Smins) with an average size range of 
10 disaccharides. Proliferation may have been induced by the modulation of other 
growth factors already present in the system or perhaps due to the synthesis or 
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formation of the extracellular matrix being affected (West & Kumar, 1989). West & 
Kumar also presented evidence for a hyaluronate receptor on BABC cells and showed 
these cells were able to endocytose both low and high weight HA, however, the 
specificity of the endothelial cell receptor reported in this study may differ from that 
reported by West & Kumar in that it is also might be specific to chondroitin sulphate, a 
phenomenon also reported by Laurent et aI, (1986). 
L929 fibroblasts were stimulated to proliferate by CS (Smin) and CS (24h) digests, 
however the other HA & CS samples had no effect on this cell type. Human dermal 
fibroblasts were also stimulated to proliferate by CS samples, however, one HA digest, 
HA (Smin), also had a significant effect on this cell type. Stimulation may result from 
the induction of growth factors or inactivation of growth inhibitors present in the serum 
or those produced by the cells themselves (Westergren-Thorsson et aI, 1989). 
The differences observed in stimulatory activity on similar cells isolated from different 
sources may be due to the number of specific receptors on the surface of the cells (Culty 
et aI, 1992) and the affinity of the receptors to the size of the oligosaccharides added 
exogenously (West & Kumar, 1989). Although not investigated in this study, another 
contributing factor may be that L929 cells are transformed cells, whereas the human 
dermal fibroblasts used in this study were normal primary cells. The state of the cell can 
effect its reaction to exogenously added GAGs as shown by Matuoka et ai, (1984) 
Heparin had an inhibitory effect on the proliferation of all cell types tested in this study, 
however the degree of inhibition was dependant on the concentration added. At 
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concentrations above 10J.1g/ml, inhibition was evident. Suppression of growth may be 
due to the heparin acting directly on the cells, however, it may also activate growth 
inhibitors or prevent growth factors from binding to cell receptors. Previous findings 
(Westergren-Thorsson et ai, 1991) suggested that the inhibition shown by heparin may 
be due to the high content of sulphate and L-iduronate in the molecule., however ORe 
(1), an unsulphated molecule, also inhibited various cell types in this study. On closer 
examination of the structure of heparin and ORe (1), it is apparent that both molecules 
contain 6(1, 4) links as opposed to the 6(1, 3) links seen in HA and es. This may 
provide one reason as to why these GAGs produce different in vitro results from HA 
andeS. 
The cell types employed in this study were chosen because they were readily available 
and easy to grow, however, in order to obtain results which would be directly 
comparable to the in vivo situation, it would have been useful to look at primary cells 
isolated from rats (ie) rat skin and wound fibroblasts and rat endothelial cells. Rat 
wound fibroblasts were cultured during the study, however further work was required to 
optimise growth conditions before using them in a screening assay. Human dermal 
fibroblasts were employed in their place as they were primary cells and their results 
from the in vitro studies could more readily be compared to any future clinical trials in 
humans 
The migration assay was applied in this study to try and identify oligosaccharides which 
would stimulate the migration of fibroblasts but may not have had any effect on the 
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proliferation of these cells in vitro. Attraction of wound repairing cells into the wound 
area is obviously vital for repair to take place, however the results demonstrated that 
only heparin and ORC (1) and pectin had the ability to do this in vitro, while HA, CS 
and ORC (2) did not. Previous findings also show heparin to be chemotactic for 
capillary endothelial cells (Azizkhan et ai, 1980) within the same concentration range 
studied in this thesis. 
The common feature between the stimulatory GAGs is again the presence of 6(1,4) 
links. This suggests that alignment and structure of the molecule is important in the 
chemoattraction of L929 cells by GAGs. The results also demonstrate that migration is 
highest when low concentrations of heparin and ORC (1) are used. When compared to 
the effect of these concentrations in the proliferation assay, it appears that no effect on 
cell proliferation was seen at these low values. These results indicate that the 
concentration of GAG added is important to achieve stimulation of migration and to 
prevent inhibition of proliferation. 
Pectin both stimulated L929 cells to both proliferate and migrate. The migration was 
enhanced at all concentrations tested, however more work is required to investigate the 
optimal concentration for migration. Within the range tested, a dose response was not 
evident. Due to these effects, pectin has the potential to be a cheap and readily available 
polysaccharide to use in the treatment of wounds, however due to time constraints in 
this study, in vivo studies could not be carried out to measure its effect. 
The animal studies undertaken were limited due to time. Based on in vitro results, only 
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two GAGs were investigated - heparin and ORC. The in vivo studies proved 
problematic in that the results were subjective and could not be easily quantitated, 
however, the difference between no effect and a positive effect in some cases were very 
obvious in the amount of fibrin and granulation tissue laid down. 
The addition of heparin (IOllg & 501lglml) caused a significant increase in the amount 
of granulation tissue laid down within the PV A sponge, with the 50llglml heparin 
causing a significant increase at Day 7 as well as Day 10. Heparin is also known to 
potentiate angiogenesis in vivo (Taylor & Folkman, 1982), however no staining of 
endothelial cells was undertaken in this study to confirm this finding. Currently, heparin 
co-adminstered with bFGF (an endothelial cell mitogen), is being studied for its 
angiogenic effect in healing wounds as heparin is known to potentiate the effect of 
bFGF in vitro (Thorton et ai, 1983). The addition of growth factors in conjunction with 
oligosaccharide fragments therefore may be an area of investigation for future work. 
In relation to the in vitro results demonstrated by heparin, the proliferation of fibroblasts 
was inhibited as also demonstrated by Ferrao & Mason, (1988) and Westergren-
Thorsson et ai, (1991), however there was no effect on endothelial cells at these 
concentrations (E. Lorimer, personal communication). Migration was stimulated by 
lOJlglml of heparin but there was no effect at lOOJlg/ml heparin. It seems likely that the 
presence of higher concentrations of heparin may be needed in vivo as the injection of 
the sample may not all be absorbed by the PV A sponge causing leakage into the 
surrounding tissues. If this is the case, then an injection of SOJlg/ml of heparin may 
result in only 21lg being absorbed (lOOlll injected = 51lg heparin of which 3Jlg may be 
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lost), which is equivalent to the in vitro results shown by the lOlls/ml heparin (21lg 
heparin). The problem, however, with injecting large amounts of heparin into the 
animal is of course the risk of haemorrhaging due to the anti-coagulant activity of 
heparin (Barrowcliffe et ai, 1992). 
The results of injecting ORC (2) into PV A sponges in the animal model were 
inconclusive and further investigation is required. Comparing the in vitro results of 
ORC (1) to those of heparin, one might expect ORC(1) also to show in vivo stimulation 
of granulation tissue formation, however, due to an error in sectioning the ORC(1) 
samples, this experiment could not be completed. It would be recommended that this 
study is repeated in future work, as ORC has the potential to be a cheap and readily 
available polysaccharide to use in the treatment of wounds. 
The results indicated that inhibition of fibroblast proliferation in vitro by heparin did not 
affect the ability of the cells to be chemoattracted and this was supported in the in vivo 
animal model. It was thought initially that stimulation of proliferation would be an 
essential requirement for an oligosaccharide to possess in order for it to be bioactive in 
vivo, however, heparin has shown that inhibition of a particular cell type is not 
necessarily detrimental to its in vivo effect. 
Several significant findings have emerged from the study : selected oligosaccharides 
fragments generated from HA and CS stimulated proliferation of various types of 
fibroblasts and endothelial cells in vitro, however they did not have any effect on the 
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migration of fibroblasts; ORC (1) and heparin both inhibited L929 proliferation at 
concentrations of greater than 100/J.g!ml and stimulated the migration of L929 at 
concentrations of less than 1/J.g!ml; pectin stimulated the proliferation of fibroblasts and 
endothelial cells and stimulated the migration of L929 cells; while heparin encouraged 
granulation tissue formation in wounded rats in vivo. 
Although the in vitro results of both proliferation and migration indicated that several 
oligo saccharides may have a role to play in the process of wound healing, it is clear that 
translating these results directly to the animal situation and further into potential clinical 
efficacy is not an easy task. 
I believe the first step of identifying a number of potential candidates for wound 
stimulation has been completed, but there are obviously a great deal of animal studies 
required to identify a "true" wound stimulating factor for use in the clinic and hospital. 
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CHAPTER8: FUTURE WORK 
8.1 Oligosaccharides 
The in vitro and in vivo studies described in the previous chapters were carried out 
using crude enzymatic digests of the various polysaccharides. Future work should 
investigate large scale production of selective sizes of fragments. Small amounts of pure 
fragments were obtained in this study, however there was not enough produced to 
undertake both in vitro and in vivo screening. Investigation of selective sizes would give 
important information about the size ranges necessary to observe in vitro effects on cell 
proliferation and cell migration of various cell types and granulation tissue formation 
etc. in animal models. 
8.2 Additional In Vitro Studies 
The in vitro studies discussed in this thesis relied on the cell types which were readily 
available and easy to grow. Future studies should look at specific cells from humans as 
this is the final destination for the commercial product. For the purposes of wound 
healing studies, it would be beneficial to have a source of fibroblasts from a human 
wound, however, these may be difficult to obtain. It would also be useful to look at the 
effect of oligosaccharide fragments on human endothelial cells. As the in vivo model in 
this study was based on the rat model, different rat cells could also be sourced. This 
study looked at rat wound fibroblasts initially but they did not grow well in culture and 
were omitted from subsequent investigations. More work into the optimal culture 
conditions would be necessary in order to use these routinely in proliferation studies. 
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Another area of investigation may be to look at the addition of growth factors in 
conjunction with oligosaccharide fragments, as previous evidence using heparin in 
conjunction with bFGF has been shown to be angiogenic in vitro (Thorton et ai, 1983). 
8.3 Animal Models 
The aIm of this thesis was to produce a collagen sponge containing a bioactive 
oligosaccharide fragment. Due to time constraints, no in vivo studies were carried out 
using these collagen sponges to assess the effect of the fragments, however initial 
studies were carried out on inert PV A sponges. Future work should investigate the 
addition of collagen, as it is important to assess how the collagen and fragments interact 
independently and together in vivo. 
Future work may involve carrying out in vivo studies on other types of animal models 
such as the pig excisional wound model (paresio, 1994) or impaired wound models. The 
pig model is a suitable model as the healing more closely resembles that of humans. 
Such models have been used extensively to test wound dressings (in house ; Paresio, 
1994), however, the most appropriate model would be full or partial thickness wounds 
to better simulate an impaired wound and this could be carried out possibly using 
diabetic pigs. 
8.4 Histological Evaluation 
This thesis briefly investigated staining the different cell types present in sections of 
implanted PV A sponges impregnated with heparin. More work is needed to develop the 
methods to determine what cells are being recruited into the wound as this can give 
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important infonnation regarding the inflammatory response and presence of granulation 
tissue in the wound. Several antibodies are available to cells and extracellular matrix 
molecules involved in the wound healing process, therefore work is needed to optimise 
the concentrations of antibodies which will give adequate staining of the antigens 
concerned. Several methods of visualising the cells could be developed further such as, 
immunostaining & immunofluorescence. 
Further work is also necessary on the visual analysis of the histological sections. In this 
thesis, it was a subjective assessment using a grading scale of 1-5, however, it may be 
possible to develop a method via an Image Analysis system to count specific cell 
numbers or calculate percentage areas of granulation tissue observed. This would give 
quantitative analyses of the sections which could be validated for others to use in the 
future. 
8.S ORC and Chondroitin Sulphate 
Johnson & Johnson now have patents for collagen sponges containing ORC, CS and 
ORC fragments. This now gives scope for developing the work already carried out on 
these oligosaccharides into a commercial product that has intellectual protection. 
Currently, a clinical trial is being set up in which collagen sponges containing ORC are 
being tested. Following the results of the trial, it is hoped that the product will be 
launched commercially. 
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